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1 ZINC(II)CYCLEN COORDINATION TO UTP, TTP OR 
PYROPHOSPHATE INDUCES PYRENE EXCIMER EMISSION 
 
 
 
 
 
 
 
Pyrene labelled Zn2+-cyclen 1 and bis-Zn2+-bis-cyclen 2 complexes were synthesized. The 
reversible coordination at physiological pH of Zn2+-cyclens to phosphate anions and to imide 
moieties, as present in thymine and uracil nucleotides, is well known. In the presence of 
analytes bearing a phosphate and an imide or two phosphate groups the formation of a ternary 
complex consisting of two pyrene-labelled metal complexes and the analyte molecule, is 
observed. The close proximity of the pyrene labels in the complex induces pyrene excimer 
emission, which is observable by the unarmed eye. By this, the presence of UMP, UDP, UTP 
and TTP in buffered aqueous solution is signalled, while other nucleotides are not able to 
induce excimer emission. In the same way, Zn2+-Cyclen-pyrene acts as luminescent 
chemosensor for PPi and Fructose-1,6-bisphosphate in aqueous buffer.  
 
Florian Schmidt, Stefan Stadlbauer and Burkhard König, Dalton Trans. 2010, accepted. 
 
Synthesis of compound 1 and investigations were performed by F. Schmidt. S. Stadlbauer provided compound 2 presented inhere. 
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1.1 INTRODUCTION 
Nucleotides are the building blocks of DNA- and RNA-biopolymers, which store the genetic 
information of an organism and provide the blueprint of protein biosynthesis.1 The selective 
recognition of specific nucleotides is a prerequisite for all processes they are involved.  
Protein nucleotide receptors fulfil this important task in cell biology:2-12 The nucleotide 
receptors P1- and P2 bind mainly ATP and UTP.6 By this, P1-type receptors are regulating 
specific ATP transporters that are responsible for the release of ATP into the extracellular 
space.6 Furthermore, P2X-type receptors are known as mainly ATP controlled Ca2+-channels.6 
Receptors of the P2Y-subtype are G-protein coupled and show mainly ATP selectivity.6 The 
endogenous Ras-like proteins A (RalA) and RalB, which are both GTPases, were identified to 
be specific GTP binders and are by this responsible for GTP-dependent exocytosis.12 The 
membrane fusion protein Synexin (Annexin VII) was suggested to be a Ca2+-conditional GTP 
binding protein whose fusion activity is substantially enhanced upon GTP binding and 
deactivated by GTP hydrolysis.11  
Inspired by the biological models artificial systems for nucleotide recognition and 
detection have been investigated, mainly targeting adenosine and guanidine nucleotides. 
Bioluminescence assays,13 enzyme-coupled electrochemical sensors,14-16 fluorimetric and 
colorimetric approaches17-23 have been described for ATP detection. Recently, Yoon et al.24 
reported a pincer-like bis-pyrene ligand that binds to the phosphate moiety of NTPs, but only 
addition of ATP changed the excimer emission. Another colorimetric sensor for ATP was 
published by Soto et al.25 based on 1,3,5-triarylpent-2-en-1,5-diones. The corresponding 
pyrylium dye changes color from yellow to red in the presence of PPi and to magenta, when 
ATP is added. Only the response to GMP and ADP was reported. A selective GTP receptor 
was reported by Chang et al.:26 The emission of a benzylimidazolium dye at 540 nm increases 
up to 80-fold when GTP is added, while all other nucleotides had little or no effect. Kwon et 
al.27 presented a symmetrical, benzene-based tripodal imidazolium receptor coordinating the 
nucleotide. The addition of GTP quenches fluorescence intensity, while the addition of ATP, 
ADP or AMP enhances the fluorescence intensity. 
The number of reported receptors which are selective for uracil- or thymine 
nucleotides is much smaller.28-29 Zeng et al.30 published a 1,7-bis-pyrene-Zn2+-cyclen complex 
coordinating to the imide unit of the nucleobase. A protonated amino group of the receptor is 
proposed to coordinate to the anionic phosphate unit bringing the pyrene units in close 
proximity which results in enhanced excimer emission. The authors report good selectivities 
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even in the presence of other nucleotides, but all investigations were performed in 
MeCN/HEPES (1:9) and MeCN/Tris-HCl (1:9) mixtures. Another TTP-sensor was described 
by Kwon et al.31 They use the FRET-pair FIrpic-Zn2+-DPA, an acceptor with preference for 
the triphosphate moiety and mCP-Zn2+-cyclen, a donor binding the imide-anion to signal the 
presence of TTP in a nucleotide-induced 1:1:1-ensemble. A drawback is the required excess 
of FIrpic-Zn2+-DPA (2 equiv.) for quantitative observation of FRET-based emission of the 
Ir(III)-complex, as otherwise 2:1- ensembles of only mCP-Zn2+-cyclen and TTP are also 
possible. 
 
We report the differentiation of nucleotides using only one single sensor molecule:  
Zn2+-Cyclen-pyrene 1 or Bis-Zn2+-bis-cyclen-pyrene 2. Both compounds are able to interact 
via reversible coordination with phosphate- and imide-moieties and therefore form ternary 
complexes with uracil- and thymine-based nucleotides in HEPES buffer at physiological 
conditions. Other analytes that induce the formation of 2:1 aggregates are PPi and Fructose-
1,6-bisphosphate.  The ternary complexes are easily detected due to an increase in pyrene-
excimer emission at 500 nm, while the monomer emission at 400 nm decreases.  
 
 
1.2 RESULTS & DISCUSSION 
 
1.2.1 Design and Synthesis of Pyrene Zn2+-cyclen Complexes 
Zn2+-cyclen complexes are known for their affinity to phosphate anions 32-35 and imides.32, 34-
37 The pyrene functionalized Zn2+-cyclens 1 and 2 (Figure 1) were expected to coordinate to 
Pyrophosphate, Fructose-1,6-bisphosphate, uracil- and thymine-nucleotides with binding 
affinities for the mononuclear Zn2+-cyclen complexes at physiological conditions in the 
millimolar range.32, 36, 38 A stoichiometry of 2:1, Zn2+-cyclen complex to anion is foreseen for 
both complexes 1 and 2.39 Moreover, compound 2 is expected to show enhanced binding 
affinity for phosphate anions and imides resulting in increased sensitivity.37 In such ternary 
complexes, e.g. 12-UTP (Figure 1), the two pyrene fluorophors are in close proximity and thus 
enhanced excimer emission at about 500 nm is expected upon excitation at 360 nm. 
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Figure 1: Receptors 1 and 2 and the proposed binding motif for 12-UTP 
 
 
Amino-group bearing cyclen derivatives 440-41 and 542 as well as Pyrene-1-carboxylic acid 343-
44 were synthesized as precursors for the preparation of 1 and 2 according to literature known 
procedures. 
As shown in Scheme 1, Zn2+-Cyclen-pyrene 1 was prepared from 3 and 4 by amide bond 
formation using standard peptide coupling conditions (TBTU and HOBt, Method A) or 
conversion of 3 into the acid chloride by treatment with Thionyl chloride (Method B).45 For 
the coupling of 5 and 3 to 7 only Method A was used. 
Boc protecting groups of the cyclen ligands were removed under acidic conditions. 
Deprotonation of the hydrochloride salts with a basic anion exchanger gave the free amine 
cyclen ligands, which were reacted with either 1 or 2 equiv. of Zn2+-salts, respectively. 
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Scheme 1: Synthesis of pyrene-metal-chelates. a) TBTU, HOBt, DIPEA, dry DMF/DCM (Method A); b) 
SOCl2, DMF (Method B); c) DMAP, DIPEA, dry DMF/DCM (Method B); d) HCl-Et2O, DCM, basic anion 
exchanger; e) ZnCl2, MeOH, H2O; f) Zn(ClO4)2, MeOH, H2O 
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1.2.2 Fluorescence Screening of Nucleotides 
The emission response of 1 and 2 to the presence of adenine, cytosine, guanine, hypoxanthine, 
thymine and uracil nucleotides, Ortho- and Pyrophosphate (Pi, PPi), thymidine-dimer (TpT), a 
pentameric ssDNA sequence (pTACCG) and Fructose-1,6-bisphosphate was investigated in a 
well plate format assay in buffered solution (HEPES 50 mM, NaCl 154 mM, pH 7.4, 25°C). 
Solutions ([analyte]well = 0.17 mM) of each analyte were mixed with solutions of compounds 
1 and 2 ([1]well = [2]well = 0.33 mM) in a stoichiometric ratio of 1:2 and the emission spectra 
were recorded at an excitation wavelength of 360 nm. UDP, UTP and TTP containing 
solutions exhibit enhanced excimer emission at about 500 nm, while the monomer emission at 
400 nm decreased in comparison to the other samples. The change in emission wavelength is 
observable by the naked eye as a color change from blue to turquoise (Figure 3). Compound 1 
shows, in addition, enhanced excimer emission with added UMP, PPi and Fructose-1,6-
bisphosphate, while IDP and ITP induce pyrene excimer formation with compound 2. To 
evaluate the screening results more quantitatively, we compared the excimer-to-monomer 
emission ratio of both pyrene-metal-chelates in the presence and in the absence of the analyte 
to obtain the enhancement factor Ffe. 
 
blanknm
nm
analytenm
nm
fe F
F
F
F
F 







 404
500
404
500     Equation 1 
 
As shown in Figure 2, an about 20-fold enhancement of excimer-to-monomer emission ratio 
for compound 1 is observed upon addition of TTP, UDP, UTP or PPi. The largest change of 
about 25-fold is induced by PPi. UMP is the only NMP enhancing the ratio (fourfold). 
Moreover, Fructose-1,6-bisphosphate results in a 5-fold enhancement of Ffe. All other tested 
compounds only lead to comparably small changes in the emission ratio of compound 1.46 
Compound 2 turned out to be less selective in nucleotide binding as beside TTP, UDP and 
UTP, also IDP and ITP induced an increase of Ffe. However, the addition of PPi, UMP or 
Fructose-1,6-bisphosphate did not affect the emission ratio.47 The interaction of Zn2+-Cyclen 
with the deprotonated amide N(3)–H of Inosine has been reported with a binding affinity of 
log K = 4.2 at pH 8.6.36 The data support the observed IDP and ITP induced excimer 
formation.48 The interaction between Zn2+-cyclen binding sites and nucleotides correlates to 
the overall negative charge of the anions: Triphosphates have a much higher affinity to the 
6 
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metal complex binding sites and induce therefore much larger changes in the monomer-
excimer emission ratio than monophosphates. 
In addition, fluorescence quantum yields of compounds 1 (ΦF = 0.11 ± 0.02) and 2 (ΦF = 0.30 
± 0.04) alone and in combination with several analytes inducing either excimer emission or 
not were determined in a well plate format assay. Addition of not excimer inducing 
nucleotides to compound 1 generally increased the quantum yield: ΦF, AMP = 0.22 ± 0.03 
> ΦF, CMP = 0.19 ± 0.03 > ΦF,GMP = 0.13 ± 0.02; the same trend was reported in literature.49 
For compound 2, a similar trend was observed: ΦF, AMP = 0.30 ± 0.04 > ΦF, CMP = 0.28 ± 0.04 
> ΦF,GTP = 0.20 ± 0.03; however, in general fluorescence quantum yield of 2 was not 
increased by addition of any analyte. For excimer inducing nucleotides, compound 1 did not 
show any significant change in quantum yield (ΦF, UMP = 0.12 ± 0.02, ΦF, UTP = 0.11 ± 0.02). 
A nucleobase dependent trend can not be derived, as only uridine and thymidine phosphates 
amongst all nucleotides induce excimer emission. In contrast, for compound 2 the 
fluorescence quantum yields were found to decrease by addition of excimer inducing 
nucleotides such as ITP and UDP: ΦF, ITP = 0.18 ± 0.03, ΦF, UDP = 0.19 ± 0.03. Also in this 
case, a nucleobase dependent trend is hardly observed. (For spectral data see Supporting 
Information) 
 
 
a 
 
b 
Figure 2: Visible emission changes of the screening experiment. (a) 0.33 mM Zn2+-Cyclen-pyrene 1 and (b) 
Bis-Zn2+-bis-cyclen-pyrene 2, respectively, in the presence of 0.5 equiv. of analyte upon excitation at 316 nm; 
turquoise emission indicates excimer formation initiated by analyte (2:1 binding event), bluish emission 
indicates absence of excimer; photographs taken on a PeqLab Superbright UV table with a Canon EOS 450D 
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Figure 3: Change in fluorescence enhancement factor Ffe of compounds 1 and 2 upon addition of 
phosphate ions. 0.5 equiv. of analyte was mixed with 1 equiv. of compound 1 (black) or compound 2 (white); 
all screening experiments were done in aqueous HEPES buffer at a concentration of [1] = [2] = 0.33 mM and 0.5 
equiv. of each analyte 
 
 
1.2.3 Fluorescence Titrations 
Based on the screening results, fluorescence titration experiments were performed to 
investigate binding affinity, stoichiometry and possible cooperative effects of our system. 
Pyrene-metal-chelate 1 and 2 were titrated under identical conditions with the most 
representative analytes identified in the screening. Figure 4 shows a typical titration curve for 
compound 1 and PPi initiating the excimer formation. The initial induction period of the 
titration curves indicates cooperative binding. Titration curves reach a maximum of emission 
change at 0.5 equiv. of added analyte. Addition of more than 0.5 equiv. of the analyte leads to 
decreasing values. This can be explained, as the addition of further analyte is disrupting the 
excimer-emitting ternary 2:1 complexes of pyrene-metal-chelate and analyte and successively 
changing them to monomer-emitting 1:1-aggregates. However, disruption of 2:1-aggregates is 
a less favorable process compared to their formation indicated by non-symmetric curve 
progression. Non-linear fitting methods (Hill-equation, Equation 2) were applied to extract 
binding affinities in the range of 10–4 – 10–5 M and Hill coefficients (1.7 < nHill < 3.4), 
indicating cooperative effects, from the titration curves (Table S1). Job’s plot analyses 
confirm the expected stoichiometry of 2:1 for aggregates of PPi, UMP, UDP, UTP, TTP and 
Fructose-1,6-bisphosphate with compound 1. Again, the overall charge of the anion 
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determines the stability of the aggregate: Di- and triphosphates lead at a given concentration 
to a more complete formation of the ternary complex than monophosphates, which is seen by 
a more pronounced emission ratio change. (Figures 5, 6, S1-3) 
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Figure 4: Fluorescence titration of compound 1 with PPi in aqueous HEPES buffer (pH 7.4). [1] = 
0.25 mM, [PPi] = 0.5 mM; (a) titration curve (left) and Job’s plot analysis (right); emission spectra for (b) 0.0-0.5 
equiv. and (c) 0.5-1.4 equiv. of added PPi, respectively; (b) successive excimer formation by addition of up to 
0.5 equiv. of PPi; (c) disruption of the 2:1-aggregates by further addition of PPi; due to the finally formed 1:1-
aggregate, pyrene monomer emission 1:1-(1-PPi)-aggregate and 1 itself are not congruent as the bound anion 
also influences the emission of the fluorophor 
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Figure 4 (cont.): Fluorescence titration of compound 1 with PPi in aqueous HEPES buffer (pH 7.4). [1] = 
0.25 mM, [PPi] = 0.5 mM; (a) titration curve (left) and Job’s plot analysis (right); emission spectra for (b) 0.0-0.5 
equiv. and (c) 0.5-1.4 equiv. of added PPi, respectively; (b) successive excimer formation by addition of up to 
0.5 equiv. of PPi; (c) disruption of the 2:1-aggregates by further addition of PPi; due to the finally formed 1:1-
aggregate, pyrene monomer emission 1:1-(1-PPi)-aggregate and 1 itself are not congruent as the bound anion 
also influences the emission of the fluorophor 
 
 
 
0.0
1.0x
10
-4
2.0x
10
-4
3.0x
10
-4
0.0
0.2
0.4
0.6
0.8
1.0
1.2
1.4
1.6
1.8
I e
xc
/m
on
conc. of analyte [mol/L]
 UMP
 UDP
 UTP
 TTP
 Fru
0.5 eq TTP0.5 eq UXP, Fru-1,6-bisP
 
Figure 5: Fluorescence titration of compound 1 with nucleotides and Fructose-1,6-bisphosphate in 
aqueous HEPES buffer (pH 7.4). Titration curves (upper left) and Job’s plot analyses (bottom, left) of 
compound 1 and UMP (R = H), UDP (R = H), UTP (R = H), TTP (R = Me) and Fru-1,6-bisP, respectively; [1] = 
0.5 mM, [UMP] = [UDP] = [UTP] = [Fru-1,6-bisP] = 1.0 mM, [TTP] = 5.0 mM; on upper right side, suggested 
structures of the formed 2:1-aggregates leading to observable excimer emission 
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Figure 5 (cont.): Fluorescence titration of compound 1 with nucleotides and Fructose-1,6-bisphosphate in 
aqueous HEPES buffer (pH 7.4). Titration curves (upper left) and Job’s plot analyses (bottom, left) of 
compound 1 and UMP (R = H), UDP (R = H), UTP (R = H), TTP (R = Me) and Fru-1,6-bisP, respectively; [1] = 
0.5 mM, [UMP] = [UDP] = [UTP] = [Fru-1,6-bisP] = 1.0 mM, [TTP] = 5.0 mM; on upper right side, suggested 
structures of the formed 2:1-aggregates leading to observable excimer emission 
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Figure 6: Emission spectra of compound 1 titrated with UTP. [1] = 0.5 mM, [UTP] = 1.0 mM; left side 
shows successively addition of up to 0.5 equiv. of nucleotide hence, formation of 2:1-aggregates indicated by 
arising excimer and decreasing monomer emission; right side displays disruption of 2:1 stoichiometry observable 
as increase in monomer emission, while excimer emission decreases 
 
The assembly process of the 2:1 aggregate of the nucleotides and 1 is concentration sensitive: 
No induced excimer formation is observed at concentrations of 1 and UTP of 0.10 mM. The 
emission titration indicates the formation of a 1:1 aggregate (Figure 7). As the interaction of 
the charged phosphate moieties of the nucleotide with the Lewis-acidic Zn2+-Cyclen is 
stronger than the imide – metal complex interaction at the pH of the experiments, the binding 
process is dominated by this interaction. The formation of the ternary 2:1 aggregates requires 
a concentration range where phosphate and imide interaction with Zn2+-Cyclen are both 
possible. 
0,1 0,2 0,3 0,4 0,5 0,6 0,7 0,8 0,9 1,0
-0,04
-0,03
-0,02
-0,01
0,00
0,01
0,02
0,03
0,04
0,0 0,1 0,2 0,3 0,4 0,5 0,6 0,7 0,8 0,9 1,0
-0,04
-0,03
-0,02
-0,01
0,00
0,01
0,02
0,03
0,04
 
 
I e
xc
/m
on
*x
co
m
po
un
d 
1
xcompound 1
0.0 0.1 0.2 0.3 0.4 0.5 0.6 0.7 0.8 0.9 1.0
0.0
0.2
0.4
0.6
0.8
1.0
0.0 0.1 0.2 0.3 0.4 0.5 0.6 0.7 0.8 0.9 1.0
0.0
0.2
0.4
0.6
0.8
1.0
 
 
I e
xc
/m
on
*x
co
m
po
un
d 
1
xcompound 1
 UMP UMP
 UDP
 UTP
 Fru-1.6-BisP
1 Zinc(II)cyclen Coordination to UTP, TTP or Pyrophosphate Induces Pyrene Excimer Emission 
 
 
 
 
 
 
400 450 500 550 600
0
100
200
300
400
500
I*
c0 1
/c
t 1 [
 a
.u
.]
 [nm]
 0 eq       2.0 eq   
 0.1 eq    2.5 eq   
 0.2 eq    3.5 eq   
 0.4 eq    7.2 eq
 0.6 eq    9.2 eq
 0.8 eq    47.0 eq
 1.0 eq    49.0 eq
 1.5 eq    59.0 eq
0.0 5.0x10-4 1.0x10-3 1.5x10-3 2.0x10-3 2.5x10-3 3.0x10-3
0
50
100
150
200
250
300
350
I
conc. of UTP [mol/L]
 
Figure 7: Fluorescence titration of compound 1 with UTP at lower concentration. Emission spectra (left), 
corresponding titration curve (right) and Job’s plot of compound 1 (0.1 mM) titrated with UTP (0.5 mM, 
1.0 mM, 5.0 mM) in aqueous HEPES buffer; no excimer is formed as can be derived from the emission  spectra, 
which is furthermore confirmed by the shape of the resulting titration curve and the obtained Job’s plot 
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Titration curves of compound 2 with UDP, UTP, IDP or ITP are analogous to the 
observations for compound 1 and binding constants were found to be about 10–3 – 10–4 M. 
Job’s plot analysis confirms the expected 2:1 stoichiometry. Figure 8 shows the 
corresponding titration curves and Job’s plot analyses. Emission titration spectra are provided 
in the Supporting Information. (Figure S4) 
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Figure 8: Titration of compound 2 with IDP, ITP, UDP and UTP. Fluorescence titration of compound 2 with 
IDP, ITP, UDP and UTP (left); Job’s plot analyses of compound 2 (0.5 mM) titrated with IDP, ITP, UDP and 
UTP (1.0 mM) in aqueous HEPES buffer at pH 7.4 (right) 
 
12 
1 Zinc(II)cyclen Coordination to UTP, TTP or Pyrophosphate Induces Pyrene Excimer Emission 
 
 
 
 
    PPi UMP UDP UTP TTP IDP ITP Fru-1,6-BisP
log Kapp. 4.3±0.1* 3.8±0.0** 4.0±0.2** 3.9±0.5** 3.9±0.1*** 4.0±0.1** --- --- 3.8±0.1** 
nHill 3.4±0.5 2.0±0.1 2.0±0.3 1.7±0.5 1.1±0.1 3.0±0.3 --- --- 1.9±0.1 1 
n 2:1 2:1 2:1 2:1 1:1 2:1 --- --- 2:1 
log Kapp. --- --- 3.8±0.1** 3.7±0.1** --- 3.9±0.1** 3.5±0.5** --- 
nHill --- --- 2.9±0.4 2.5±0.4 --- 2.3±0.3 1.8±0.7 --- 2 
n --- --- 2:1 2:1 --- 2:1 2:1 --- 
 
Table 1: Apparent binding affinities derived from fluorescence titrations of compound 1 and 2 with 
selected anions. * [1] = 0.25 mM,  ** [1] = 0.5 mM, *** [1] = 0.1 mM; for all ternary complexes means ± s.d. 
(range) of binding affinity log Kapp. given in L2/mol2, for binary UTP-1-complex log Kapp. given in L/mol; all 
titrations were repeated at least three times 
 
 
Next, the emission response of a 12-UTP aggregate (1, 0.48 mM; UTP, 0.24 mM) upon 
addition of ATP was investigated. With increasing amounts of ATP a decrease in excimer 
emission occurred, but the addition of 0.5 equiv. of ATP is not sufficient to fully disrupt the 
2:1-aggregates. The addition of 2 equiv. of ATP is necessary to annihilate the excimer 
emission. (Figure 9) 
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Figure 9: Disruption of 12-UTP by added ATP in aqueous HEPES buffer at pH 7.4. Emission spectra (left) 
of (black) compound 1 (blank; [1] = 0.5 mM), (red) 1 with 0.5 equiv. of UTP, (green) 1 with 0.5 equiv. of UTP 
and ATP, respectively, and (blue) 1 with 0.5 equiv. of UTP and 2.5 equiv. of ATP; changes in Ffe (right) 
 
The influence of buffer and pH on the aggregate formation was tested. A titration of 
compound 1 with UTP in TRIS buffer at pH 7.4 gave under identical conditions same results 
as in aqueous HEPES buffered solution (Figure 10). Variation of the pH of the solution 
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between 6.5, 7.4 and 8.0 changes the emission response slightly. Monomer emission of 
compound 1 was found to decrease with increasing pH, while the excimer emission is not pH 
dependent within the investigated pH range (Figure 11). 
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Figure 10: Titration of 1 with UTP in TRIS buffer. Subsequent formation of 12-UTP and disruption by further 
addition of UTP is observed in aqueous TRIS buffered solution. Conditions were identical to that previously 
used for investigations in HEPES buffer. 
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Figure 11: pH Dependence of pyrene monomer and excimer emission. (a) ([1] = 0.5 mM); (b) after addition 
of 0.5 equiv. of UTP, the spectra of 2:1-(1-UTP)-aggregate show only changes in the region of monomer 
emission by variation of pH 
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1.3 CONCLUSIONS 
Titrations of Zn2+-Cyclen-pyrene 1 at specific concentrations in aqueous buffer with 
phosphate anions revealed that the addition of 0.5 equivalents of UTP, UDP, TTP or PPi 
induced a strong increase in pyrene excimer emission observable with the unarmed eye. The 
effect was less pronounced for UMP, GTP and Fructose-1,6-bisphosphate; all other tested 
nucleotides did not affect the excimer emission. We explain the observation by the formation 
of a 2:1 aggregate of 1 and the respective nucleotide or pyrophosphate; the stoichiometry was 
confirmed by Job´s plot analyses. Zn2+-cyclen complexes are known to interact with 
phosphate anions and with imide groups. Nucleotides, such as UTP or TTP, can act as a 
bidentate guest templating the assembly of two complexes 1. This places their two pyrene 
moieties in close proximity, which results in an increased excimer emission intensity. 
Compound 2 shows a different selectivity pattern and increased excimer emission is observed 
in the presence of UTP, UDP, IDP and ITP. Addition of excess nucleotides restored for both 
complexes 1 and 2 the monomer emission by formation of the respective 1:1 complexes.  
Compared to reported FRET-based nucleotide sensing methods that require a separate donor-
acceptor pair for detection, single compounds like 1 or 2 are sufficient under our conditions to 
indicate the presence of a certain nucleotide. The selectivity among the different nucleotides 
is similar or even superior to previously reported fluorescence nucleotide sensors. The easy 
synthetic availability of the pyrene Zn2+-cyclen complexes and the directly to observe excimer 
emission are advantages of the sensing method, while the restricted concentration range is a 
limitation. The induced excimer emission of pyrene-functionalized metal complexes by 
twofold coordination to a bidentate ligand is a simple concept to visualize the presence of 
analytes. Although practical applications of 1 or 2 in nucleotide sensing have restrictions, the 
examples illustrate and confirm the principle of the approach for the luminescent detection of 
complex analytes. 
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1.4 EXPERIMENTAL SECTION 
 
1.4.1 General 
Absorption spectroscopy. Absorption spectra were recorded on a Varian Cary BIO 50 
UV/VIS/NIR Spectrometer by use of a 1 cm quartz cuvettes (Hellma) and Uvasol solvents 
(Merck or Baker). 
Emission spectroscopy. Fluorescence spectra were recorded on a Varian Cary Eclipse 
fluorescence spectrophotometer either by use of a 3 mm quartz cuvettes (Hellma) or in 
wellplates (384 wells; provided by Greiner) and an appropriate wellplate reader. As solvent 
systems, HEPES or TRIS buffered aqueous solutions were used. 
NMR spectroscopy. Bruker Avance 600 (Cryo) (1H: 600.1 MHz, 13C: 150.1 MHz, T = 
300 K), Bruker Avance 400 (1H: 400.1 MHz, 13C: 100.6 MHz, T = 300 K), Bruker Avance 
300 (1H: 300.1 MHz, 13C: 75.5 MHz, T = 300 K). The chemical shifts are reported in δ [ppm] 
relative to internal standards (solvent residual peak). The spectra were analyzed by first order, 
the coupling constants are given in Hertz [Hz]. Characterization of the signals: s = singlet, 
d = doublet, t = triplet, q = quartet, m = multiplet, bs = broad singlet, dd = double doublet, 
ddd = double double doublet. Integration is determined as the relative number of atoms. 
Assignment of signals in 13C-spectra was determined with DEPT-technique (pulse angle: 
135°) and given as (+) for CH3 or CH, (–) for CH2 and (Cquat.) for quaternary Cquat.. Error of 
reported values: chemical shift: 0.01 ppm for 1H-NMR, 0.1 ppm for 13C-NMR and 0.1 Hz for 
coupling constants. The solvent used is reported for each spectrum. 
Mass spectrometry. Varian CH-5 (EI), Finnigan MAT 95 (CI), Finnigan MAT TSQ 7000 
(ESI).  
IR spectrometry. Recorded with a Bio-Rad FTS 2000 MX FT-IR. 
Melting point. Melting points were determined on Büchi SMP or a Lambda Photometrics 
OptiMelt MPA 100. 
TLC analysis and column chromatography. Analytical TLC plates (silica gel 60 F254) and 
silica gel 60 (70-230 or 230-400 mesh) for column chromatography were purchased from 
Merck. Spots were visualized by UV light and/or staining with Ninhydrin in EtOH.  
Dry DMF was purchased from Fluka, Dichloromethane (DCM) was dried by adsorption and 
stored over molecular sieves. Petrol ether (PE) had a boiling range of 70-90°C. All other 
solvents and chemicals were of reagent grade and used without further purification. 
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1.4.2 Binding Studies 
 
1.4.2.1 Fluorescence Screening of Analytes 
The interaction of Zn2+-Cyclen-pyrene 1 or Bis-Zn2+-bis-cyclen-pyrene 2 with Pi, PPi, AMP, 
ADP, ATP, CMP, CDP, CTP, GMP, GDP, GTP, IMP, IDP, ITP, TTP, UMP, UDP, UTP, 
TpT, pTACCG, Fructose-1,6-bisphosphate was investigated in screening experiments in 
buffered aqueous solution (HEPES 50 mM, NaCl 154 mM, pH 7.4, 25°C) using a well plate 
with 384 wells. To a 0.5 mM solution of the metal-complex 0.5 equiv. of each analyte were 
added yielding a volume of 120 µL per well. The final concentrations were 0.33 mM for Zn2+-
Cyclen-pyrene and mM for Bis-Zn2+-bis-cyclen-pyrene, respectively. The emission spectra 
were recorded at an excitation wavelength of 360 nm. 
 
Screening conditions 
Solvent:     HEPES buffer 50 mM, NaCl 154 mM, pH 7.4 
Volume/well:     120 µL; analytepyrenewell VVV   
Zn2+-cyclen complexes:    
mM17.0mM33.0
µL40µL80
mM500mM500 00



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analyte
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pyrene
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analyte
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pyrene
analytepyrene
cc
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.c.c
  
1.4.2.2 Fluorescence Titrations of Representative Analytes 
To a cuvette with 50 µL of a 0.50 mM solution of Zn2+-Cyclen-pyrene 1 in HEPES buffer 
aliquots of an analyte solution were added (PPi, ATP, GTP, IDP, ITP, TTP, UMP, UDP, UTP, 
TpT, pTACCG, Fructose-1,6-bisphosphate). After equilibration for 2 min, an emission 
spectrum was recorded at an excitation wavelength of 360 nm. For determination of the 
binding constants, the obtained fluorescence output was volume corrected, plotted against the 
concentration of added analyte and evaluated by non-linear fitting methods. The 
stoichiometry was investigated by Job’s plot analysis from separate measurements. Therefore, 
for each molar fraction data point the corresponding mixing ratio was prepared anew from 
equimolar solutions of metal complex and analyte. 
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Titration conditions 
Solvent:     HEPES buffer 50 mM, NaCl 154 mM, pH 7.4 
Starting volume:    50 µL 
Conc. (Zn2+-cyclen complexes): 0.10 mM (for 1:1-ensemble 1 and UTP) 
0.25 mM (for PPi) 
0.50 mM (for all other analytes) 
Conc. (analytes):   2 x [compound 1/2] in general; [TTP] = 5.0 mM 
 
In a cuvette 50 µL of a 0.50 mM solution of Zn2+-Cyclen-pyrene 1 in HEPES buffer were 
propounded and 2.5 µL of a 5.0 mM (0.5 equiv.) solution of UTP were added yielding a 2:1 
ratio. Then, 2.5 µL of a 5.0 mM (0.5 equiv.) solution of ATP and finally, a further 2.0 equiv. 
were added. Emission spectra were recorded at an excitation wavelength of 360 nm for each 
data point. 
 
1.4.3 Investigation in Aqueous TRIS buffer 
To a cuvette with 50 µL of a 0.50 mM solution of Zn2+-Cyclen-pyrene 1 in TRIS buffer 
(50 mM, NaCl 0.035 mM, pH 7.4) aliquots of an UTP solution (5.0 mM) were added. Then, 
emission spectra were recorded at an excitation wavelength of 360 nm. The obtained data was 
compared to the results obtained from measurements in HEPES buffered solution.  
 
1.4.4 pH-Dependency of Excimer-Formation and Effect on Cross-Selectivity 
Separate samples at three different pH values (6.5, 7.4 and 8.0) were prepared and emission 
spectra were recorded at an excitation wavelength of 360 nm. Therefore, 50 µL of a 0.50 mM 
solution of Zn2+-Cyclen-pyrene 1 in HEPES with appropriate pH were put into a cuvette. 
Then, 0.5 equiv. of UTP (2.5 µL of a 5.00 mM solution) were added. The obtained spectra for 
different pH values were compared. 
 
1.4.5 Determination of Fluorescence Quantum Yields 
For evaluation of quantum yields of emission, compounds 1 and 2 (0.33 mM) either in 
combination with analytes (0.17 mM) or not were investigated in a well plate format assay at 
identical conditions as described for the screening experiments. Quinine sulfate dihydrate in 
0.1 N H2SO4 (ΦF = 0.55, λexc. = 345 nm) was used for referencing. Emission spectra for each 
probe were recorded at three different combinations of emission and excitation slit widths 
(5/5, 5/10, 10/5 [nm/nm]), while PMT voltage was constant for each testing series 
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(compound 1: 550 V, compound 2: 500 V, Quinine sulfate dihydrate: 500 V and 550 V, 
respectively). Subsequently, integrals ∫F of solvent-baseline corrected spectra were 
determined. Additionally, UV spectra of each probe were recorded. According to Equation 3, 
the fluorescence quantum yields ΦF for each probe at all slit width combinations were 
calculated and finally given as mean ± s.d. of these three slit width combinations. 
 
ref.F
2
ref.
probe
ref.
probe
360 nm
probe
345 nm
ref.
probeF Φn
n
F
F
A
AΦ  , , 


 
    Equation 3 
 
 
1.4.6 Syntheses 
Following compounds were synthesized according to literature known procedures and 
determined to be consistent with analyitical data derived from the corresponding published 
syntheses: Tri-tert-butyl 10-(2-aminoethyl)-1,4,7,10-tetraazacyclododecane-1,4,7-tricarboxy-
late 4,40-41 Bis(3-boc-cyclen)-triazene-ED 5,42, 50  1,8-dihydropyrene-1-carboxylic acid 3.43-44 
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Tri-tert-butyl 10-[2-(pyrene-1-carboxamido)ethyl]-1,4,7,10-tetraazacyclododecane-1,4,7-
tricarboxylate (6) 
Method A 
Pyrene-1-carboxylic acid 3 (0.12 g, 0.49 mmol) was dissolved in a nitrogen flushed round 
bottom flask in 2 mL of dry DCM. In the following, DIPEA (0.24 g, 250 µL, 1.8 mmol) and 
HOBt monohydrate (0.07 g, 0.5 mmol) dissolved in a small amount of dry DMF were added. 
Then, the solution was cooled down to 0°C in an ice water bath, TBTU (0.16 g, 0.5 mmol) 
was added and the reaction mixture was stirred for 30 min, before Tri-tert-butyl 10-(2-
aminoethyl)-1,4,7,10-tetraazacyclododecane-1,4,7-tricarboxylate 4 (0.20 g, 0.4 mmol) was 
given to the reaction mixture in small portions. After 1 h of stirring at 40°C, the solvents were 
evaporated and the isolated crude product was purified by column chromatography on flash 
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silica gel (EtOAc : PE = 7 : 3) yielding a slightly yellow, amorphous solid (0.27 g, 0.4 mmol, 
94%). 
MP: 121°C ― 1H-NMR (400 MHz, CDCl3, COSY, ROESY, HSQC, HMBC): δ [ppm] = 
8.51 (d, 3JH,H = 9.1 Hz, 1H, 11), 8.20 (d, 3JH,H = 7.6 Hz, 2H, 14+16), 8.17-8.11 (m, 2H, 3+12), 
8.11-8.05 (m, 2H, 6+12), 8.05-7.99 (m, 2H 5+15), 7.08 (s, 1H, 18), 3.74 (dt, 3JH,H = 6.0 Hz, 
5.4 Hz, 2H, 19), 3.44 (bs, 4H, 23), 3.37 (bs, 8H, 25+26), 2.99-2.80 (m, 2H, 20), 2.71 (bs, 4H, 
22), 1.70-0.95 (m, 27H, 31+35) ― 13C-NMR (100 MHz, CDCl3, COSY, ROESY, HSQC, 
HMBC): δ [ppm] = 170.5 (Cquat., 1C, 17), 155.9 (Cquat., 2C, 32), 155.4 (Cquat., 1C, 28), 132.3 
(Cquat., 1C, 1), 131.1 (Cquat., 2C, 4+7), 130.8 (Cquat., 1C, 13), 128.6 (Cquat., 1C, 10), 128.5 (+, 
1C, 12), 128.4 (+, 1C, 6), 127.1 (+, 1C, 5), 126.2 (+, 1C, 15), 125.6 (+, 2C, 14+16), 124.8 
(Cquat., 1C, 9; +, 1C, 2), 124.6 (Cquat., 1C, 11), 124.4 (+, 1C, 8), 124.3 (+, 1C, 3), 79.7 (Cquat., 
2C, 34), 79.5 (Cquat., 1C, 30), 55.1 (–, 2C, 22), 52.5 (–, 1C, 20), 50.0 (–, 2C, 23), 48.2 (–, 4C, 
25+26), 37.6 (–, 1C, 19), 28.5 (+, 6C, 35), 28.2 (+, 3C, 31) ― IR (ATR) [cm–1]: ~  = 2973, 
2931, 2816, 2357, 1682, 1527, 1456, 1413, 1364, 1153, 1105, 1030, 976, 848, 755, 633 ― 
UV (MeCN) [nm]: λ (ε) = 339 (1900), 325 (1900) ― ESI-MS (H2O/MeOH + 10 mmol/L 
NH4Ac): m/z (%) = 644.2 (2) [MH+ – Boc], 744.4 (100) [MH+], 766.3 (3) [MNa+] ― HR-MS 
PI-LSI (MeOH/Glycerine): (C42H58N5O7) calc. 744.4336 [MH+], found 744.4326  
 
Method B 
Pyrene-1-carboxylic acid 3 (0.50 g, 2.0 mmol) was suspended in SOCl2 (14.50 g, 
121.8 mmol, 8.8 mL) and finally brought in solution by addition of a few drops of DMF. 
After stirring the reaction mixture for 2 h under reflux conditions, the solvents were removed 
to obtain the crude Pyrene-1-carboxylic acid chloride. The in-situ formed acid chloride was 
then dissolved under nitrogen atmosphere in dry DCM/DMF (50 mL; 9 : 1) and DMAP 
(0.03 g, 0.2 mmol) was added, followed by a solution of Tri-tert-butyl 10-(2-aminoethyl)-
1,4,7,10-tetraazacyclo-dodecane-1,4,7-tricarboxylate 4 (0.84 g, 1.6 mmol) and DIPEA 
(0.53 g, 4.1 mmol, 0.56 mL) in dry DCM (5 mL). After 5 h stirring at reflux, the mixture was 
allowed to reach room temperature and water (50 mL) was added. The formed precipitate was 
filtered off and the layers were separated. In the following, the aqueous layer was extracted 
with DCM (3 x 50 mL) and the combined organic layers were washed with aqueous 1.25 M 
NaOH (3 x 30 mL). Finally, the combined aqueous layers were re-extracted with DCM (4 x 
60 mL), dried over MgSO4 and filtrated. Evaporation of the solvents gave the crude product, 
which was then purified by column chromatography on flash silica gel using a gradient of 
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MeOH in DCM (0% → 2%). The so obtained slightly yellowish foam was identified as the 
product (0.81 g, 67%) identical to that prepared by Method A. 
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N-[2-(1,4,7,10-Tetraazacyclododecan-1-yl)ethyl]pyrene-1-carboxamide 
Tri-tert-butyl 10-[2-(pyrene-1-carboxamido)ethyl]-1,4,7,10-tetraazacyclododecane-1,4,7-tri-
carboxylate 6 (0.35 g, 0.47 mmol) was dissolved in 5 mL of DCM, cooled to 0°C in an ice 
water bath while stirring and then, HCl saturated Et2O (9.41 mL) was added slowly. Reaching 
room temperature, the reaction mixture was stirred a further 16 h, while a precipitate was 
formed. After evaporation of the solvent under reduced pressure, the desired product was 
obtained as a yellowish, amorphous solid (0.27 g, 0.45 mmol, 97%).  
MP: 188°C (decomp.) ― 1H-NMR (400 MHz, D2O, DEPT135): δ [ppm] = 7.89-7.29 (m, 9H, 
aryl-CH), 3.35 (m, 2H, 19), 3.05-2.71 (bs, 8H, 25+26), 2.71-2.56 (m, 6H, 20+22), 2.55-2.40 
(bs, 4H, 23) ― 13C-NMR (100 MHz, D2O, DEPT135): δ [ppm] = 171.1 (Cquat., 1C, 17), 131.8 
(Cquat., 1C, 1), 129.9 (Cquat., 1C, 4), 129.5 (Cquat., 1C, 7), 128.9 (Cquat., 1C, 13), 128.0 (+, 1C, 
6), 127.7 (Cquat., 1C, 10), 127.6 (+, 1C, 12), 126.5 (+, 1C, 5), 125.7 (+, 1C, 15), 125.2 (+, 2C, 
14+16), 124.8 (+, 1C, 2), 124.3 (+, 1C, 11), 123.5 (+, 1C, 3), 123.2 (Cquat., 1C, 9), 122.8 
(Cquat., 1C, 8), 50.7 (–, 1C, 20), 47.3 (–, 2C, 22), 43.8 (–, 2C, 26), 41.9 (–, 2C 25), 41.3 (–, 2C, 
23), 35.3 (–, 1C, 19) ― ES-MS (MeCN/TFA): m/z (%) = 222.5 (56) [M + 2H+]2+, 444.1 (100) 
[MH+] 
Ion exchange chromatography over a strong basic anion exchange resin (OH–-form) was used 
to obtain the free amine. A column was filled with ion exchanger (1.5 cm x 3 cm) and rinsed 
first with a mixture of H2O/MeOH (1 : 1) then followed by pure H2O. The ammonium salt 
was dissolved in a small amount of H2O and eluted from the column to yield the free amine 
ligand. 
1H-NMR (400 MHz, CD3OD, NOESY, HSQC, HMBC): δ [ppm] = 8.45 (d, 3JH,H = 9.3 Hz, 
1H, 11), 8.22-8.16 (m, 3H, 3+14+16), 8.15-8.11 (d, 3JH,H = 9.3 Hz, 1H, 12), 8.11-8.07 (m, 2H, 
2+6), 8.06-8.02 (m, 2H, 5+18), 8.00 (dd, 3JH,H = 7.6 Hz, 7.7 Hz,  1H, 15), 3.59 (t, 3JH,H = 
6.6 Hz, 2H, 19), 2.75 (t, 3JH,H = 6.6 Hz, 2H, 20), 2.57-2.47 (m, 12H, 22+23+25), 2.42-2.34 
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(m, 4H, 26) ― 13C-NMR (100 MHz, CD3OD, NOESY, HSQC, HMBC): δ [ppm] = 172.6 
(Cquat., 1C, 17), 133.8 (Cquat., 1C, 1), 132.5 (Cquat., 1C, 4), 132.4 (Cquat., 1C, 7), 132.0 (Cquat., 
1C, 13), 129.7 (+, 1C, 6), 129.6 (Cquat., 1C, 10), 129.5 (+, 1C, 12), 128.2 (+, 1C, 5), 127.6 (+, 
1C, 15), 127.0 (+, 1C, 16), 126.8 (+, 1C, 2), 125.7 (Cquat., 1C, 9), 125.49 (+, 1C, 11), 125.48 
(Cquat., 1C, 8), 125.48 (+, 1C, 3), 54.7 (–, 2H, 20), 52.4 (–, 2C, 22), 47.0 (–, 2C, 26), 46.0 (–, 
2C, 25), 45.2 (–, 2C, 23), 39.2 (–, 1C, 19) 
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Zinc(II)-{N-[2-(1,4,7,10-tetraazacyclododecan-1-yl)ethyl]pyrene-1-carboxamide} dichloride (1) 
N-[2-(1,4,7,10-Tetraazacyclododecan-1-yl)ethyl]pyrene-1-carboxamide (157 mg, 0.35 mmol) 
was dissolved in 3 mL of MeOH and warmed up to 40°C. Then, ZnCl2 (48 mg, 0.35 mmol; 
193 µL, β = 250 mg/mL ) as aqueous solution was added drop by drop while stirring and the 
mixture was heated 1 h to 60°C. In the following, MeOH was evaporated and water was 
removed by lyophilisation to get the crude product, which was precipitated with Et2O from 
hot MeOH. The precipitate was isolated by centrifugation yielding a beige, amorphous solid 
(130 mg, 0.35 mmol, 99%). 
MP: 185°C (decomp.) ― 1H-NMR (400 MHz, D2O, ROESY, HSQC, HMBC): δ [ppm] = 
7.89-7.69 (m, 1H, pyrene-CH), 7.58-7.43 (m, 1H, pyrene-CH), 7.41-7.26 (m, 2H, pyrene-
CH), 7.26-7.14 (m, 2H, pyrene-CH), 7.14-7.03 (m, 1H, pyrene-CH), 7.03-6.93 (m, 1H, 
pyrene-CH), 6.93-6.78 (m, 1H, pyrene-CH),  3.31 (bs, 2H, 19), 2.72 (bs, 2H, 20), 2.53 (bs, 
2H, 25), 2.40 (bs, 4H, 23+26), 2.22 (bs, 2H, 22), 2.05 (bs, 2H, 25’), 2.47-2.30 (m, 4H, 
22’+26’), 1.78 (bs, 2H, 23’) ― 13C-NMR (100 MHz, D2O, ROESY, HSQC, HMBC): 
δ [ppm] = 170.4 (Cquat., 1C, 17), 131.7 (Cquat., 1C, pyrene-C), 130.1 (Cquat., 1C, pyrene-C), 
129.7 (Cquat., 1C, pyrene-C), 129.1 (Cquat., 1C, pyrene-C), 127.7 (Cquat., 1C, pyrene-C), 127.7 
(+, 2C, pyrene-C), 126.7 (+, 1C, pyrene-C), 125.8 (+, 1C, pyrene-C), 125.2 (+, 2C, pyrene-C), 
124.9 (+, 1C, pyrene-C), 124.3 (+, 1C, pyrene-C), 123.8 (+, 1C, pyrene-C), 123.3 (Cquat., 1C, 
pyrene-C), 123.0 (Cquat., 1C, pyrene-C), 51.2 (–, 1C, 20), 49.0 (–, 2C, 22), 44.1 (–, 2C, 26), 
43.1 (–, 2C, 25), 41.9 (–, 2C, 23), 34.0 (–, 1C, 19) ― ES-MS (MeCN/TFA): m/z (%) = 506.2 
(100) [M2+ – H+], 542.1 (10) [M2+ + Cl–] 
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Pyrene-1-carboxylic acid {2-[4,6-bis-(1,4,7,10-tetraaza-cyclododec-1-yl)-[1,3,5]triazin- 
2-yl]-ethyl}-1,4,7-tricarboxylic acid tri-tert-butyl ester (7) 
Pyrene-1-carboxylic acid 3 (0.15 g, 0.60 mmol), DIPEA (0.62 mL, 3.61 mmol), TBTU 
(0.21 g, 0.66 mmol), and HOBt (0.10 g, 0.66 mmol) were dissolved under nitrogen 
atmosphere in dry DMF (4 mL) under ice cooling and stirred for 1 h. Subsequently, amine 5 
(0.50 g, 0.46 mmol) was added. The reaction was allowed to warm to room temperature and 
stirred 30 min, then a further 7 h at 40°C. The reaction progress was monitored by TLC 
(EtOAc : PE = 4 : 1). After completion of the reaction the solvent was removed and the crude 
product was purified by column chromatography on flash silica gel (EtOAc : PE = 3 : 2; 
Rf = 0.3) yielding compound 7 (0.34 g, 0.26 mmol, 57%) as a lightly yellow solid. 
MP: 210°C. ― 1H-NMR (600 MHz Cryo, CDCl3, ROESY, HSQC, HMBC): δ [ppm] = 8.50-
8.37 (m, 1H, 11), 8.16-8.10 (m, 2H, 14+16), 8.09-7.98 (m, 4H, 2+3+6+12), 7.98-7.93 (m, 2H, 
5+15), 5.15 (bs, 1H, 18), 3.96-2.83 (m, 36H, 19+20+26+27+29+30), 1.35, 1.41 (s, 50H, boc-
CH3), 0.65 (bs, 4H, boc-CH3) ― 13C-NMR (150 MHz Cryo, CDCl3, ROESY, HSQC, 
HMBC): δ [ppm] = 170.6 (Cquat., 1C, 17), 166.1 (Cquat., 2C, 24), 165.1 (Cquat., 1C, 22), 157.5-
154.9 (Cquat., 6C, 32+36), 132.0 (Cquat., 2C, 1+4), 130.9 (Cquat., 1C, 7), 130.6 (Cquat., 1C, 13), 
128.2 (Cquat., 1C, 10), 128.1 (+, 2C, 6+12), 126.9 (+, 1C, 15), 126.0 (+, 1C, 5), 125.4 (+, 1C, 
14/16), 125.3 (+, 1C, 16/14), 124.7 (+, 1C, 2), 124.5 (Cquat., 1C, 9), 124.5 (+, 1C, 11), 124.3 
(Cquat., 1C, 8), 124.2 (+, 1C, 3), 79.9 (Cquat., 2C, 34), 79.6 (Cquat., 4C, 38), 50.1 (–, 16C, 
26+27+29+30), 40.5 (–, 1C, 19/20), 40.0 (–, 1C, 20/19), 28.4 (+, 18C, 35+39) ― IR (ATR) 
[cm–1]: ~  = 2976, 1686, 1539, 1496, 1474, 1410, 1364, 1246, 1161, 1109, 973, 851, 777, 759  
― UV (CHCl3) [nm]: λ (ε) = 343 (31200), 329 (22300), 278 (37300), 267 (23300), 242 
(77600) ― ESI-MS (DCM/MeOH + 10 mmol/L NH4Ac): m/z (%) = 548.9 (20) [M – 2C4H8 
– Boc + 2H+]2+, 577.0 (30) [M – C4H8 – Boc + 2H+]2+, 605.0 (15) [M – Boc + 2H+]2+, 627.0 
(10) [M – C4H8 + 2H+]2+, 655.1 (14) [M + 2H+]2+, 1308.9 (100) [MH+] 
23 
1 Zinc(II)cyclen Coordination to UTP, TTP or Pyrophosphate Induces Pyrene Excimer Emission 
 
 
 
 
N
NN
N
17
O
1
3
2
10
11
12
4
9
6
5
8
13
14
15
16
7
N 22
N 23
24
N
N
31
N
25
N28 N
27
29
30
26
NH 21
20 19
HN18
H
H
H
H
H
H
 
Pyrene-1-carboxylic acid {2-[4,6-bis-(1,4,7,10-tetraaza-cyclododec-1-yl)-[1,3,5]triazin- 
2-ylamino]-ethyl}-amide 
Compound 7 (150 mg, 0.12 mmol) was dissolved in DCM (4 mL) and cooled to 0°C. 
Subsequently, 4.6 mL HCl saturated Et2O were added. The solution was stirred 15 min at 0°C 
and additionally 18 h at room temperature. The solvent was removed in vacuo yielding 
quantitatively a colorless solid. 
1H-NMR (400 MHz, CD3OD): δ [ppm] = 8.56 (d, 3JH,H = 8.7 Hz, 1H, 11), 8.38-8.19 (m, 5H, 
2+3+4+16+18), 8.18-8.10 (m, 2H, 5+12), 8.07 (dd, 3JH,H = 7.5 Hz, 7.5 Hz, 1H, 15), 4.00-2.67 
(m, 36H, 19+20+26+27+29+30, solvent signal) ― 13C-NMR (100 MHz, CD3OD): δ [ppm] = 
173.0 (Cquat., 1C, 17), 164.7 (Cquat., 1C, 22), 156.8 (Cquat., 2C, 24), 134.1 (Cquat., 1C, 4), 132.6 
(Cquat., 1C, 7), 132.0 (Cquat., 1C, 13), 131.9 (Cquat., 1C, 1), 130.0 (+, 1C, 12), 129.9 (+, 1C, 6), 
129.8 (Cquat., 1C, 10), 128.4 (+, 1C, 5), 127.8 (+, 1C, 15), 127.3 (+, 1C, 16), 127.1 (+, 1C, 14), 
126.8 (+, 1C, 2), 125.7 (Cquat., 1C, 9), 125.7 (+, 2C, 3+11), 125.4 (Cquat., 1C, 8), 47.0, 45.6, 
44.9, 41.5, 40.3 (–, 18C, 19+20+26+27+29+30) ― ES-MS (H2O/MeOH + 10 mmol/L 
NH4Ac): m/z (%) = 354.7 (100) [M + 2H2+]2+, 708.4 (10) [MH+], 822.5 (4) [MH+ + TFA] 
To obtain the corresponding free base, a weak basic ion exchanger resin was swollen for 
15 min in water and washed neutral with water. A column was charged with resin (805 mg, 
40.0 mmol hydroxy equivalents at a given capacity of 5 mmol/g). The hydrochloride salt 
(115 mg, 0.12 mmol) was dissolved in water, put onto the column and eluated with water. The 
elution of the product was controlled by pH indicator paper (pH > 10) and was completed 
when pH again was neutral. The eluate was concentrated and lyophilised to yield (69 mg, 
0.10 mmol, 83%) a lightly yellow solid. 
MP: 192°C ― 1H-NMR (600 MHz, CD3CD : CDCl3 = 1 : 1, COSY, ROESY, HSQC, 
HMBC): δ [ppm] = 8.39 (d, 3JH,H = 9.2 Hz, 1H, 11), 8.20 (dd, 3JH,H = 7.0 Hz, 7.2 Hz,  2H, 
14+16), 8.15 (d, 3JH,H = 7.9 Hz, 1H, 3), 8.11 (d, 3JH,H = 9.0 Hz, 1H, 6), 8.09 (d, 3JH,H = 6.5 Hz, 
1H, 2), 8.07 (d, 3JH,H = 8.0 Hz, 1H, 12), 8.04 (d, 3JH,H = 8.7 Hz, 1H, 5), 8.02 (dd, 3JH,H = 7.4 
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Hz, 7.5 Hz, 1H, 15), 4.20-3.49 (m, 12H, cyclen-CH2, 19+20), 3.25-3.09 (m, 8H, cyclen-CH2), 
3.01 (bs, 6H, cyclen-CH2), 2.97 (s, 2H, cyclen-CH2), 2.93 (bs, 8H, cyclen-CH2) ― 13C-NMR 
(150 MHz, CD3CD : CDCl3 = 1 : 1, COSY, ROESY, HSQC, HMBC): δ [ppm] =171.2 (Cquat., 
1C, 17), 166.5 (Cquat., 1C, 24), 166.3 (Cquat., 1C, 24’), 165.5 (Cquat., 1C, 22), 132.0 (Cquat., 1C, 
4), 130.6 (Cquat., 1C, 7), 129.94 (Cquat., 1C, 13), 129.92 (Cquat., 1C, 1), 128.1 (+, 1C, 6), 127.9 
(+, 1C, 12), 127.7 (Cquat, 1C, 10), 126.4 (+, 1C, 5), 125.8 (+, 1C, 15), 125.4 (+, 1C, 16), 125.1 
(+, 1C, 14), 124.3 (+, 1C, 2), 123.9 (Cquat., 1C, 9), 123.7 (+, 1C, 3), 123.6 (Cquat., 1C, 8), 123.4 
(+, 1C, 11), 46.3 (–, 3C, cyclen-CH2), 45.9 (–, 2C, cyclen-CH2), 44.9 (–, 6C, cyclen-CH2), 
42.8 (–, 1C, cyclen-CH2), 42.6 (–, 2C, cyclen-CH2), 42.2 (–, 2C, cyclen-CH2), 39.7 (–, 1C, 
19), 39.1 (–, 1C, 20) ― IR (ATR) [cm–1]: ~  = 3372, 3266, 2935, 2764, 2697, 1623, 1536, 
1480, 1417, 1355, 1284, 1230, 1145, 1081, 972, 852 ― UV (MeOH) [nm]: λ (ε) = 341 
(12300) 327 (9400), 276 (15500), 266 (10000), 242 (28800), 227 (31700) ― ESI-MS 
(EE/MeOH + 10 mmol/L NH4Ac): m/z (%) = 354.7 (100) [M + 2H2+]2+, 708.4 (8) [MH+], 
822.5 (4) [MH+ + TFA] ― HR-MS PI-LSI (C38H54N13O) calc. 708.4574 [MH+], found 
708.4567 
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Bis-Zinc(II)(pyrene-1-carboxylic acid {2-[4,6-bis-(1,4,7,10-tetraaza-cyclododec-1-yl)-
[1,3,5]triazin-2-ylamino]-ethyl}-amide) tetraperchlorate (2) 
Pyrene-1-carboxylic acid {2-[4,6-bis-(1,4,7,10-tetraaza-cyclododec-1-yl)-[1,3,5]triazin-2-
ylamino]-ethyl}-amide (58 mg, 0.08 mmol) was dissolved in 1 mL of MeOH and heated to 
65°C to give a clear yellow solution. Subsequently, Zinc(II)perchlorate (64 mg, 0.17 mmol) 
dissolved in 1 ml of MeOH was added slowly. The reaction mixture was stirred for additional 
20 h at 65°C. The solvent was removed in vacuo and the residue was redissolved in water and 
lyophilized. Bis-Zn2+-bis-cyclen pyrene 2 (101 mg, 0.08 mmol, 100%) was obtained as a 
colorless solid. 
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MP: 193°C ― 1H-NMR (300 MHz, CD3CN): δ [ppm] = 8.51-8.34 (m, 1H, 11), 8.33-7.99 (m, 
7H, pyrene-CH), 7.95-7.68 (m, 1H, pyrene-CH), 7.39 (bs, 1H, 18), 7.06-5.63 (m, 7H, 
28+30+21), 4.54-2.40 (m, 36 H, 19+20+26+27+29+30) ― IR (ATR) [cm–1]: ~  = 3487, 
3182, 1605, 1530, 1427, 1342, 1285, 1048, 975, 931,858, 810, 775, 621 ― UV (HEPES pH 
7.4, 25 mM) [nm]: λ (ε) = 344 (15000), 330 (10900), 277 (16700), 267 (11200), 243 (27400), 
230 (36400) ― ES-MS (TFA/MeCN): m/z (%) = 447.2 (62) [M4+ + CH3COO–]3+, 476.7 
(100) [M4+ + 2CH3COO–]2+ 
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Figure S1: Emission spectra of compound 1 titrated with (a) UMP and (b) UDP, respectively. [1] = 
0.5 mM, [UMP] = [UDP] = 1.0 mM; left side shows successively addition of up to 0.5 equiv. of nucleotide 
hence, formation of 2:1-aggregates indicated by arising excimer and decreasing monomer emission; right side 
displays disruption of 2:1 stoichiometry observable as increase in monomer emission, while excimer emission 
decreases 
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b 
Figure S2: Titration of compound 1 with Fructose-1,6-bisphosphosphate. (a) Titration curve (left) and Job’s 
plot analysis (right) for titration of [1] = 0.5 mM with [Fru-1,6-bisP] = 1.0 mM at pH 7.4 in HEPES buffered 
aqueous solution. (b) Obtained emission spectra show the typical behavior of successive formation (left) and 
disruption (right) of the corresponding ternary complex 
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Figure S3: Emission spectra obtained for titration of compound 1 with TTP. Obtained emission spectra 
show the typical behavior of successive formation (left) and disruption (right) of the corresponding ternary 
complex; [1] = 0.5 mM, [TTP] = 5.0 mM 
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Figure S4: Emission spectra obtained for titration of compound 2 with IDP, ITP, UDP and UTP. Obtained 
emission spectra show the typical behavior of successive formation (left) and disruption (right) of the 
corresponding ternary complex; compound 2 (0.5 mM) was titrated with (a) IDP, (b) ITP, (c) UDP and (d) UTP 
(1.0 mM) in aqueous HEPES buffer at pH 7.4 
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Figure S4 (cont.): Emission spectra obtained for titration of compound 2 with IDP, ITP, UDP and UTP. 
Obtained emission spectra show the typical behavior of successive formation (left) and disruption (right) of the 
corresponding ternary complex; compound 2 (0.5 mM) was titrated with (a) IDP, (b) ITP, (c) UDP and (d) UTP 
(1.0 mM) in aqueous HEPES buffer at pH 7.4 
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Figure S5: Emission spectra for analyte screening with compound 1 in HEPES buffered solution.  
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Figure S6: Emission spectra for analyte screening with compound 2 in HEPES buffered solution.  
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Figure S7: UV spectra (dashed line) and emission 
spectra (solid lines) for determination of 
fluorescence quantum yield of compound 1 alone 
or in combination with selected analytes in HEPES 
buffered solution and Quinine sulfate dihydrate 
(in 0.1 N H2SO4) as reference. Emission spectra 
were recorded at three different combinations of 
emission and excitation slit widths: 5 nm / 5 nm 
(black), 5 nm / 10 nm (red), 10 nm / 5 nm (green) 
 
 
 
200 250 300 350 400 450 500 550 600
0
100
200
300
400
500
600
700
0,00
0,05
0,10
0,15
0,20
quinine sulfate dihydrate
 [nm]
ab
s.
  I
 [a
.u
.]
1 Zinc(II)cyclen Coordination to UTP, TTP or Pyrophosphate Induces Pyrene Excimer Emission 
 
 
 
 
250 300 350 400 450 500 550 600
0
100
200
300
400
0.0
0.1
0.2
0.3
0.4
0.5
I [
a.
u.
]
 [nm]
compound 2
ab
s.
250 300 350 400 450 500 550 600
0
100
200
300
400
500
0.0
0.1
0.2
0.3
0.4
0.5
compound 2 + AMP
I [
a.
u.
]
 [nm]
ab
s.
250 300 350 400 450 500 550 600
0
100
200
300
400
0.0
0.1
0.2
0.3
0.4
0.5
compound 2 + CMP
I [
a.
u.
]
 [nm]
ab
s.
250 300 350 400 450 500 550 600
0
50
100
150
200
250
300
0.0
0.1
0.2
0.3
0.4
0.5
compound 2 + GTP
I [
a.
u.
]
 [nm]
ab
s.
 
250 300 350 400 450 500 550 600
0
50
100
150
200
250
0.0
0.1
0.2
0.3
0.4
0.5
compound 2 + ITP
I [
a.
u.
]
 [nm]
ab
s.
250 300 350 400 450 500 550 600
0
50
100
150
200
250
0.0
0.1
0.2
0.3
0.4
0.5
compound 2 +UDP
I [
a.
u.
]
 [nm]
ab
s.
 
 
Figure S8: UV spectra (dashed line) and emission 
spectra (solid lines) for determination of 
fluorescence quantum yield of compound 1 alone 
or in combination with selected analytes in HEPES 
buffered solution and Quinine sulfate dihydrate 
(in 0.1 N H2SO4) as reference. Emission spectra 
were recorded at three different combinations of 
emission and excitation slit widths: 5 nm / 5 nm 
(black), 5 nm / 10 nm (red), 10 nm / 5 nm (green) 
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2 DNA Staining in Agarose Gels with Zinc(II)Cyclen-Pyrene 
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A p ne  gels is reported. 
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2.1
DNA separation on agarose gels is a standard technique in molecular biology. Ethidium 
brom
However, its genotoxic potential is controversially discussed. At physiologically relevant 
cond ode of Ethidium bromide to 
DN 3 
intercalators π-stacked base pairs results in local structural changes in DNA (e.g. 
unwi in
polymerases and other DNA-related proteins is disrupted, thus DNA transcription is affected. 
Furth r, 
especiall
bulging s
bacteriophage and bacterial assays, but not in mammalian cells. 6 In contrast, the Ames test 
revea
and a mu
exposure
Ethidium bromide should therefore be handled with care, generating additional costs in gel 
staini g 
variety o
PicoGree
not genotoxic,12
composit
reagents ium bromide and therefore, are suggested not to be 
sto  at
and suggested to be non-mutagenic. However, the sensitivity of Methylene Blue for DNA 
sta g i
e report now a water-soluble fluorescent DNA staining reagent Zn2+-Cyclen-pyrene 1. 
Coordination of the pyrene metal-chelate to DNA induces pyrene-pyrene excimer formation, 
which is easily detected. By this, staining down to 10 ng of DNA in agarose gels was 
achieved. Preliminary cytotoxicity studies on two different cell lines indicate that Zn2+-
Cyclen-pyrene 1 may have lower cytotoxicity compared to Ethidium bromide. Moreover, 
storage at special conditions is not necessary. 
 
  INTRODUCTION 
ide is the most commonly used reagent for visualization of the separated fragments.1] 
itions, intercalation is the predominantly occurring binding m
A.2- Intercalation is very often associated with mutagenic potential as insertion of such 
 between 
nd g and lengthening of the DNA double helix). Consequently, interaction with DNA 
e frameshift mutations are conceivable, since the widening of π-stacked base pairs 
y in repetitive DNA sequences can lead to either leaving a single unpaired base or 
everal bases out of the helix. This propensity was indeed observed, however, only in 
4-
ls that only metabolites of Ethidium bromide are mutagenic in Salmonella typhimurium7 
tagenic potential of Ethidium bromide in E. coli was reported to depend on UV light 
.8 
n and imaging and disposal of waste.9-11 To overcome drawbacks in DNA staining, a 
f alternative stains are available: SYBR Green I/II, SYBR Gold, SYBR Safe, 
n, GelGreen, GelRed, Midori Green, RedSafe, OliGreen, BlueView are stated to be 
 but the structure of the dyes, conditions of the mutagenicity tests and 
ion of the DMSO stock solutions is not always available.8 Furthermore, these 
are often less stable than Ethid
red  room temperature. Nile Blue A and Methylene Blue are water-soluble DNA stains 
inin s significantly lower compared to Ethidium bromide. 
W
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.2  RESULTS & DISCUSSION 
The ability of Zn2+-cyclen complexes to bind phosphate anions and imide functional groups in 
aqueous solution is well known.13-19 Dye-labelled Zn2+-cyclen complexes should therefore 
allow the staining of oligonucleotides in gels, as previously reported for phosphorylated 
proteins.20-22 Figure 1 shows the Zn2+-cyclen-dye conjugates used in this study. The pyrene-
labelled compounds 1 and 2 are intended to signal the presence of an oligonucleotide by 
analyte induced excimer formation. 
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Figure 1: Dye-labelled Zn2+-cyclen complexes used in gel staining. Compounds 1 and 2 were previously 
found to discriminate uridine-phosphates from other nucleotides by analyte induced excimer formation;23 
compound 4 was reported to be a phospho-protein staining reagent by emission increase upon binding to 
phosphate groups in proteins21 
 
 
2.2.1 Staining of DNA with Zn2+-Cyclen-pyrene 
Plasmid DNA phMGFP was enzymatically cleaved by NdeI giving two linear strands of 
dsDNA (2241 bp, 2466 bp). This linear dsDNA and the circular plasmid were 
electrophoretically resolved on an agarose gel and stained by Zn2+-Cyclen-pyrene 1 or 
Ethidium bromide. Both procedures yield identical staining patterns as shown in Figure 2. 
Compound 1 indicates the presence of the DNA by its enhanced excimer emission. 
Compounds 2-4 were investigated likewise on their staining ability, but failed to 
identify DNA in the gel by a significant emission signal. All metal complexes 1-4 are 
expected to interact with the oligophosphate backbone of the DNA, and to a smaller extend, 
with thymine imide moieties. The experiments show, that the affinity of the complexes to the 
DNA analyte is under the experimental conditions not sufficient to achieve a non-covalent 
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labelling. Only in the case of 1, presumably by stabilizing the DNA-complex aggregate by 
pyrene-pyrene interactions, a sufficient affinity is reached. (Figure 3) 
 
 
Figure 2: Staining of a linearized and a circular plasmid phMGFP with Ethidium bromide or complex 1. 
Gel run of linearized (left lanes) and circular (right lanes) plasmid DNA on an agarose gel (0.8%) stained with 
either Zn2+-Cyclen-pyrene 1 or Ethidium bromide; images were taken on a PeqLab Superbright UV table (λmax = 
316 nm) with a Canon EOS 450D; using a high-pass filter (490 nm) bluish gel background emission appears in 
greenish color 
 
 
 
Figure 3: Proposed interaction of Zn2+-Cyclen-pyrene with DNA and staining mechanism due to analyte 
induced pyrene excimer formation. Metal-chelates are suggested to bind to phosphodiesters of the backbone 
while pyrene-pyrene interactions additionally stabilize the binding to DNA by -stacking; due to formed pyrene-
excimers upon irradiation, pyrene-emission is changed that finally allows the detection of lightened up DNA 
bands on the gel 
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was used to inves te the response of the probes emission properties to gel matrices. 
Agarose and polyacrylamide gels containing UMP behave different when soaked in a solution 
f 1: While the agarose gel develops quickly the typical turquoise excimer emission upon 
radiation at 366 nm, no excimer emission is observed for Polyacrylamide. 
To exclude the intercalation of the pyrene moiety into the dsDNA as binding motif, 
the staining ability of Zn2+-Cyclen-pyrene 1 was compared to its non-complexed ligand. No 
staining was observed with the ligand (Figure 4) showing that the zinc(II)complex is essential 
for the staining ability of compound 1. 
 
Uridinemonophosphate (UMP), which is able to induce enhanced excimer emission of 1,23-24 
tiga
o
ir
 
Figure 4: Comparison of gel staining with complex 1 and the corresponding zinc-ion free ligand. Gel runs 
of plasmid DNA phMGFP stained with either Zn2+-Cyclen-pyrene 1 (left) or the non-complexed ligand (right) at 
comparable conditions; (left) distinct visualization of DNA band as pronounced fluorescent signal; (right) no 
staining of DNA could be observed when using the non-complexed, pyrene-labelled aza-macrocycle suggesting 
that 1. coordinative interactions are crucial for this staining method and 2. pyrene intercalation does not occur; 
this image was taken without using any filter and thus shows the total fluorescence of the stain upon irradiation 
 
 
2.2.2 Sensitivity Comparison of Zn2+-Cyclen-pyrene with Ethidium Bromide 
To estimate the sensitivity of the staining reagent, dilution series (mDNA/lane [ng] ~ 700, 350, 
75, 88, 44, 22, 11, 5) of plasmid phMGFP were transferred on two independent agarose gels 
e gel run with Zn2+-Cyclen-pyrene 1 and Ethidium bromide, respectively, 
at comparable concentrations (~1 mM). As deduced from the obtained images shown in 
Figure 5, compound 1 is not as sensitive as Ethidium bromide. However, DNA amounts of 
~10 ng could be visualized with Zn2+-Cyclen-pyrene. 
1
and stained after th
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Figure 5: Sensitivity comparison of Zn2+-Cyclen-pyrene and Ethidium bromide as staining reagents. 
Identical dilution rows (from left to right: mDNA/lane [ng] ~ 700, 350, 175, 88, 44, 22, 11, 5) were transferred in 
two separate gels followed by electrophoresis; staining with (left) Ethidium bromide (~1 mM) and (right) 
compound 1 (~1 mM) demonstrate the staining performance of both; in comparison, Ethidium bromide shows 
better sensitivity however, compound 1 is able to visualize concentrations of DNA of ~10 ng 
 
 
2.2.3 Gel Extraction Experiments after Staining with Zn2+-Cyclen-pyrene 
Gel extraction experiments of the Zn2+-Cyclen pyrene stained plasmid were performed. Gel 
extraction is a standard technique to isolate DNA from gels for further amplification or 
cloning. In addition, the experiment shows if compound 1 initiates major chemical 
modifications in the DNA (e.g. DNA cleavage) when bound to it. Plasmid phMGFP was 
transferred on a gel and treated with compound 1 staining solution. The fluorescent DNA 
band was cut out and subsequently, extracted using a QIAquick Gel Extraction Kit. 
Afterwards, the recycled DNA was again electrophorized and then stained with Ethidium 
bromide. Comparison of re-extracted plasmid and a control sample of the plasmid confirmed 
that Zn2+-Cyclen-pyrene 1 has not affected the plasmid phMGFP since only one DNA band 
bands. In this case, staining with compound 1 
hould be of advantage. In fact, direct comparison shows that for Zn2+-Cyclen-pyrene 1 a 
better resolution of the band was observed, but with lower intensity. (Figure 6) 
with comparable migration characteristics could be identified. 
 
2.2.4 Staining of Short DNA Strands 
The ability to stain short DNA strands (~300 bp) was investigated comparing Zn2+-Cyclen-
pyrene 1 and Ethidium bromide. Staining of short strands (<150 bp) using Ethidium bromide 
generally results in cloudy, not well-defined 
s
42 
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Figure 6: Short dsDNA (~300 bp) – comparison of staining ability of Ethidium bromide and Zn2+-Cyclen-
pyrene 1. Two identical gels with dsDNA with a length of about 300 bp were stained in a solution of either 
Ethidium bromide or compound 1; as generally known for Ethidium bromide, short DNA fragments (<150 bp) 
lead to cloudy and not well-defined bands as also demonstrated on the left side for this length; staining with 
Zn2+-Cyclen-pyrene 1 leads obviously to DNA bands with improved resolution, however, intensity is lower 
compared to Ethidium bromide; in this case, Ethidium bromide stained gel was photographed in parallel with 
compound 1 stained gel on a PeqLab Superbright UV table (λmax = 316 nm) with a Canon EOS 450D and using a 
high-pass filter (490 nm) 
 
 
 series, HeLa cells were cultivated, transferred in a well-plate and 
eated in separate trials with Ethidium bromide and Zn2+-Cyclen-pyrene 1, respectively (100, 
ethylthiazol-2-yl)-2,5-
mortality. 
(Figure 7) In a s
2.2.5 Determination of Cytotoxicity 
To compare the cytotoxic potential of complex 1 to Ethidium bromide, preliminary studies 
ere performed. In a firstw
tr
50, 25, 10, 1, 0.1 µM). Upon incubation for three days, 3-(4,5-Dim
diphenyltetrazolium bromide (MTT) was added, whose conversion into purple-colored 
Formazan is proportional to the cell viability rate.25 Results obtained from fluorescence read 
out of the well-plates suggest that Zn2+-Cyclen-pyrene 1 is less toxic compared to Ethidium 
bromide: While more than 60% of HeLa cells survived the treatment with 100 µM of 
compound 1, the same concentration of Ethidium bromide caused complete cell 
econd series, V-79 cells were tested under comparable conditions for 
cytotoxic reaction in presence of compound 1, Ethidium bromide and also the commercially 
available DNA staining reagent RedSafe, which is offered as stock solution in DMSO 
(20 000x) and described as very safe. Cell staining with Giemsa solution and counting of 
stained cell colonies surprisingly showed a significantly enhanced cytotoxic effect for 
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mortality in the culture 
solution. While metabolites of Ethidium bromide only lead to noticeable cell mortality at 
concentrations >25 µM, Zn2+-Cyclen-pyrene 1 and its metabolites seem not to affect the cells 
at all. (Figure 7) 
 
RedSafe and metabolites on this metabolizing cell line. Even the highest dilution (1:40 000 of 
a 20 000x stock solution) added to the cells lead to complete cell 
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Figure 7: Results of preliminary cytotoxicity studies obtained for HeLa and V-79 cell lines. HeLa cells were 
incubated in a well-plate in independent trials for three days with Zn2+-Cyclen-pyrene 1 and Ethidium bromide, 
respectively (100, 50, 25, 10, 1, 0.1 µM); V-79 cells were investigated under comparable conditions in Petri 
culture dishes in the presence of Zn2+-Cyclen-pyrene 1, Ethidium bromide (both at 100, 50, 25, 10, 1, 0.1 µM) 
and RedSafe (1:10 000, 1:20 000, 1:40 000 of a 20 000x stock solution in DMSO); fluorescence read out due to 
conversion of MTT into Formazan by surviving cells (HeLa) or counting intact cell colonies after Giemsa 
staining (V-79) represent cell viability that was finally plotted as columns (means ± s.d.) against concentration of 
substances investigated; solvent control was set to 100%; Zn2+-Cyclen-pyrene 1 was found to hardly influence 
non-metabolizing HeLa and to be affectless on metabolizing V-79 cells; in comparison, treatment of both cell 
lines with Ethidium bromide resulted in higher cell mortality, while RedSafe was found to show obviously 
dramatically increased cytotoxicity as shown on V-79 cells 
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Figure 7 (cont.): Results of preliminary cytotoxicity studies obtained for HeLa and V-79 cell lines. HeLa 
cells were incubated in a well-plate in independent trials for three days with Zn2+-Cyclen-pyrene 1 and Ethidium 
bromide, respectively (100, 50, 25, 10, 1, 0.1 µM); V-79 cells were investigated under comparable conditions in 
Petri culture dishes in the presence of Zn2+-Cyclen-pyrene 1, Ethidium bromide (both at 100, 50, 25, 10, 1, 
0.1 µM) and RedSafe (1:10 000, 1:20 000, 1:40 000 of a 20 000x stock solution in DMSO); fluorescence read 
out due to conversion of MTT into Formazan by surviving cells (HeLa) or counting intact cell colonies after 
Giemsa staining (V-79) represent cell viability that was finally plotted as columns (means ± s.d.) against 
concentration of substances investigated; solvent control was set to 100%; Zn2+-Cyclen-pyrene 1 was found to 
hardly influence non-metabolizing HeLa and to be affectless on metabolizing V-79 cells; in comparison, 
treatment of both cell lines with Ethidium bromide resulted in higher cell mortality, while RedSafe was found to 
show obviously dramatically increased cytotoxicity as shown on V-79 cells 
 
A likely reason for the increased cytotoxicity of RedSafe may be the presence of DMSO, 
which permeates cell membranes. Hence, the uptake of RedSafe in cells may be dramatically 
ONCLUDING REMARKS 
2+
ound to be marginally less sensitive, 
but showed better resolution of short dsDNA fragments (~300 bp). However, this staining 
increased compared to the trials performed with aqueous solutions of either compound 1 or 
Ethidium bromide. 
 
 
2.3 C
Inhere, the application of Zn -Cyclen-pyrene 1 as DNA staining reagent on agarose gels was 
demonstrated. Based on coordinative interactions between the metal-chelate and the 
phosphate backbone in DNA being additionally stabilized by pyrene-pyrene π-stacking 
interactions, irradiation results in formation of pyrene excimers. These excimers allowed the 
detection of DNA bands as brightened up, well resolved signals on gels. In contrast, 
intercalation of the pyrene moiety into DNA could be excluded. In comparison to Ethidium 
bromide as a standard staining reagent, compound 1 was f
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method is limited to agarose gels. Nevertheless, important features of 1 are excellent water-
solubility and a presumably low cytotoxic potential according to preliminary cell-based 
studies presented inhere. Though, to further confirm its comparably low risks, a more 
comprehensive cytotoxicity profile has to be drawn and also mutagenicity studies would be of 
high interest. 
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2.6 ATERIALS  ETHODS
 
2.6.1 General 
Absorption spectroscopy. Absorption spectra were recorded on a Varian Cary BIO 50 
UV/VIS/NIR Spectrometer by use of 1 cm quartz cuvettes (Hellma) and Uvasol solvents 
(Merck or Baker). 
NMR spectra. Bruker Avance 400 (1H: 400.1 MHz, 13C: 100.6 MHz, T = 300 K). The 
chemical shifts are reported in δ [ppm] relative to internal standards (solvent residual peak). 
The spectra were analyzed by first order, the coupling constants are given in Hertz [Hz]. 
Characterization of the signals: s = singlet, d = doublet, t = triplet, m = multiplet, dd = double 
doublet, dt = double triplet. Integration is determined as the relativ
13Assignm
angle: 135°) and given as (+) for CH3 or CH, (–) for CH
Error of reported values: chemical shift: 0.01 ppm for H-NMR, 0.1 ppm for C-NMR and 
0.1 Hz for coupling constants. The solvent used is reported for each spectrum. 
Mass spectra. MS analysis was performed on a Finnigan MAT 95 (LSI) and a Finnigan MAT 
TSQ 7000 (ESI).  
IR spectra. IR spectra were recorded with a Bio-Rad FTS 2000 MX FT-IR. 
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Melting point. Melting points were determined on a Büchi SMP or a Lambda Photometrics 
OptiMelt MPA 100. 
TLC analysis and column chromatography. Analytical TLC plates (silica gel 60 F254) and 
silica gel 60 (70-230 or 230-400 mesh) for column chromatography were purchased from 
Merck. Spots were visualized by UV light and/or staining with ninhydrine in EtOH.  
Dry DMF was purchased from Fluka, dichloromethane (DCM) was dried by adsorption and 
stored over molecular sieves. All other solvents and chemicals were of reagent grade and used 
without further purification. 
 
Electrophoresis of DNA on agarose gels. Plasmid DNA (circular and linearized) was 
electrophoretically resolved on 0.8% Agarose in TAE buffer (20 mM Tris/acetate, 1 mM 
EDTA) at a voltage of 100 V. The loading buffer consisted of 0.25% (w/v) Bromophenolblue, 
eneral, incubating for 5-10 min was sufficient to fully resolve the DNA 
ands on the gels. Destaining in pure deionized water was not strictly necessary, but helpful 
hen staining was performed in highly concentrated solutions of compound 1 to improve the 
st. pyrene moiety itself, a highly concentrated solution 
 
0.25% (w/v) xylenecyanol and 40% (w/w) Sucrose. For short dsDNA fragments (~300 bp), 
agarose gels of 2% were prepared. 
Zn2+-Cyclen-pyrene staining. Staining with Zn2+-Cyclen-pyrene 1 was done by soaking the 
gels in a solution of the fluorescent metal complex in deionized water at a probe concentration 
of 10–4 – 10–3 M. In g
b
w
contra To test the staining ability of the 
of the metal-free ligand of compound 1 in MeOH was prepared and diluted with deionized 
water (~10–3 M). After soaking the gel in this staining bath for up to 1 h, destaining was 
performed in water. 
Staining with compounds 2-4. Staining with fluorescent metal-chelates 2-4 was done
according to the procedure for staining with compound 1 as described above. 
Ethidium bromide staining. Staining with Ethidium bromide was performed according to 
standard procedures by treating the gels with an aqueous solution of Ethidium bromide 
(~1 mM when freshly prepared). Depending on the concentration of the staining bath, gels 
were soaked about 5-30 min. If necessary, gels were destained by washing with pure 
deionized water or an aqueous MgCl2 (~mM) solution for up to 30 min.  
Imaging. Zn2+-Cyclen-pyrene gels were placed on a PeqLab Superbright UV table (λmax = 
316 nm) and images were taken either by a Pentax K10D or a Canon EOS 450D. Ethidium 
bromide gels were imaged on either a standard UV table and photographed or as described for 
Zn2+-cyclen-pyrene gels.  
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Plasmid digestion. phMGFP DNA (Monster Green® Fluorescent Protein phMGFP vector 
Promega GmbH, Mannheim, Germany) was digested using NdeI restriction enzyme 
(CA/TATG) incubated in NEBuffer 4 (both New England Biolabs Inc., Frankfurt/Main, 
Germany) for 2 h at 37°C. By this, phMGFP (4707 bp) is cut at position 387 and 2628. 
Gel extraction. For gel extraction, a QIAquick Gel Extraction Kit (Qiagen GmbH, Hilden, 
ermany) was used. Gel extraction was performed according to manufacturer instructions. 
 
2.6.2 Cytotoxicity Investigations 
Cell lines and cell culture conditions. The human epithelial cervical cancer cell line HeLa 
[CCL-17, American Type Culture Collection (ATCC)] was cultured in MEM Earle’s 
medium. 500 mL MEM were supplemented with 0.8 mL Amphotericin B (250 µg/mL), 5 mL 
Penicillin/Streptomycin (10 000 U/mL / 10 000 µg/mL), 5 mL L-Glutamine (200 mM), 5 mL 
NEA (100x) and 50 mL fetal bovine serum (all from Biochrom AG, Berlin, Germany). Cells 
were split in 1:6-ratio twice a week. Chinese hamster lung fibroblast cells V-79 (HGPRT+) 
(ATCC, Manassas VA, USA) were maintained in DMEM (PAN Biotech, Aidenbach, 
Germany) supplemented with 10 µg/mL Thioguanine (Sigma Aldrich, Taufkirchen, 
Germany) and 10% fetal calf serum (PAN Biotech, Aidenbach, Germany) and split in 1:5-
ratio every seven days. All cells were cultured in a humidified incubator at 37°C in a 5% CO2 
eilmann et al.26 In brief, following trypsinization, HeLa cells were counted and 
1 250 cells/well were seeded into a 96 well plate (Techno Plastic Products AG, Trasadingen, 
witzerland). Afterwards, cells were exposed to compound 1 or Ethidium bromide dissolved 
 30% of EtOH (final concentrations: 0.1, 1, 10, 25, 50, 100 µM) for 72 h at 37°C and 5% 
CO2. For quantification of viability, cells were incubated with 15 µL/well MTT (tetrazolium) 
solution (4 mg/mL) for 4 h, which was then converted into insoluble, violet Formazan. After 
removal of the supernatant, 150 µL SDS solution (10%) was added to dissolve the formazan 
crystals. The next day, absorption was measured at 560 nm using a SpectraFluorPlus 
microplate reader (Tecan GmbH, Crailsheim/Germany). 
G
atmosphere. 
Determination of cytotoxicity. The cytotoxic effect of Zn2+-Cyclen-pyrene 1 and Ethidium 
bromide, respectively, was determined using two different cell lines, non-metabolizing HeLa 
(ATCC CCL-17) and metabolizing V-79 (HGPRT+).  
For evaluation of cytotoxicity on HeLa cells, the colorimetric MTT (tetrazolium) assay was 
conducted as previously described by Mosmann25 in a modified manner according to 
H
1
S
in
2 DNA Staining in Agarose Gels with Zinc(II)Cyclen-Pyrene 
 
 
 
 
49 
In a second cell culture based experiment according to Lindl,27 V-79 cells were also tested on 
the cytotoxic potential of RedSafe (Intron Biotechnology Inc., Seongnam, South Korea) 
beyond Zn2+-Cyclen-pyrene 1 and Ethidium bromide. In this assay format, approximately 200 
V-79 cells were seeded into Petri dishes of 6 cm in diameter (Corning Incorporated, Corning 
NY, USA) and exposed to compound 1 and Ethidium bromide dissolved in H2O at the same 
final concentrations described above; in the case of RedSafe, defined amounts of a 
commercially available 20 000x stock solution in DMSO were added to the cell medium to 
obtain the final concentrations (1:10 000, 1:20 000, 1:40 000). After 72 h of incubation at 
37°C in 5% CO2 atmosphere, cells were fixed (Methanol : Glacial acetic acid = 3 : 1), stained 
(Giemsa solution) and colonies were counted.  
All tests were performed in quadruplicates and all experiments have been repeated two times. 
Solvent control was set to 100%. Results were plotted as bar graphs and are expressed as 
means ± s.d. (range). 
 
2.6.3 Synthesis 
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b, c
Scheme S1: Synthesis of carboxyfluorescein
DIPEA, DMF/DCM; b) HCl-Et2O, DCM; c) strong basic anion exchange resin; d) ZnCl2, H2O, pH 7-8 
 
Following compounds were synthesized according to literature known procedures and 
determined to be consistent with analytical data derived from the corresponding published 
procedures: Zn2+-Cyclen-pyrene 1,23 Bis-Zn2+-bis-cyclen-pyrene 2,23 Bis-Zn2+-bis-cyclen-
carboxyfluorescein 4,21 3-Boc-cyclen,28 Tri-tert-butyl 10-(2-aminoethyl)-1,4,7,10-
tetraazacyclododecane-1,4,7-tricarboxylate 5.29 
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Regioisomeric Tri-tert-butyl 10-[2-(3',6'-dihydroxy-3-oxo-3H-spiro[isobenzofuran-1,9'-
anthene]-5/6-ylcarboxamido)ethyl]-1,4,7,10-tetraazacyclododecane-1,4,7-tricarboxylate (6) 
uorescein (0.10 g, 0.27 mmol) was filled in a 
-mixture of DCM and 
MF. Then, DIPEA (0.15 g, 164 µL, 1.20 mmol) and HOBt monohydrate (0.05 g, 
.32 mmol) were added and the mixture was cooled in an ice water bath to 0°C. After 
ng for 30 min, Tri-tert-butyl 10-(2-
mmol) was 
iven to the reaction mixture in small portions while stirring. 
 the following, the mixture was stirred for 2 h at 40°C then, the solvents were evaporated 
ified by column chromatography on flash-silica-gel 
HCl3 : MeOH = 11 : 1) to obtain the product as yellow, amorphous solid (0.19 g, 
 Hz, 0.4H, 21b), 8.05 (d, 3JH,H = 8.0 Hz, 0.4H, 22b), 7.59 (s, 0.4H, 19b), 
(+, 0.4C, 19b), 
.4 (Cquat., 1C, 14), 55.5 (–, 2C, 28), 50.4 (–, 1C, 26a/b), 48.6-48.2 (–, 6C, 
.8 (+, 6C, 41) ― 
x
A regioisomeric mixture of 5/6-Carboxyfl
nitrogen-flushed round bottom flask and dissolved in 5 ml of a 2:1
D
0
addition of TBTU (0.10 g, 0.32 mmol) and stirri
aminoethyl)-1,4,7,10-tetraazacyclododecane-1,4,7-tricarboxylate (0.21 g, 0.40 
g
In
and finally, the crude product was pur
(C
0.21 mmol, 81%). 
MP: 214°C ― 1H-NMR (400 MHz, CD3OD, COSY, ROESY, HSQC, HMBC): δ [ppm] = 
8.41 (s, 0.6H, 22a), 8.18 (dd, 3JH,H = 8.1 Hz, 4JH,H = 1.5 Hz, 0.6H, 20a), 8.11 (dd, 3JH,H = 
8.0 Hz, 4JH,H = 1.1
7.28 (d, 3JH,H = 8.1 Hz, 0.6H, 19a), 6.68 (d, 3JH,H = 2.2 Hz, 2H, 2+12), 6.59 (dd, 4JH,H = 
8.7 Hz, 5JH,H = 4.8 Hz, 2H, 5+9), 6.52 (dt, 3JH,H = 8.7 Hz, 4JH,H = 1.7 Hz, 2H, 3+11), 3.73-3.30 
(m, 14H, 25a/b+29+31+32), 2.91 (t, 3JH,H = 6.6 Hz, 1.2H, 26a), 2.82-2.64 (m, 4.8H, 26b+28), 
1.49-1.37 (m, 27H, 37+42) ― 13C-NMR (100 MHz, CD3OD, COSY, ROESY, HSQC, 
HMBC): δ [ppm] = 170.5 (Cquat., 1C, 16a/b), 168.2 (Cquat., 0.6C, 23a), 168.0 (Cquat., 0.4C, 
23b), 161.5 (Cquat., 2C, 4+10), 157.5 (Cquat., 2C, 38), 157.2 (Cquat., 1C, 34), 156.5 (Cquat., 0.6C, 
18a), 154.6 (Cquat., 0.4C, 18b), 154.0 (Cquat., 2C, 6+8), 142.1 (Cquat., 0.4C, 20b), 137.7 (Cquat., 
0.6C, 21a), 135.4 (+, 0.6C, 20a), 130.3 (+, 0.4C, 21b), 130.1 (+, 2C, 5+9), 128.7 (Cquat., 1C, 
17a/b), 126.2 (+, 0.4C, 22b), 125.7 (+, 0.6C, 19a), 124.8 (+, 0.6C, 22a), 123.9 
113.8 (+, 2C, 3+11), 110.7 (Cquat., 2C, 1+13), 103.6 (+, 2C, 2+12), 81.1 (Cquat., 2C, 40), 81.0 
(Cquat., 1C, 36), 79
29+31+32), 36.5 (–, 0.6C, 25a), 36.1 (–, 0.4C, 25b), 29.1 (+, 3C, 37), 28
50 
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IR (ATR) [cm–1]: ~  = 2976, 2935, 2830, 1760, 1657, 1611, 1456, 1417, 1365, 1246, 1155, 
1109, 993, 849, 761, 664, 605 ― UV (MeCN): λ (ε) = 454 (500), 480 (500)  ― 
ESI-MS (H2O/MeOH + 10 mmol/L NH4Ac): m/z (%) = 874.5 (100) [MH+], 774.4 (12) [MH+ 
– Boc], 437.7 (32) [M + 2H+], 287.6 (64) [M + 2H+ – 3Boc] ― HR-MS PI-LSI 
(MeOH/DCM/NBA): (C46H60N5O12) calc. 874.4238 [MH+], found 874.4225  
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Regioisomeric N-[2-(1,4,7,10-Tetraazacyclododecan-1-yl)ethyl]-3',6'-dihydroxy-3-oxo-3H-
spiro[isobenzofuran-1,9'-xanthene]-5/6-carboxamide tetrahydrochloride (7 · 4 HCl) 
, 1C, 26b), 44.2-41.5 (–, 6C, 29+31+32), 36.8 (–, 0.6C, 25a), 36.4 (–, 
 
Compound 6 (0.12 g, 0.13 mmol) was dissolved in 2 mL of DCM and cooled to 0°C in an ice 
water bath, while stirring. After slow addition of HCl saturated Et2O (2.65 mL), the mixture 
was allowed to reach room temperature and stirring continued a further 16 h, while a 
yellowish precipitate was formed. To get the desired product, the solvents were removed 
under reduced pressure yielding an orange amorphous solid (0.10 g, 0.13 mmol, quant.). 
MP: 175°C (decomp.) ― 1H-NMR (400 MHz, D2O, DEPT135): δ [ppm] = 8.71-6.80 (m, 9H, 
aryl-CH), 3.73-2.75 (m, 21H, CH2 + amide-NH) ― 13C-NMR (100 MHz, D2O, DEPT135): 
δ [ppm] = 132.0 (+, 2C, 5+9), 118.6 (+, 2C, 3+11), 102.5 (+, 2C, 2+12), 52.5 (–, 2C, 28), 48.1 
(–, 1C, 26a), 47.9 (–
0.4C, 25b) further signals could not be detected ― ESI-MS (MeCN/TFA): m/z (%) = 287.5 
(100) [M + 2H+], 574.2 (26) [MH+] 
–A column was filled with a strong basic anion exchange resin (OH -form; 1.5 cm x 3 cm) and 
rinsed first with a mixture of water/MeOH (1 : 1) then followed by pure water. The above 
obtained compound was dissolved in a small amount of water and eluted from the column 
thus yielding quantitatively the salt-free ligand 7. 
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Regioisomeric Zinc(II){N-[2-(1,4,7,10-tetraazacyclododecan-1-yl)ethyl]-3',6'-dihydroxy-3-
xo-3H-spiro[isobenzofuran-1,9'-xanthene]-5/6-carboxamid} dichloride (3) 
was dissolved in 2 mL of warm water and Zinc(II)-
MR (100 MHz, D2O, HSQC): δ [ppm] = 170.6 (Cquat., 1C, 16a/b), 168.5 (Cquat., 
 
.2 (+, 0.6C, 20a), 130.7-130.5 (+, 2C, 
o
The salt-free ligand 7 (92 mg, 0.16 mmol) 
chloride (23 mg, 0.17 mmol) was added. The mixture was heated up to reflux for 4 h while 
pH 7-8 was adjusted throughout the reaction by addition of aqueous LiOH solution (1 M) if 
necessary. In the following, the crude product was obtained after lyophilizing as an orange 
solid, which was then purified by precipitation from a mixture of 2-Propanol/MeOH with 
Et2O. The resulting brown solid was pelletized by centrifugation, dissolved in water and 
freeze-dried again to gain the pure product (110 mg, 0.16 mmol, 99%) as an orange, 
amorphous solid. 
MP: 187°C ― 1H-NMR (400 MHz, D2O, HSQC): δ [ppm] = 8.43 (s, 0.6H, 22a), 8.20-7.98 
(m, 1.4H, 20a+21b+22b), 7.59 (s, 0.4H, 19b), 7.28 (s, 0.6H, 19a), 6.88 (dd, 4JH,H = 8.7 Hz, 
5JH,H = 4.8 Hz, 2H, 2+12), 6.76-6.47 (m, 4H, 3+5+9+11), 3.73-2.74 (m, 21H, CH2 + amide-
NH) ― 13C-N
0.6C, 23a), 168.3 (Cquat., 0.4C, 23b), 165.0 (Cquat., 2C, 4+10), 163.9 (Cquat., 0.6C, 18a), 155.2 
(Cquat., 0.4C, 18b), 154.7 (Cquat., 2C, 6+8), 145.5 (Cquat., 0.4C, 17a), 144.2 (Cquat., 0.6C, 17b),  
138.1 (Cquat., 0.4C, 20b), 135.1 (Cquat., 0.6C, 21a), 132
2+12), 129.0 (+, 0.4C, 21b), 127.9 (+, 0.4C, 22b), 127.7 (+, 0.6C, 19a), 126.4 (+, 0.6C, 22a), 
125.3 (+, 0.4C, 19b), 116.5-115.8 (+, 2C, 3+11), 112.5-112.1 (Cquat., 2C, 1+13), 102.8 (+, 2C, 
5+9), 52.5-51.9 (–, 0.4C+0.6C, 25a/b), 48.1 (–, 0.6C, 26a), 47.9 (–, 0.4C, 26b), 46.7 (–, 2C, 
28),  44.3-41.5 (–, 6C, 29+31+32), 36.8-36.5 (–, 0.4C+0.6C, 25’a/b) ― ESI-MS (M): m/z (%) 
= 318.6 (100) [M2+], 636.2 (52) [M2+ – H+], 672.2 (35) [M2+ + Cl–] 
52 
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3 DETECTION OF PROTEIN PHOSPHORYLATION ON SDS-PAGE 
USING PROBES WITH A PHOSPHATE-SENSITIVE EMISSION 
RESPONSE 
 
 
 
Fluorescent probes for the detection of protein phosphorylation on SDS-PAGE are presented. 
The probes were designed using a dinuclear metal-chelate phosphate recognition unit and an 
environment-sensitive fluorophore. The specificity of the probes is determined by their 
binding site selectivity towards phosphate ions and the emission wavelength shift induced by 
table without specialized equipment like a 
laser-based gel scanner or a cooled camera detector.  
 
the change in the electrostatic environment of the fluorophore upon binding to a 
phosphorylated amino acid residue. The staining is fully reversible due to the non-covalent 
binding of the probe. Gel bands with less than 100 µg of phosphorylated -Casein are 
detectable with the new probes on a normal UV-
 
This chapter was published by Alexander Riechers, Florian Schmidt, Stefan Stadlbauer and Burkhard König, Bioconjug. Chem. 2009, 20, 
804-810 and registered at the European Patent Office (EPC 09155910.4-2117). 
 
Synthesis was done by F. Schmidt (compound 1) and S. Stadlbauer (compound 2). A. Riechers performed all gel based investigations 
presented inhere. 
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3.1 INTRODUCTION 
Staining of SDS gels is a standard technique in molecular biology. While silver- and 
Coomassie-staining are widely used for total protein staining, a number of stains selective for 
certain functional groups have emerged. Glycosylation,1-2 His-tags3 and phosphorylation4-5 are 
typical protein modifications targeted by selective gel stains reported so far. With respect to
g pathways and 
luorescence detection is the method of choice due to its inherent sensitivity. 
p
i tor,16 which changes its 
emission wavelength when bound to inorganic phosphate in solution, we designed 
fluorescently labeled bis-zinc(II)cyclen triazine complexes for staining of phosphorylated 
proteins in SDS gels. Bis-zinc(II)cyclen triazine was found to have a higher affinity towards 
phosphate than mononuclear zinc(II)cyclen complexes and was therefore used as the 
recognition moiety. As fluorophores, we selected the widely employed Carboxyfluorescein 
and 7-(Diethylamino) coumarin since a similar fluorophore has shown large solvatochromic 
emission shifts,17 which we associate to its sensitivity to the environment.18 The resulting 
 
its biological importance, phosphorylation6-7 is widely regarded as the most significant post-
translational modification. Phosphorylation plays an important part in signalin
it is estimated that 30% of the entire proteome becomes phosphorylated at some point.8 While 
there are phospho-specific antibodies available,9-10 they require blotting of the proteins onto a 
polyvinyldifluoride (PVDF) or nitrocellulose membrane and may also be specific for 
additional epitopes in proximity to the phosphorylation site. Alternatively, 32P-labeling of the 
proteins provides a very sensitive tool for detection of phosphorylation,11-12 however, the 
handling and disposal of radioactive material are costly, potentially hazardous and 
increasingly regulated. When staining for sub-stoichiometric features such as 
phosphorylation, f
The reported13 and commercially available4-5 fluorescent phospho-specific stains gain their 
sensitivity from their binding site specificity. While other fluorescent probes for 
hosphorylated amino acids have been reported,14 their selectivity has only been 
demonstrated for peptides without other metal-chelating amino acids like Histidine, 
Tryptophan or Cysteine. 
 
Herein, we report two novel phospho-specific gel stains based on the interaction of a 
metal-chelate binding site and a covalently attached fluorophore. We have previously 
described the binding of a Bis-zinc(II)cyclen triazine to phosphorylated Serine and 
Histidine.15 Since these artificial receptors showed high affinity under physiological 
conditions, we set about using this interaction in molecular biology. Based on these findings 
and a previously reported mono-zinc(II)cyclen coumar n recep
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ted in Figure 1 while the emission response concept is shown in 
cheme 1.  
 
 
3.2 
 
probes 1 and 2 are depic
S
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Figure 1: Probes 1 and 2 used for staining of phosphoproteins. Counterions are not shown. 
 
To lu  dilution series of 
pho or n-phosphory-
late ro -PPase 
and used as a control to ensure the emission response would not depend on the amino acid 
composition of the pro ecessary 
until ttle
 
 
 
eva ate the phospho-staining selectivity and sensitivity of our probes, a
sph ylated bovine -Casein was electrophoretically resolved from the no
d p tein BSA. In addition, a sample of -Casein was dephosphorylated using 
tein. After fixation, the gels were stained and destained when n
 li  or no background was visible.  
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Scheme 1: Probes 1 and 2 discriminate phosphorylated from nonphosphorylated proteins on SDS gels via 
emission intensity and wavelength shift, respectively. 
 
Probe 1 showed a distinct emission in the bands of phosphorylated -Casein, whereas the 
bands of dephosphorylated -Casein and BSA are barely visible (Figure 2). Bis-zinc(II)cyclen 
triazine complexes coordinate phosphate groups strongly, but we also expect an affinity of the 
probe to non-phosphorylated proteins due to the coordination of Histidine by the bis-
zinc(II)cyclen triazine15, 19 or further unspecific interactions. However, these interactions do 
not interfere with the specific detection of phosphorylation: The emission of the probe is 
quenched, when bound to non-phosphorylated amino acid residues and the emission remains, 
when bound to phosphorylated amino acid residues. Similar emission quenching effects have 
been previously reported for the interaction of Riboflavin with a zinc(II)imidazole complex20  
and for zinc(II)porphyrin with Histidine.21 To prove that the observed effects originate from 
the coordination of the bis-zinc(II)cyclen triazine complex and not from the binding of the 
fluorophore itself, a control gel was prepared and treated with Carboxyfluorescein. No 
staining could be observed in this experiment.  
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Figure 2: Gel stained with probe 1. Each lane contains 1 µg BSA (66 kDa). From left to right: lane 1: 1 µg -
Casein (23 kDa) dephosphorylated, lanes 2-8: 1 µg, 500 ng, 250 ng, 125 ng, 62 ng, 31 ng, 15 ng -Casein. Top 
image was taken on a UV table (-ex = 316 nm), lower image shows CBB R-250 total protein restain.  
 
When bound to phosphorylated -Casein, probe 2 showed a strong redshift in the emission 
compared to unphosphorylated -Casein and BSA (Figure 3). We attribute this spectral 
change to the different electronic environments when the probe molecule is either 
unspecifically interacting with non-phosphorylated amino acid residues, such as Histidine 
(unphosphorylated -Casein and BSA) or is coordinating a negatively charged 
phosphorylated amino acid residue (phosphorylated -Casein). These findings are in 
greement with the reported redshift in emission of a mono-zinc(II)cyclen coumarin complex 
anners or cooled camera detectors as 
escribed in the protocols of commercially available phosphoprotein gel stains our probes 
reach similar limits of detection.  
 
 
a
upon coordination to inorganic phosphate ions.16 To quantify this change in emission, 
fluorescence spectra of the gel bands were obtained using a photonic multi-channel analyzer 
equipped with a fiber optic (Figure 4). As with probe 1, a control gel was treated with the 
fluorophore itself, and again no staining was observed. 
 
With both probes, the dilution series proved that 62 ng of phosphorylated -Casein are still 
detectable on a normal UV-table by the unaided eye (which was protected from UV light) 
while imaging was performed with common digital cameras. Hence, even without the use of 
specialized equipment like laser-illuminated gel sc
d
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Figure 3: Gel stained with probe 2. Each lane contains 1 µg BSA (66 kDa). From left to right: lane 1: 1 µg -
Casein (23 kDa) dephosphorylated, lanes 2-8: 1 µg, 500 ng, 250 ng, 125 ng, 62 ng, 31 ng, 15 ng -Casein. Top 
image was taken on a UV table (ex = 316 nm), lower image shows CBB R-250 total protein restain.  
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Figure 4: Normalized emission spectra of gel bands stained with probe 2 acquired through a 455 nm 
longpass filter (ex = 316 nm). BSA band showed the same spectrum as dephosphorylated -Casein (data not 
shown).  
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monstrated the application of two new non-covalent, reversible and fluorescent 
DS-PAGE probes capable of indicating protein phosphorylation. The probes show different 
uorescence responses discriminating phosphorylated from non-phosphorylated proteins. 
phosphorylated protein by a significant increase of 
mission intensity, probe 2 is the first phosphoprotein gel stain to change its emission 
spectrum upon binding to a phosphorylated protein. The probes achieve their selectivity 
through a combination of the specificity of the dinuclear metal chelate binding site towards 
phosphate oxoanions and a modulation of the chromophore emission due to the proximity of 
the phosphorylated amino acid. The environment-sensitive fluorophore allows a clear 
distinction between phosphorylated and non-phosphorylated proteins on SDS-PAGE and 
allow the detection of 62 ng of phosphorylated -Casein on a normal UV-table. Evaluations 
of other metal chelate fluorophore conjugates and applications of the existing probes to 
monitor signaling pathways are currently under way.  
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3.5 MATERIALS & METHODS 
 
3.5.1 General 
All reactions were performed under an inert atmosphere of N2 using standard Schlenk 
techniques if not otherwise stated. A Varian Cary BIO 50 UV/VIS/NIR Spectrometer was 
used. A 1 cm quartz cell was purchased from Hellma and Uvasol solvents from Merck or 
Baker. Absorption and emission maxima are given in nm, molar absorptivities (ε) are given in 
M–1 cm–1. IR spectra were recorded on a Bio-Rad FT-IR FTS 155 and a Bio-Rad FTS 2000 
MX FT-IR using a Specac Golden Gate Mk II ATR accessory where stated. NMR 
spectrometers used were: Bruker Avance 600 (1H: 600.1 MHz, 13C: 150.1 MHz, T = 300 K), 
Bruker Avance 400 (1H: 400.1 MHz, 13C: 100.6 MHz, T = 300 K) and Bruker Avance 300 
(1H: 300.1 MHz, 13C: 75.5 MHz, T = 300 K). The chemical shifts are reported in δ [ppm] 
relative to internal standards (solvent residual peak). The spectra were analyzed by first order, 
the coupling constants are given in Hertz [Hz]. Characterization of the signals: s = singlet, d = 
doublet, t = triplet, q = quartet, m = multiplet, bs = broad singlet, dd = double doublet. 
Integration is determined as the relative number of atoms. Assignment of signals in 13C-
spectra was determined with DEPT-technique (pulse angle: 135 °) and given as (+) for CH3 or
pm for 1H-NMR, 0.1 ppm for 13C-NMR and 0.1 Hz for coupling constants. The solvent used 
 
CH, (–) for CH2 and (Cquat) for quaternary C. Error of reported values: chemical shift: 0.01 
p
is reported for each spectrum. Mass spectra were recorded on Finnigan MAT TSQ 7000 
(ESI). Melting Points were determined on a Büchi SMP-20 melting point apparatus and are 
uncorrected. TLC analyses were performed on silica gel 60 F-254 with a 0.2 mm layer 
thickness. Detection was via UV light at 254 nm / 366 nm or by staining with Ninhydrin in 
EtOH. For preparative column-chromatography, Merck Geduran SI 60 silica gel was used. 
Commercially available solvents of standard quality were used. Unless otherwise stated, 
purification and drying was done according to accepted general procedures. Compounds 3 and 
5 were synthesized according to literature known procedures.22-23 
 
Dephosphorylation by -PPase treatment. Bovine -Casein (40 µg, purchased from Sigma-
Aldrich) was treated with 400 U of -PPase (purchased from New England Biolabs) in Tris-
HCl (50 mM), NaCl (100 mM), Dithiothreitol (2 mM), MnCl2 (2 mM), EGTA (0.1 mM), 
0.01% Brij 35, pH 7.5 at 30°C for 6 h.  
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SDS-PAGE. Proteins were resolved on mini gels under denaturating and reducing Laemmli 
conditions on a PeqLab 45-1010-i apparatus. The gels consisted of a 4% Acrylamide (w/v), 
20 mM Tris-HCl (pH 6.8), 0.1% SDS (w/v) stacking gel and a 15% Acrylamide (w/v), 
375 mM Tris-HCl (ph 8.8), 0.1% SDS (w/v) running gel. A 25 mM Tris, 192 mM Glycine, 
0.1% SDS (w/v) running buffer (pH 8.3) was used. Protein samples were heated to 70°C for 
10 min with reducing and denaturating RotiLoad 1 sample buffer (purchased from Carl Roth, 
Germany) before being loaded onto the gel. The gels were run at 150 V until the proteins 
entered the running gel, then the voltage was increased to 250 V. Water cooling was used 
during the entire run. Fixation was accomplished by treating the gels with 50% MeOH / 10% 
AcOH twice, for 30 min and overnight, respectively.  
taining and imaging. The gels were soaked in deionized water (4 x 10 min) before being 
r, when 
e probes were used at higher concentrations, the gels could be destained by washing with 
l
 was accomplished with 0.1% 
oomassie R-250, 50% MeOH, 10% AcOH for 1 h. Destaining was accomplished in 7% 
1
S
treated with a solution of probe 1 or 2 in deionized water for 1 h with a probe concentration of 
10–7 M. We found destaining was not strictly necessary at this concentration, howeve
th
deionized water until a nonfluorescent background was obtained. Due to their non-covalent 
binding mode,24 the probes could be completely removed by repeated washing of the gel with 
water. Conveniently, removal of the probes was not necessary for Coomassie restaining. 
The gels were wrapped in cling film to prevent them from drying out and placed on a PeqLab 
Superbright UV table (ex = 316 nm). Images were taken using either a Pentax K10D or a 
Traveler DC 8500. Emission spectra of individual protein bands were obtained using the same 
UV table and a Hamamatsu PMA-11 photonic multi-channel analyzer. Data were acquired 
using the supplied PMA Optic software. A 455 nm ongpass filter was placed on top of the gel 
to prevent the UV light saturating the detector. Longpass filters with a shorter cutoff proved 
unsuitable as they showed a strong fluorescence when subjected to the UV light.  
After fluorescence imaging, a restain for total protein
C
AcOH, 10% MeOH over night. The gels were again wrapped in cling film and scanned using 
an office scanner.  
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.5.2 Synthesis of Probes 1 and 2 3
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Figure S1: Preparation of probes 1 and 2 
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Regioisomeric 1,4,7-Tri-tert-butyl 10,10'-{6-[2-(3',6'-dihydroxy-3-oxo-3H-spiro[isobenzo-
furan-1,9'-xanthene]-5/6-ylcarboxamido)ethylamino]-1,3,5-triazine-2,4-diyl}bis(1,4,7,10-
tetraazacyclododecane-1,4,7-tricarboxylate) (6) 
In a nitrogen flushed round bottom flask, regioisomeric 5/6-Carboxyfluorescein (0.15 g, 
0.40 mmol) was dissolved in 10 mL of a mixture of DCM and DMF (2:1), then DIPEA 
.17 g, 180 µL, 1.32 mmol) and HOBt monohydrate (0.07 g, 0.48 mmol) were added. While 
irring, the mixture was cooled to 0°C in an ice water bath to add TBTU (0.15 g, 0.48 mmol). 
tyl 10,10'-[6-(2-aminoethylamino)-1,3,5-triazine-2,4-
ude product was purified by column chromatography 
(CHCl3 : MeOH = 15 : 1) on flash-silica-gel yielding compound 6 as an orange amorphous 
solid (0.34 g, 0.23 mmol, 59%). 
MP: 207°C ― 1H-NMR (600 MHz, MeOD, COSY, ROESY, HSQC, HMBC): δ [ppm] = 
8.36 (s, 0.7H, 22a), 8.13 (d, 3JH,H = 7.9 Hz, 0.7H, 20a), 8.07 (d, 3JH,H = 8.1 Hz, 0.3H, 21b), 
8.03 (d, 3JH,H = 8.0 Hz, 0.3H, 22b), 7.61 (s, 0.3H, 19b), 7.24 (d, 3JH,H = 8.0 Hz, 0.7H, 19a), 
6.68 (dd, 3JH,H = 1.8 Hz, 5JH,H = 1.8 Hz, 2H, 2+12), 6.57 (dd, 4JH,H = 8.7 Hz, 5JH,H = 8.7 Hz, 
2H, 5+9), 6.52 (dd, 3JH,H = 8.7 Hz, 4JH,H = 2.3 Hz, 2H, 3+19), 3.99-3.20 (m, 36H, 25a/b, 
26a/b, 32+33+35+36), 1.45-1.37 (m, 54H, 41+45) ― 13C-NMR (150 MHz, MeOD, COSY, 
ROESY, HSQC, HMBC): δ [ppm] = 170.4 (Cquat., 0.3C, 16b), 170.3 (Cquat., 0.7C, 16a), 168.5 
(Cquat., 0.7C, 23a), 168.3 (Cquat., 0.3C, 23b), 167.8 (Cquat., 2C, 30), 167.5 (Cquat., 0.7C, 28a), 
167.3 (Cquat., 0.3C, 28b), 161.3 (Cquat., 2C, 4+10), 158.0 (Cquat., 6C, 38+42), 156.7 (Cquat., 
0.7C, 18a), 154.4 (Cquat., 0.3C, 18b), 153.9 (Cquat., 2C, 6+8), 142.4 (Cquat., 0.3C, 20b), 138.0 
(Cquat., 0.7C, 21a), 135.5 (+, 0.7C, 20a), 130.2 (+, 0.3C, 21b), 130.1 (+, 2C, 5+9), 128.5 (Cquat., 
(0
st
After 30 min, 1,4,7-Tri-tert-bu
diyl]bis(1,4,7,10-tetraazacyclo-dodecane-1,4,7-tricarboxylate) 3 (0.47 g, 0.44 mmol) was 
added in portions and the reaction mixture was heated to 40°C for 2 h. Subsequently, the 
solvents were evaporated and the cr
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(+, 0.7C, 19a), 124.8 (+, 0.7C, 22a), 124.0 (+, 0.3C, 
9b), 113.7 (+, 2C, 3+11), 110.8 (Cquat., 2C, 1+13), 103.7 (+, 2C, 2+12), 81.5 (Cquat., 2C, 38), 
), 79.4 (Cquat., 1C, 14), 51.4 (–, 16C, 32+33+35+36), 41.7 (–, 0.7C, 25a), 
1C, 17a/b), 126.1 (+, 0.3C, 22b), 125.6 
1
81.4 (Cquat., 4C, 42
41.5 (–, 0.3C, 25b), 40.9 (–, 0.7C, 26a), 40.8 (–, 0.3C, 26b), 29.9 (+, 6C, 41), 28.8 (+, 12C, 
45) ― IR (ATR) [cm–1]: ~ = 3318, 2971, 2935, 1766, 1689, 1665, 1539, 1466, 1410, 1365, 
1247, 1157, 1024, 852, 811, 751, 665 ― UV (MeCN): λ (ε) = 454 (2200), 481 (1900) ― ESI-
MS (DCM/MeOH + 10 mmol/L NH4Ac): m/z (%) = 720.0 (100) [M + 2H+], 1439.0 (5) 
[MH+]  
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Regioisomeric N-{2-[4,6-di(1,4,7,10-Tetraazacyclododecan-1-yl)-1,3,5-triazin-2-ylamino] 
ethyl}-3',6'-dihydroxy-3-oxo-3H-spiro[isobenzofuran-1,9'-xanthene]-5/6-carboxamide 
nonahydrochloride (7) 
Compound 6 (80 mg, 0.05 mmol) was dissolved in as little DCM as possible and cooled to 
0°C before HCl saturated Et2O (1.06 mL) was added slowly to this solution. Stirring was 
continued for 16 h while the reaction mixture was allowed to reach room temperature. 
Formation of a yellowish precipitate was observed. The desired product was obtained by 
 vacuum as a red amorphous solid (50 mevaporation of the solvent in g, 0.05 mmol, quant.), 
which was deprotonated by ion exchange column on weakly basic anion exchanger resin. 
O, COSY, HSQC, HM δ
, 3.87-3.39 (m, 12H, 25+26+36), 3.27-2.88 (m, 24H, 
32+33+35) ― 13C-NMR (150 MHz, D2O, COSY, HSQC, HMBC): δ [ppm] = 179.9 (Cquat., 
1H-NMR (600 MHz, D2 BC):  [ppm] = 8.43 (s, 2H, 24), 7.97 (s, 0.6H, 
22a), 7.93-7.86 (d, 3JH,H = 7.4 Hz, 0.4H, 21b), 7.85-7.79 (d, 3JH,H = 7.4 Hz, 0.4H, 22b), 7.74 
(bs, 0.6H, 20a), 7.44 (s, 0.4H, 19b), 7.02 (bs, 0.6H, 19a), 6.99-6.70 (m, 2H, 2+12), 6.61-6.41 
(m, 2H, 3+11), 6.41-6.13 (m, 2H, 5+9)
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2C, 30), 174.2 (Cquat., 0.4C, 16b), 173.2 (Cquat., 0.6C, 16a), 171.5 (Cquat., 1C, 28), 170.1 (Cquat., 
0.4C, 23b), 169.5 (Cquat., 0.6C, 23a), 167.2-166.3 (Cquat., 2C, 4+10), 158.6-158.4 (Cquat., 2C, 
6+8), 157.9 (Cquat., 0.6C, 18a), 157.2 (Cquat., 0.4C, 18b), 143.7 (Cquat., 0.4C, 20b), 140.7 (Cquat., 
0.6C, 21a), 135.6 (Cquat., 0.4C, 17b), 135.2 (Cquat., 0.6C, 17a), 131.9-131.5 (+, 2C, 2+12), 
130.7 (+, 0.6C, 19a), 129.5 (+, 0.4C, 22b), 129.2 (+, 0.4C, 21b), 128.7 (+, 0.4C, 19b), 128.4 
(+, 1.2C, 20a+22a), 123.3 (+, 2C, 3+11), 104.4 (+, 2C, 5+9), 46.5-45.2 (–, 12C, 33+35+36), 
43.9 (–, 4C, 32), 40.8-40.6 (–, 1C, 25a/b), 39.9 (–, 1C, 26) ― ESI-MS (H2O/MeOH + 0.10% 
TFA): m/z (%) = 280.1 (100) [M + 3H+]3+, 419.8 (63) [M + 2H+]2+, 838.5 (4) [MH+], 874.4 
(3) [MH+ + HCl] 
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Bis-Zinc(II)(N-{2-[4,6-di(1,4,7,10-tetraazacyclododecan-1-yl)-1,3,5-triazin-2-ylamino] 
ethyl}-3',6'-dihydroxy-3-oxo-3H-spiro[isobenzofuran-1,9'-xanthene]-5/6-carboxamide) 
tetrachloride (1) 
Deprotonated compound 7 (48 mg, 0.06 mmol) was dissolved in 2 mL of warm water, then 
H-NMR (600 MHz, D2O, COSY, HSQC, HMBC): δ [ppm] = 8.14-6.06 (m, 9H, aryl), 4.25-
.62 (m, 35H, amide-NH+CH2) ― 13C-NMR (150 MHz, D2O, COSY, HSQC, HMBC): 
δ [ppm] = 174.1-103.2 (Cquat. & –,  24C, 1-23+28+30), 46.3-38.7 (–, 18C, 25+26+32-36) ― 
UV (40 mM TRIS-buffer, 10 mM MgCl2, 2 mM DTE, pH 7.6): λ (ε) = 321 (6400), 497 
(56300) ― Fluorescence (40 mM TRIS-buffer, 10 mM MgCl2, 2 mM DTE, pH 7.6): exc. 
Zinc(II)chloride (16 mg, 0.12 mmol) was added. After pH-adjustment to 7-8 with saturated 
NaHCO3, aq., the mixture was heated to 100°C for 2 h while stirring. The desired product was 
isolated by lyophilisation of the reaction mixture as a dark orange, amorphous solid (48 mg, 
0.04 mmol, 75%).  
1
2
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, I-MS (H2O/MeOH + 10 mmol/L NH4Ac): m/z (%) = 
481.8 (37) [M4+ – 2H+]2+, 511.4 (70) [M4+ – H+  CH3COO–]2+ 
 
494 nm emission max. 526 nm ― ES
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7-Diethylamino-2-oxo-2H-chromene-3-carboxylic acid {2-[4,6-bis-(1,4,7,10-tetraaza-
cyclododec-1-yl)-[1,3,5]triazin-2-yl]-ethyl}-1,4,7-tricarboxylic acid tri-tert-butyl ester (8) 
7-Diethylamino-2-oxo-2H-chromene-3-carboxylic acid (150 mg, 0.56 mmol), DIPEA 
(386 µL, 2.24 mmol), TBTU (203 mg, 0.63 mmol), and HOBt monohydrate (97 mg, 
0.63 mmol) were dissolved under nitrogen atmosphere in dry DMF (4 mL) under ice cooling 
and stirred for 1 h. Subsequently amine 3 (635 mg, 0.59 mmol) dissolved in DMF (2 mL) was 
added drop wise. The reaction was allowed to warm to room temperature and was stirred 
30 min at room temperature and 3 h at 40°C. The reaction progress was monitored by TLC 
(CHCl3 : MeOH = 97.5 : 2.5). After completion of the reaction the solvent was removed and 
the crude product was purified by flash column chromatography on flash silica gel 
(CHCl3 : MeOH = 97.5 : 2.5; Rf EtOAc = 0.60) yielding compound 8 (684 mg, 0.52 mmol, 
3%) as a yellow solid. 
P: 147°C ― 1H-NMR (400 MHz, CDCl3, COSY, HSQC, HMBC): δ [ppm] = 8.90 (bs, 1H, 
15), 8.65 (s, 1H, 10), 7.39 (d 3 3  = 8.9 Hz, 4JH,H = 2.4 Hz, 
H, 13), 6.46 (d, 4JH,H = 2.3 Hz, 1H, 12), 5.02 (bs, 1H, 18), 3.42 (q, 3JH,H = 7.1 Hz, 4H, 2), 
.76-3.11 (m, 36H, 16+17+23+24+26+27), 1.40 (s, 18H, 32), 1.42 (s, 36H, 36), 1.21 (t, 
H,H = 7.1 Hz, 6H, 1) ― 13C-NMR (100 MHz, CDCl3, COSY, HSQC, HMBC): δ [ppm] = 
65.8 (Cquat., 3C, 19+21), 163.7 (Cquat., 1C, 14), 162.5 (Cquat., 1C, 8), 157.6 (Cquat., 1C, 6), 156.2 
quat., 6C, 29+33), 152.5 (Cquat., 1C, 4), 148.0 (+, 1C, 10), 131.1 (+, 1C, 5), 110.1 (Cquat., 1C, 
9), 109.9 (+, 1C, 13), 108.3 (Cquat., 1C, 11), 96.5 (+, 1C, 12), 79.6 (Cquat., 6C, 31+35), 50.2 (–, 
16C, 23+24+26+27), 45.0 (–, 2C, 2), 40.8 (–, 1C, 17), 39.6 (–, 1C, 16), 28.4, 28.5 (+, 18C, 
32+36), 12.4 (+, 2C, 1) ― IR (ATR) [cm–1]:
9
M
, JH,H = 8.9 Hz, 1H, 5), 6.82 (dd, JH,H
1
3
3J
1
(C
 ~= 2974, 2933, 1686, 1619, 1584, 1532, 1512, 
1466, 1409, 1364, 1246, 1158, 971, 751 ― UV (CHCl3): λ (ε) = 419 (41000) ― ESI-MS 
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(DCM/MeOH + 10 mmol/L NH4Ac): m/z (%) = 362.2 (17) [M + 2H+ – 5Boc]2+, 412.3 (34) 
[M + 2H+ – 4Boc]2+, 462.3 (55) [M + 2H+ – 3Boc]2+, 512.4 (51) [M + 2H+ – 2Boc]2+, 562.5 
(25) [M + 2H+ – Boc]2+, 612.5 (12) [M + 2H+]2+, 1324.0 (100) [MH+]  
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 (m, 2H, 12+13), 3.89 (bs, 8H, cyclen-CH2), 3.75 (t, JH,H = 
3
M
d 
. 
(60 mg, 59 µmol) was dissolved in water, put onto the column and eluated with water. The 
 
7-Diethylamino-2-oxo-2H-chromene-3-carboxylic acid {2-[4,6-bis-(1,4,7,10-tetraaza-cyclo-
dodec-1-yl)-[1,3,5]triazin-2-ylamino]-ethyl}-amide (9) 
Compound 8 (275 mg, 0.21 mmol) was dissolved in DCM (4 mL) and cooled to 0°C. 
Subsequently, 4.5 mL of HCl saturated Et2O were added. The solution was stirred 15 min at 
0°C and an additional 20 h at room temperature. The solvent was removed in vacuo, the 
residue was redissolved in water and extracted with DCM (3x). Subsequently the combined 
organic layers were dried over MgSO4 and the solvent was evaporated yielding the protonated 
hydrochloride of compound 9 as a yellow solid in quantitative yield (213 mg, 0.21 mmol).  
1H-NMR (400 MHz, CDCl3, COSY, HSQC, HMBC): δ [ppm] = 8.72 (s, 1H, 10), 7.96 (d, 
3JH,H = 8.4 Hz, 1H, 5), 7.56-7.37 3
5.6 Hz, 2H, 17), 3.57-3.72 (m, 6 H, 2+16), 3.54-2.97 (m, 24H, cyclen-CH2), 1.13 (t, JH,H = 
7.3 Hz, 6H, 1) ― 13C-NMR (100 MHz, CDCl3, COSY, HSQC, H BC): δ [ppm] = 164.1 
(Cquat., 1C, 14), 163.6 (Cquat., 1C, 21), 161.4 (Cquat., 1C, 8), 155.8 (Cquat., 1C, 19), 155.2 (Cquat., 
1C, 21’), 154.9 (Cquat., 1C, 6), 147.6 (+, 1C, 10), 143.2 (Cquat., 1C, 4), 132.5 (+, 1C, 5), 118.1 
(+, 1C, 13), 117.9 (Cquat., 1C, 9), 117.6 (Cquat., 1C, 11), 108.8 (+, 1C, 12), 52.6 (–, 2C, 2), 48.3 
(–, 2C, cyclen-CH2), 47.7 (–, 2C, cyclen-CH2), 46.1 (–, 4C, cyclen-CH2), 44.3 (–, 6C, cyclen-
CH2), 44.0 (–, 2C, cyclen-CH2), 39.9 (–, 1C, 17), 39.0 (–, 1C, 16), 10.1 (+, 2C, 1) ― ESI-MS 
(MeCN/TFA): m/z (%) = 362.3 (100) [M + 2H+]2+, 723.5 (10) [MH+] 
To obtain the free base of compoun 9 a weakly basic ion exchanger resin was swollen for 
15 min in water and washed neutral with water A column was charged with resin (473 mg, 
40.0 mmol hydroxy equivalents at a given capacity of 5 mmol/g). The hydrochloride salt 
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 =
H2), 3.02 (bs, 8H, cyclen-CH2), 1.04 (t, 3JH,H = 7.1 Hz, 6H, 1) ― 13C-NMR 
50 MHz, D2O, COSY, ROESY, HSQC, HMBC): δ [ppm] = 166.8 (Cquat., 2C, 21), 166.7 
quat., 1C, 19), 165.3 (Cquat., 1C, 8), 163.1 (Cquat., 1C, 14), 157.0 (Cquat., 1C, 6), 153.6 (Cquat., 1C, 
4), 148.1 (+, 1C, 10), 131.7 (+, 1C, 12), 111.4 (+, 1C, 13), 107.6 (Cquat., 1C, 9), 106.0 (Cquat., 
1C, 11), 95.5 (+, 1C, 5), 46.1 (–, 4C, cyclen-CH2), 45.7 (–, 4C, cyclen-CH2), 45.1 (–, 2C, 2), 
44.7 (–, 4C, cyclen-CH2), 42.8 (–, 2C, cyclen-CH2), 42.4 (–, 2C, cyclen-CH2), 40.1 (–, 1C, 
16), 39.4 (–, 1C, 17), 11.8 (+, 2C, 1) ― IR (ATR) [cm–1]:
elution of the product was controlled by pH indicator paper (pH > 10) and was completed 
when pH was again neutral. The eluate was concentrated and lyophilised to yield (43 mg, 
59 µmol, 100%) the free base 9 as a yellow solid. 
MP: 169°C ― 1H-NMR (600 MHz, D2O, COSY, ROESY, HSQC, HMBC): δ [ppm] = 8.28 
(bs, 1H, 15), 8.09 (s, 4JH,H  1.8 Hz, 1H, 10), 7.24 (d, 3JH,H = 9.2 Hz, 1H, 12), 6.58 (d, 3JH,H = 
9.0 Hz, 1H, 13), 6.13 (d, 4JH,H = 1.8 Hz, 1H, 5), 3.62 (bs, 8H, cyclen-CH2), 3.48 (t, 3JH,H = 5.2 
Hz, 2H, 17), 3.38 (t, 3JH,H = 4.6 Hz, 2H, 16), 3.27 (q, 3JH,H = 7.0 Hz, 4H, 2), 3.12 (bs, 16H, 
cyclen-C
(1
(C
 ~ = 3382, 3315, 2968, 2732, 1694, 
1576, 1537, 1506, 1417, 1350, 1231, 1134, 1079, 809 ― UV (CHCl3): λ (ε) = 260 nm 
(12500), 426 (43300) ― ESI-MS (TFA/MeCN): m/z (%) = 241.7 (10) [M + 3H+]3+, 362.2 
(100) [M + 2H+]2+, 723.5 (6) [MH+], 837.4 (3.0) [MH+ + TFA] ― HR-MS: (C35H58N14O3) 
calc. 723.4895 [MH+], found 723.4915 
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Bis-Zinc(II)(7-Diethylamino-2-oxo-2H-chromene-3-carboxylic acid {2-[4,6-bis-(1,4,7,10-
tetraaza-cyclo-dodec-1-yl)-[1,3,5]triazin-2-ylamino]-ethyl}-amide) tetraperchlorate (2)  
Compound 9 (43 mg, 59 µmol) was dissolved in 1 mL of water and heated to 65°C to get a 
clear yellow solution. ubsequently Zinc(II)perchlorate (44 mg, 119 µmol) dissolved in 1 ml 
of water was added slowly. The reaction mixture was stirred for an additional 28 h at 65°C. 
The solvent was removed in vacuo and the residue was redissolved in water and lyophilized. 
Probe 2 (74 mg, 59 µmol, 100%) was obtained as a yellow solid.  
S
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MP: 166°C ― 1H-NMR (300 MHz, CD3CN): δ [ppm] = 9.23 (bs, 1H, NH), 8.72 (s, 1H, CH), 
7.58 (d, 3JH,H = 9.1 Hz, 1H, CH), 6.80 (d, 3JH,H = 9.1 Hz, 1H, CH), 6.55 (s, 1H, CH), 5.35-
6.65 (m, 6H, cyclen-NH), 4.50-3.71 (m, 8H, cyclen-CH2), 3.49 (q, 3JH,H = 7.0 Hz, 6H, ethyl-
CH2, ethylene diamine-CH2), 3.37 (bs, 2H, ethylene diamine-CH2), 3.26 (bs, 12H, cyclen-
CH2), 3.02 (bs, 8H, cyclen-CH2), 2.45 (bs, 4H, cyclen-CH2), 1.19 (t, 3JH,H = 7.0 Hz, 6H, ethyl-
CH3) ― IR (ATR) [cm–1]: ~ = 3246, 2938, 2864, 1558, 1457, 1421, 1342, 1287, 1083, 968, 
793 ― UV (HEPES pH 7.4, 25 mM): λ (ε) = 432 (25800) ― ESI-MS (TFA/MeCN): m/z (%) 
= 425.1 (28) [M4+ – 2H+]2+, 455.7 (50) [M4+ – H+ + CH3COO–]2+, 485.5 (100) [M4+ + 
2CH3COO–]2+ 
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All compounds were synthesized by F. Schmidt. NMR binding investigations were performed by I. C. Rosnizeck. 
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Zinc(II)cyclen-peptide hybrid compounds and bis-zinc(II)cyclen complexes are prepared as 
potential binders of the guanine nucleotide binding protein Ras, an important molecular 
switch in cellular signal transduction. The design of the compounds is based on the previous 
observation that zinc(II)cyclen complexes could serve as lead compounds for inhibitors of 
Ras-effector interaction and thus be able to interrupt Ras induced signal transduction. 
Zinc(II)cyclen selectively stabilizes conformational state 1 of active Ras, a conformational 
state with drastically decreased affinity to effector proteins like Raf-kinase. To achieve higher 
binding affinities of such Ras-Raf interaction inhibitors, zinc(II)cyclen conjugates with short 
peptides, derived from the sequence of the Ras-activator SOS, were  prepared by solid phase 
synthesis protocols. Dinuclear bis-zinc(II)cyclen complexes were obtained from alkyne-azide 
cycloaddition reactions. NMR investigations of the prepared compounds revealed that the 
peptide conjugates do not lead to an increase in Ras binding affinity of the metal complex – 
peptide conjugates. The dinuclear zinc complexes lead to an immediate precipitation of the 
protein prohibiting spectroscopic investigations of their binding. 
4 ZINC(II)CYCLEN PEPTIDE CONJUGATES INTERACTING 
WITH THE WEAK EFFECTOR BINDING STATES OF RAS  
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N 
he development of small molecules for the inhibition of protein-protein interactions is of 
high curr
sufficien  approach to 
imp ve 
binding s ands may lead to improved binding affinities by 
add ve 
ways to inhibit protein-protein interactions by chemical inhibitors: They can either block the 
inte ce
inhibition) leading to an altered binding ability of the surface of the protein interface.1 
Ras ot
certain human cancer types,7-9 m, in an equilibrium 
between at least two confor 10 Ras variants, which exist 
pred w a more than 20-fold decreased affinity to 
eff or 
concentr , that the azamacrocyclic metal complex Zn2+-1,4,7,10-
Tet za
equilibriu
Zn2+ yc 13-15 finity near the 
-phosphate at the active site of Ras stabilizing conformation of state 1. Ras in conformational 
state , w
effector-protein complex formation in the cell, did not show significant interaction with Zn2+-
Cycle . T
for Zn2+-cyclen binding could be obtained 31P NMR 
spectroscopy. Therefore, Zn -Cyclen can serve as lead for inhibitors of Ras-Raf interaction. 
In th  w
The mutant Ras(T35A) was chosen because it predominantly exists in the conformational 
state , w
wild-type
the formation of such Ras-effector-protein complexes induces certain cell signalling pathways 
leadi g t  of considerable 
inte t.7
4.1  INTRODUCTIO
T
ent interest due to possible implications in medicinal chemistry. However, achieving 
t binding affinity and selectivity is still challenging.1-3 A very common
ro the affinity and selectivity of a low affinity binder is the introduction of additional 
ites. Such bi- or multivalent lig
iti or even cooperative action of the different binding sites.4-6 There are two principal 
rfa  (competitive inhibition) or induce changes in the proteins conformation (allosteric 
pr ein, which is known for several years to play an important role in pathogenesis of 
 exists in its active, GTP-bound for
mational states (state 1 and state 2).
ominately in conformational state 1 sho
ect proteins.11 This affinity is too low in order to transduce the signal at physiological 
ations. We could show
raa cyclododecane (Cyclen) selectively binds state 1,12 and that it is able to shift the 
m totally towards that weak effector-binding conformation at higher concentration. 
-C len shows affinity to phosphate ions  and binds with millimolar af
 2 hich represents the strong effector binding mode, and thus is responsible for Ras-
n he same results are obtained for GDP-bound, inactive Ras, here again no indication 
in the active site as studied by 
2+
is ork we used the GTP analogue GppNHp in order to resist GTPase activity of Ras. 
 1 hich should be recognized by the ligand, and because for this mutant in contrast to 
 Ras all resonances can be obtained in the [1H-15N]-HSQC NMR experiments. As 
n o unregulated cell growth in tumour cells, its selective inhibition is
res  However, a 20-fold excess of Zn2+-Cyclen is required to shift the equilibrium 
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The structure of the metal-cyclen complex with Ras was solved recently16 where two 
Zn2 - yc
bidentate ligands based on the Zn2+-cyclen binding motif were synthesized: 1. Heterotopic 
pepti e-m
the Ras-effector-protein interaction.  2. Bidentate bis(Zn -cyclen) metal-complexes, as 
previous NMR-investigations show 2+-Cyclen 
on th pr
 
 
4.2  RESULTS & DISCUSSION  
 
4.2.1  Ligand Design 
Figure 1 shows the solution structure of the Ras.Mg2+.GppNHp complex in the conformational 
state that is only weakly interacting with effectors. This state is stabilised by Zn2+-Cyclen 
bound to the -phosphate of GppNHp.16 
 
ly towards state 1 due to the low binding affinity of the metal-complex to the active 
s.12  
+ c len binding sites could be identified. To increase the binding affinity, two types of 
d etal complex hybrid-ligands, as it was known that short peptides can interfere with 
17-19 2+
ed that there is more than one binding site for Zn
e otein surface of Ras.16 
 
Figure 1: Solution structure of Zn2+-Cyclen complexed to Ras.Mg2+.GppNHp in conformational state 1. 
The solution structure of Ras complexed with Zn2+-cyclen was taken from Rosnizeck et al.16; Zn2+-Cyclen is 
depicted in white; the second binding site of Zn2+-Cyclen is indicated in red, the amino acids of Ras interacting 
in the crystal structure of the Ras-SOS complex with the SOS-pentapeptide from amino acid 822-826 (Leu-Lys-
Met-Ile-Arg)18 are labelled in green 
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In the approach presented here Zn2+-Cyclen bound to its site close to the -phosphate group of 
GppNHp should be linked with a second interacting group via a flexible linker. State 1 is 
assumed to be closely related to the conformation of Ras found in the complex with its 
nucleotide exchange factor SOS (son of sevenless).20-21 Therefore, the crystal structure of the 
Ras-SOS complex18 was used to derive Zn2+-cyclen – peptide ligands (Figure 2) containing a 
possible additional interacting site with Ras. The pentapeptide contains three amino acids 
(Leu822, Ile825, Arg826) from the sequence of the exchange factor SOS, which directly 
interact with Ras. The amino acids that do not contribute to the interaction with Ras have been 
replaced by glycines in order to allow for more flexibility. Next, the distance between the 
binding position of Zn2+-Cyclen at the proteins active centre and the peptide was estimated 
and the peptide was tethered to Zn2+-Cyclen by spacers of different lengths. 
 
 
 
 
Figure 2: Zn2+-Cyclen - peptide hybrid ligands 1 for Ras binding. 
 
Two binding sites for Zn2+-cyclen complexes had been identified on the surface of the Ras 
protein.16 One is located close to the -phosphate of the bound nucleotide, the other is located 
close to the C-terminus of Ras. In binding site 1 the Zn2+ ion is directly coordinated to the 
phosphate group, in binding site 2 to the imidazole nitrogen of His166 of Ras. Dinuclear 
bis(Zn2+-cyclen) complexes that recognize the two binding sites should therefore show an 
increased affinity to Ras-GTP, if they act synergistically or even cooperatively. (Figure 4) 
However, if the PEG linker would be smaller than the distance between the Ras GTP binding 
site and the Zn2+-Cyclen surface binding site, the compound should be able to cross-link the 
proteins. PEG-linked bis(Zn2+-cyclen) complexes based on tri- and tetra(ethylene glycol) units 
should be suitable to probe the hypothesis. 
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Figure 4: Bis(Zn2+-cyclen) complexes 18 and bis(Cu2+-cyclen) complexes 19 
 
 
4.2.2  Synthesis and Characterization of Zn2+-Cyclen - peptide Hybrid Ligands 
Solid phase peptide synthesis (SPPS) and Fmoc-strategy were used to prepare ligands 1 in 
analogy to our previously published protocols.22-23 The appropriate PEG spacers, assuring 
sufficient water solubility of the target molecules, were synthesized as shown in Scheme 1. 
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Scheme 1: Synthesis of Fmoc-protected amino-PEG-acid spacers 9. a) TsCl, NaOH; b) NaN3, DMF; c) Pd/C, 
H2, THF; d) Boc2O, DCM; e) 2-bromoacetic acid, NaOH, THF/toluene; f) HClaq. (~18%); g) Fmoc-succinimide, 
K2CO3, water 
 
Ethylene glycols were mono-tosylated according to literature known procedures giving 
compounds 3a and 3b.24-25 For the preparation of azides 4a and 4b two different reaction 
conditions have been reported.25-27 In our hands, the room temperature reactions gave higher 
79 
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to 80°C. The clean catalytic reduction of 4a was performed yields compared to heating 
analogously to the reported conversion of 4b27 and the amines were Boc protected to give 
6a-c.28-29 The subsequent alkylation step with 2-Bromoacetic acid in the presence of Sodium 
hydroxide provided the corresponding acids in moderate yields. Finally, the Boc-protection 
groups were replaced by Fmoc. The synthesis of compound 9c was performed following an 
already published method.30 
An N-protected cyclen carboxylic acid was prepared for later use in the Fmoc SPPS protocol 
(Scheme 2). Compound 1331 was obtained in almost quantitative overall yield starting from 
compound 11, which was prepared according to a literature known procedure.32  
 
 
 
Scheme 2: Synthesis of cyclen carboxylic acid 13. a) Boc2O, CHCl3; b) Methyl bromoacetate, K2CO3, MeCN; 
c) LiOH, Acetone/water 
 
The pentapeptide was synthesized by standard Fmoc-b sed SPPS protocols using an 
automated peptide synthesizer on Rink amide MBHA resin. Subsequent it was coupled to 
spacers 9 and finally, compound 13 was N-ter ally added to yield the resin bound peptide-
(3-Boc)cyclen conjugate 16 (Scheme 3). TFA treatment cleaved the peptide-(3-Boc)cyclen 
conjugate from the resin and removed cyclen and the arginine side-chain protecting groups. 
Compounds 17a and 17b were purified by HPLC; compound 17c was directly reacted with 
Zinc(II)-chloride. 
 
 
 
 
 
 
 
 
 
a
min
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Scheme 3: SPPS synthesis of peptide-cyclen conjugates. a) Fmoc-AA, TBTU, HOBt, DIPEA (2x); ) b
Piperidine (40%); c) 9a/b/c, TBTU, HOBt, DIPEA (2x); d) Piperidine (40%); e) 13, TBTU, HOBt, DIPEA (2x); 
f) TFA/TIS/water (90 : 5 : 5); g) ZnCl2, water, pH 7-8. 
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ompounds 1a and 1b were characterized by STD-experiments. All compounds show a C
positive STD effect and thus bind to Ras. As an example Figure 3 shows the results obtained 
for compound 1b. Clearly the largest STD enhancement factor ASTD is observed for the cyclen 
moiety and a lower value for the peptide moiety. This suggests that Zn2+-Cyclen is involved 
in a direct interaction, but that the linker is too short in compound 1b to allow for a direct 
interaction of the peptide with Ras. In line with this observation, STD titration experiments 
show that the affinity of these compounds is not increased relative to Zn2+-Cyclen alone.  
 
1.52.53.54.55.56.57.58.5 ppm 
 
Figure 3: STD experiment with the Zn2+-Cyclen hybrid ligand 1b in the presence of Ras. Off-resonance 
spectrum (upper trace) and STD spectrum (lower trace) of a sample containing 50 µM Ras(T35A)·GppNHp in 
40 mM Tris/HCl pH 7.4 and 10 mM MgCl2 and 4.84 mM compound 1b 
 
 
4.2.3 PEG-linked bis(Zn2+-cyclen) Complexes 
Ethylene glycol based spacers with corresponding lengths were azide functionalized on each 
terminus by substitution of a previously synthesized bis-tosylate with Sodium azide following 
a literature procedure.26 (Scheme 4) Tri(ethylene glycol)-ditosylate 21a and Tetra(ethylene 
glycol)-ditosylate 21b were prepared adapting a published synthesis protocol for the 
corresponding mono-tosylates.24 
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Scheme 4: Preparation of tri- and tetra(ethylene glycol)-diazides 22. a) TsCl, KOH, THF; b) NaN3, DMF 
 
Alkyne cyclen 24 was prepared as reactant for a copper catalyzed alkyne – azide 
cycloaddition reaction33-34 with 22. (Scheme 5) Therefore, N-2-Aminoethyl-3-Boc-cyclen 
inoethyl)-1,4,7,10-tetraazacyclododecan-1,4,7-tricarbonylicacid-tri-tert-bu-
tylester-pent-4-ynamide 24.  
 
 
(10-(2-Aminoethyl)-1,4,7,10-tetraazacyclododecan-1,4,7-tricarbonylic-acid-tri-tert-butylester) 
23 was synthesized in three steps from threefold Boc protected Cyclen 11.32 The free amino 
group was alkylated by Bromoacetonitrile and hydrogenated to the corresponding amine 23.35 
Compound 23 was then reacted under peptide coupling conditions with 4-Pentynoic acid to 
give N-10-(2-Am
 
Scheme 5: Synthesis of alkyne 3-Boc-cyclen 24. a) Boc2O, CHCl3; b) Bromoacetonitrile, K2CO3, MeCN; 
c) Raney-Ni, H2, EtOH(NH3 sat.); d) 4-Pentynoic acid, EDC, HOBt, DIPEA 
 
The twofold Cu(I)-catalyzed 1,3-dipolar cycloaddition of 22b and 24 worked best using 
Copper(II)sulfate/Sodium ascorbate in aqueous methanolic solution providing 25 in su icient 
urity and good yield after filtration over flash silica gel. Acidic cleavage of the Boc groups 
e complexes 18c and 19c, respectively. Only the dinuclear complexes based on 
2b were prepared. (Scheme 6) 
ff
p
and complex formation under slightly basic conditions with Zinc(II)-chloride and Copper(II)-
chloride, gav
2
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Scheme 6: Click-reaction yielding six-fold Boc protected metal chelator and synthesis of PEG-linked 
bis(M2+-cyclen) complexes 18c and 19c. a) CuSO4, Sodium ascorbate, MeOH/water; b) HCl-Et2O, DCM; c) 
basic anion exchanger; d) ZnCl2 or CuCl2, water, pH 7-8
 
Addition of the PEG-linked bis(M2+-Cyclen) complexes (M2+ = Zn2+, Cu2+) (compounds 18c 
and 19c) led to a immediate precipitation of Ras(T35A)·GppNHp present in a concentration 
of 50 µM). This effect is clearly due to a direct interaction with the protein, since compound 
26 lacking the metal ions does not induce a precipitation, but also does not bind Ras as 
inferred from the missing STD. 
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4.3  CONCLUSIONS 
We have reported two different types of artificial ligands for state 1, the low affinity state for 
effectors of active Ras based on the known Zn2+-cyclen binding motif. It was the intention to 
strengthen the binding to the protein by additive or even cooperative effects due to the 
introduction of a second binding site for Ras. Hybrid peptide-(Zn2+-Cyclen) ligands were 
synthesized on solid-phase using Fmoc-based standard protocols for SPPS, whereas 
symmetrical PEG-linked bis(Zn2+/Cu2+-Cyclen) ligands were prepared in solution using a 
twofold “click”-reaction as the key step in the reaction sequence. Unfortunately, the peptide-
(Zn2+-Cyclen) ligands did not show a significantly increased binding affinity to Ras compared 
to the parent compound Zn2+-Cyclen. The PEG-linked bis(Zn2+/Cu2+-Cyclen) ligands 
precipitated the protein immediately, thus  preventing any spectroscopic studies. Most 
probably this effect is due to a cross-linking of Ras proteins by the bivalent ligand. Overall, 
rationally designed bivalent ligands for Ras protein binding are synthetically accessible, but 
among the so far investigated examples no increase in binding affinity could be observed.  
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.5  EXPERIMENTAL SECTION 
ker 
Avance 300 (1H: 300.1 MHz, 13C: 75.5 MHz, T = 300 K). The chemical shifts are reported in 
δ [ppm] relative to internal standards (solvent residual peak). The spectra were analyzed by 
first order, the coupling constants are given in Hertz [Hz]. Characterization of the signals: 
s = singlet, d = doublet, t = triplet, q = quartet, m = multiplet, bs = broad singlet, dd = double 
doublet, ddd = double double doublet. Integration is determined as the relative number of 
atoms. Assignment of signals in 13C-spectra was determined with DEPT-technique (pulse 
angle: 135°) and given as (+) for CH3 or CH, (–) for CH2 and (Cquat.) for quaternary Cquat.. 
Error of reported values: chemical shift: 0.01 ppm for 1H-NMR, 0.1 ppm for 13C-NMR and 
0.1 Hz for coupling constants. The solvent used is reported for each spectrum. Molecular 
structures with atom numbers of the synthesized compounds are provided in the Supporting 
Information to facilitate the assignment traceability. 
Mass spectrometry. Varian CH-5 (EI), Finnigan MAT 95 (CI), Finnigan MAT TSQ 7000 
SI).  
MP or a Lambda Photometrics 
 
ical TLC plates (silica gel 60 F254) and 
her solvents and chemicals were of reagent grade and used 
without further purification. 
 
 
4
 
4.5.1 General 
Absorption spectroscopy. Absorption spectra were recorded on a Varian Cary BIO 50 
UV/VIS/NIR Spectrometer by use of 1 cm quartz cuvettes (Hellma) and Uvasol solvents 
(Merck or Baker). 
NMR spectroscopy. Bruker Avance 600 (Cryo) (1H: 600.1 MHz, 13C: 150.1 MHz, 
T = 300 K), Bruker Avance 400 (1H: 400.1 MHz, 13C: 100.6 MHz, T = 300 K), Bru
(E
IR spectrometry. Recorded with a Bio-Rad FTS 2000 MX FT-IR. 
Melting point. Melting points were determined on Büchi S
OptiMelt MPA 100.
TLC analysis and column chromatography. Analyt
silica gel 60 (70-230 or 230-400 mesh) for column chromatography were purchased from 
Merck. Spots were visualized by UV light and/or staining with Ninhydrin in EtOH.  
Dry DMF was purchased from Fluka, Dichloromethane (DCM) was dried by adsorption and 
stored over molecular sieves. Solvents for SPPS were all peptide grade. Petrol ether (PE) had 
a boiling range of 70-90°C. All ot
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4.5.2 Protein Preparation 
The unlabeled C-terminal truncated T35A-mutant of human H-Ras (amino acids 1-166) was 
expressed in Escherichia coli and purified as described before.36  
Uniformly 15N-labeled protein was obtained by growing the bacteria in M9 minimal media 
containing 1 g L–1 15NH4Cl as the sole nitrogen source.37 The final purity of the proteins was 
> 95% as judged from the Sodium dodecyl sulfate-polyacrylamide gel electrophoresis. 
Nucleotide exchange from GDP to GppNHp was done using alkaline phosphatase treatment 
 
Saturation transfer difference (STD) NMR spectroscopy39-40 was used to detect the binding of 
the ligand to Ras. Compared to non-NMR m thods STD is especially well-suited for the 
detection of the weak binding expected. The on-resonance irradiation frequency was set to a 
chemical shift value of –2 ppm with an attenuation of 40 dB in the titration with Zn2+-Cyclen 
and 1a or 30 dB in the titration experiment with 1b. Off-resonance irradiation was performed 
at +30 ppm. The protein was selectively saturated by a train of 40 Gauss-shaped 90° pulses of 
as achieved using a delay of 
atically using a polynomial of 5th degree. 
Processing was performed using topspin 2.0 software (Bruker, Rheinstetten, Germany).  
The STD amplification factor ASTD 40  is defined by 
 
in the presence of low excess GppNHp analogous to John et al.38 Free nucleotides were
removed by size exclusion chromatography.  
 
4.5.3 STD NMR Spectroscopy 
NMR samples originally contained 50 µM c´Ras(T35A)·Mg2+·GppNHp in 40 mM Tris/HCl 
pH 7.4, 10 mM MgCl2, 25% D2O and 0.2 mM DSS as a reference standard. The spectra were 
recorded on a Bruker Avance 600 MHz spectrometer equipped with a 5 mm triple resonance 
cryo probe at 278 K. The ligands were dissolved in the sample buffer and titrated to the 
protein sample. 
e
50 ms length giving a total saturation time of 2 s. On- and off-resonance experiments have 
been performed in an interlaced fashion. Water suppression w
100 µs for binomial water suppression. Prior to acquisition a T1ρ-filter consisting of a spinlock 
pulse with 50 ms length and an attenuation of 15 dB was implemented in order to suppress 
protein proton resonances, which eases data evaluation.41 32k data points have been collected, 
zero-filled to 64k and multiplied by an exponential line broadening function of 0.3 Hz. After 
splitting the data into on- and off-resonance both spectra were processed and phased 
identically. Baseline correction was done autom
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  d
STD
STD KL
LPL
I
IIA 
  )(
0
0     Equation 1 
 
with [L] and [P] the total ligand and protein concentrations, respectively. I0 is the line 
intensity with off-resonance irradiation, I the line intensity with saturation of the protein 
resonances (on-resonance), Kd the dissociation constant and STD the maximum value of ASTD.  
 
4.5.4  Syntheses  
Following compounds were synthesized according to literature known procedures and 
determined to be consistent with analyitical data derived from the corresponding published 
syntheses: Toluene-4-sulfonic acid 2-[2-(2-hydroxy-ethoxy)-ethoxy]-ethyl ester 3a and 
Toluene-4-sulfonic acid 2-{2-[2-(2-hydroxy-ethoxy)-ethoxy]-ethoxy}-ethyl ester 3b,24-25 2-[2-
(2-Azido-ethoxy)-ethoxy]-ethanol 4a and 2-{2-[2-(2-Azido-ethoxy)-ethoxy]-ethoxy}-ethanol 
4b,25-27 {2-[2-(2-Hydroxy-ethoxy)-ethoxy]-ethyl}-carbamic acid tert-butyl ester 6a, (2-{2-[2-
(2-Hydroxy-ethoxy)-ethoxy]-ethoxy}-ethyl)-carbamic acid tert-butyl ester 6b and [2-(2-
Hydroxy-ethoxy)-ethyl]-carbamic acid tert-butyl ester 6c,28-29 {2-[2-(9H-Fluoren-9-yl-
methoxycarbonylamino)-ethoxy]-ethoxy}-acetic acid 9c,30 3-Boc-cyclen 11,32 1-Azido-2-[2-
(2-azido-ethoxy)-ethoxy]-ethane 22a and 1-(2-Azido-ethoxy)-2-[2-(2-azido-ethoxy)-ethoxy]-
ethane 22b,26 10-(2-Aminoethyl)-1,4,7,10-tetraazacyclododecan-1,4,7-tricarbonylic-acid-tri-
tert-butylester 23.35 
 
 
10
9
O
8
7
6
O
4
3 O
2
12
O
O
13
14
15
H 1NH 5 O11  
[2-(2-tert-Butoxycarbonylamino-ethoxy)-ethoxy]-acetic acid (7c) 
-(2-Hydroxy-ethoxy)-ethyl]-carbamic acid tert-butyl ester 6c (4.50 g, 21.9 mmol) was 
 aqueous Sodium hydroxide solution (5%; 3 x 70 mL) and the 
combined aqueous layers were washed with DCM (3 x 100 mL). Conc. HClaq. was added 
slowly to the aqueous layer until pH ~ 4 was reached while stirring. By extraction with DCM 
[2
dissolved in 200 mL of THF/toluene (1 : 1), then Bromoacetic acid (9.06 g, 65.2 mmol) was 
added. After heating the reaction mixture to 45°C, powdered Sodium hydroxide (5.40 g, 
135.0 mmol) was added and the mixture was stirred over night. Afterwards, THF was 
evaporated and water was added to the toluene layer. After separating the aqueous layer, the 
organic layer was extracted with
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moacetic acid could be removed. After further addition of conc. (3 x 50 mL) excess of Bro
HClaq. until pH ~ 2, the product was isolated by again extracting with DCM (5 x 50 mL). The 
combined organic layers were dried over MgSO4, filtrated and the solvent was evaporated 
yielding a slightly yellow oil (2.07 g, 36%). 
1H-NMR (400 MHz, CDCl3, COSY, HSQC): δ [ppm] = 8.61 (s, 1H, 1), 5.03 (s, 1H, 11), 4.16 
(s, 2H, 4), 3.77-3.71 (m, 2H, 6), 3.68-3.61 (m, 2H, 7), 3.55 (t, 3JH,H = 4.9 Hz, 2H, 9), 3.31 (bs, 
2H, 10), 1.43 (s, 9H, 15) ― 13C-NMR (100 MHz, CDCl3, COSY, HSQC): δ [ppm] = 173.2 
(Cquat., 1C, 3), 156.1 (Cquat., 1C, 12), 79.5 (Cquat., 1C, 14), 71.1 (–, 1C, 6), 70.4 (–, 1C, 7), 70.0 
(–, 1C, 9), 68.5 (–, 1C, 4), 40.2 (–, 1C, 10), 28.3 (+, 3C, 15) ― IR (ATR) [cm–1]: ~  = 3343, 
2975, 2933, 2883, 1700, 1529, 1456, 1394, 1367, 1255, 1149, 1117, 858 ― ESI-MS 
(DCM/MeOH + 10 mmol/L NH4Ac): m/z (%) = 264.0 (40) [MH+], 281.1 (100) [MNH4+], 
286.0 (27) [MNa+], 544.3 (14) [2M + NH4+], 549.2 (15) [2M + Na+] ― EA: calc. (%) for 
C11H21NO6 (263.29) + ⅓ H2O: C 49.06, H 8.11, N 5.20; found: C 49.15, H 8.00, N 4.96 
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[2-(2-Amino-ethoxy)-ethoxy]-acetic acid hydrochloride (8c) 
[2-(2-tert-Butoxycarbonylamino-ethoxy)-ethoxy]-acetic acid 7c (3.72 g, 14.1 mmol) was 
diluted with 20 mL of DCM and HCl saturated Et2O (80 mL) was added at 0°C while stirring. 
After stirring over night, the solvents were evaporated yielding the product as yellowish oil 
(2.64 mg, 94%). 
1H-NMR (400 MHz, D2O): δ [ppm] = 4.18 (s, 2H, 4), 3.75-3.65 (m, 6H, 6+7+9), 3.16 (t, 
3JH,H = 4.9 Hz, 2H, 10) ― 13C-NMR (100 MHz, D2O): δ [ppm] = 174.3 (Cquat., 1C, 3), 70.2, 
69.5, 67.6, 66.4 (–, 4C, 4+6+7+9), 39.2 (–, 1C, 10) ― ESI-MS (H2O/MeOH + 10 mmol/L 
NH4Ac): m/z (%) = 164.1 (100) [MH+], 327.2 (17) [2M + H+] 
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{2-[2-(2-tert-Butoxycarbonylamino-ethoxy)-ethoxy]-ethoxy}-acetic acid (7a) 
dded. After heating the reaction mixture to 45°C, powdered Sodium 
3), 156.2 (Cquat., 1C, 12), 79.3 (Cquat., 1C, 
13), 28.3 (+, 3C, 18) ― IR (ATR) [cm–1]:
{2-[2-(2-Hydroxy-ethoxy)-ethoxy]-ethyl}-carbamic acid tert-butyl ester 6a (4.68 g, 
14.8 mmol) was dissolved in 40 mL of THF/Toluene (1 : 1) and Bromoacetic acid (6.16 g, 
44.4 mmol) was a
hydroxide (3.55 g, 88.7 mmol) was added and the mixture was stirred over night. THF was 
evaporated and water was added to the toluene layer. After separating the aqueous layer, the 
organic layer was extracted with aqueous Sodium hydroxide solution (5%; 3 x 40 mL) and the 
combined aqueous layers were washed with DCM (3 x 40 mL). Conc. HClaq. was added 
slowly to the aqueous layer until pH ~ 4 was reached while stirring. By extraction with DCM 
(3 x 50 mL) excess of bromoacetic acid could be removed. After further addition of conc. 
HClaq. until pH ~ 2, the product was isolated by again extracting with DCM (5 x 50 mL). The 
combined organic layers were dried over MgSO4 and filtrated. Evaporation of the solvent 
gave a yellowish oil (3.10 g, 68%). 
1H-NMR (400 MHz, CDCl3, COSY, HSQC): δ [ppm] = 8.68 (s, 1H, 1), 5.12 (s, 1H, 14), 4.15 
(s, 2H, 4), 3.76-3.71 (m, 2H, 6), 3.71-3.63 (m, 4H, 7+9), 3.63-3.58 (m, 2H, 10), 3.52 (t, 
3JH,H = 5.2 Hz, 2H, 12), 3.35-3.19 (m, 2H, 13), 1.42 (s, 9H, 18) ― 13C-NMR (100 MHz, 
CDCl3, COSY, HSQC): δ [ppm] = 172.8 (Cquat., 1C, 
17), 71.2 (–, 1C, 6), 70.4 (–, 1C, 9), 70.2 (–, 2C, 7+12), 70.0 (–, 1C, 10), 68.6 (–, 1C, 4), 40.3 
(–, 1C,  ~  = 3468, 3346, 1722, 1625, 1532, 1478, 
3, 759, 737 ― ESI-MS 
R-MS PI-EI (MeOH/Glycerine): (C13H26NO7) calc. 308.1709 [MH+], 
1449, 1378, 1345, 1263, 1211, 1161, 1080, 1009, 916, 83
(DCM/MeOH + 10 mmol/L NH4Ac): m/z (%) = 308.1 (44) [MH+], 330.1 (22) [MNa+], 352.2 
(100) [MNH4+] ― H
found 308.1717 ― EA: calc. (%) for C13H25NO7 (307.34) + 4/5 H2O: C 48.53, H 8.33, N 
4.35; found: C 48.51, H 8.32, N 4.60 
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2-[2-(2-Amino-ethoxy)-ethoxy]-ethoxy}-acetic acid hydrochloride (8a) 
{2-[2-(2-tert-Butoxycarbonylamino-ethoxy)-ethoxy]-ethoxy}-acetic acid 7a (3.00 g, 
9.8 mmol) was diluted with 10 mL of water, then half concentrated HClaq. (97.6 mmol) was 
added to the solution until CO2 evolution was observed. After stirring for 1 h the reaction was 
complete as no gas bubbles were formed anymore. The solvent was removed by lyophilizing 
the aqueous solution to obtain the product as highly viscous, yellowish oil (2.40 g, quant.). 
 (400 MHz, D2O): δ [ppm] = 4.28 (s, 2H, 4), 3.84-3.75 (m, 10H, 6+7+9+10+12+14), 
MR (100 MHz, D2O): δ [ppm] = 174.3 (Cquat., 1C, 3), 
1H-NMR
3.27 (t, 3JH,H = 5.0 Hz, 2H, 13) ― 13C-N
71.1, 69.7, 69.6, 69.5, 67.6, 66.4 (–, 6C, 4+6+7+9+10+12), 39.2 (–, 1C, 13) ― ES-MS 
(MeCN/TFA): m/z (%) = 207.9 (100) [MH+], 229.9 (17) [MNa+] 
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(2-{2-[2-(9H-Fluoren-9-ylmethoxycarbonylamino)-ethoxy]-ethoxy}-ethoxy)-acetic acid (9a) 
2-[2-(2-Amino-ethoxy)-ethoxy]-ethoxy}-acetic acid hydrochloride 8a (2.45 g, 10.1 mmol) 
was diluted with 5 mL of water and Potassium carbonate (4.17 g, 30.2 mmol) was added. 
After 15 min stirring at room temperature, N-(9H-Fluoren-2-ylmethoxycarbonyloxy)-
succinimide (5.09 g, 15.1 mmol) was added in portions over 30 min and stirring was 
continued for 16 h. The solution was adjusted to pH 9 by adding aqueous Sodium hydroxide 
solution (2 M) and the aqueous layer was washed with DCM (3 x 200 mL). Conc. HClaq. was 
added while stirring to reach pH ~ 2 and the crude product was extracted with DCM 
(5 x 100 mL). After drying of the organic phase over MgSO4, filtration and evaporation of the 
solvent, the product was isolated by flash column chromatography (DCM → DCM : MeOH = 
95 : 5 → DCM : MeOH = 9 : 1; Rf DCM : MeOH = 8 : 2 = 0.23) as a greenish-yellow solid (2.76 g, 
64%). 
1MP:
3
 46°C ― H-NMR (600 MHz Cryo, CDCl3, COSY, HSQC, HMBC): δ [ppm] = 7.72 (d, 
JH,H = 7.5 Hz, 2H, 23), 7.59 (d, 3JH,H = 7.3 Hz, 2H, 20), 7.36 (dd, 3JH,H = 7.4 Hz, 7.5 Hz, 2H, 
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22), 7.28 (dd, 3JH,H = 7.4 Hz, 7.5 Hz, 2H, 21), 5.97 (bs, 1 4), 6-4. 7), 4.19 
(t, 3JH,H = 6.8, 1H, 18), 3.99 (s, 2H, 4), 3.74-3.53 (m, 8H, 6+7+9+10), 3.53-3.47 (m, 2H, 12), 
.39-3.29 (m, 2H, 13) ― 13C-NMR (150 MHz Cryo, CDCl3, COSY, HSQC, HMBC): 
H, 1  4.4 31 (m, 2H, 1
3
δ [ppm] = 174.7 (Cquat., 1C, 3), 156.7 (Cquat., 1C, 15), 144.0 (Cquat., 1C, 19), 141.2 (Cquat., 1C, 
24), 127.6 (+, 2C, 22), 127.0 (+, 2C, 21), 125.1 (+, 2C, 20), 119.9 (+, 2C, 23), 70.1-69.8 (–, 
6C, 4+6+7+9+10+12), 66.5 (–, 1C, 17), 47.2 (+, 1C, 18), 40.6 (–, 1C, 13) ― IR (ATR) [cm–1]: 
~  = 3057, 2880, 1706, 1608, 1531, 1449, 1247, 1089, 1023, 740 ― UV (MeOH) [nm]: λ (ε) 
75 944), 272 (11312), 289 (4040), 300 (4912) ― ESI-MS (DCM/MeOH + = 265 ( 52), 269 (10
10 mmol/L NH4Ac): m/z (%) = 430.2 (100) [MH+], 447.3 (12) [MNH4+], 452.2 (50) [MNa+] 
― HR-MS PI-LSI (MeOH/Glycerine): (C23H28NO7) calc. 430.1866 [MH+], found 430.1865 
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s added and the mixture was stirred over night. THF was 
vaporated and water (10 mL) was added to the toluene layer. After separating the aqueous 
yer, the organic layer was extracted with aqueous Sodium hydroxide solution (5%; 
3 x 15 mL) and the combined aqueous layers were washed with DCM (3 x 30 mL). Conc. 
HClaq. was added slowly to the aqueous layer while stirring until pH ~ 4 was reached, and was 
c. HClaq. until pH ~ 2 was 
 
(2-{2-[2-(2-tert-Butoxycarbonylamino-ethoxy)-ethoxy]-ethoxy}-ethoxy)-acetic acid (7b) 
(2-{2-[2-(2-Hydroxy-ethoxy)-ethoxy]-ethoxy}-ethyl)-carbamic acid tert-butyl ester 6b 
(0.46 g, 1.6 mmol) was dissolved in 5 mL of THF/Toluene (1 : 1), then Bromoacetic acid 
(0.66 g, 4.8 mmol) was added. After heating the reaction mixture to 45°C, powdered sodium 
hydroxide (0.38 mg, 9.5 mmol) wa
e
la
then washed with DCM (3 x 50 mL). After further addition of con
reached, the product was isolated by extraction with DCM (5 x 50 mL). Drying over MgSO4, 
filtration and evaporation of the solvent yielded a slightly yellow oil with high viscosity 
(0.52 g, 93%). 
1H-NMR (600 MHz Cryo, CDCl3, COSY, HSQC, HMBC): δ [ppm] = 4.15 (s, 2H, 4), 3.81-
3.73 (m, 2H, 6), 3.73-3.59 (m, 10H, 7+9+10+12+13), 3.55 (t, 3JH,H = 5.1 Hz, 2H, 11), 3.31 (t, 
3JH,H = 4.8 Hz, 2H, 12), 1.43 (s, 9H, 15) ― 13C-NMR (150 MHz Cryo, CDCl3, COSY, 
HSQC, HMBC): δ [ppm] = 172.5 (Cquat., 1C, 3), 156.1 (Cquat., 1C, 18), 79.2 (Cquat., 1C, 20), 
71.1 (–, 1C, 6), 70.5-69.8 (–, 6C, 7+9+10+12+13+15), 68.7 (–, 1C, 4), 40.2 (–, 1C, 16), 28.3 
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(+, 3C, 21) ― IR (ATR) [cm–1]: ~  = 3346, 2972, 2927, 2870, 1712, 1521, 1454, 1366, 1277, 
1251, 1122, 631, 535, 499, 408 ― ESI-MS (DCM/MeOH + 10 mmol/L NH4Ac): m/z (%) = 
251.9 (57) [MH+ – Boc], 259.9 (20) [MH+ – C4H8], 352.0 (76) [MH+], 369.1 (100) [MNH4+], 
374.0 (12) [MNa+] ― HR-MS PI-EI (MeOH/Glycerine): (C15H29NO8) calc. 352.1966 [MH+], 
found 352.1969 ― EA: calc. (%) for C15H29NO8 (351.40) + 3/5 H2O: C 49.74, H 8.40, N 
3.87; found: C 49.76, H 8.10, N 4.64 
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(2-{2-[2-(2-Amino-ethoxy)-ethoxy]-ethoxy}-ethoxy)-acetic acid hydrochloride (8b) 
(2-{2-[2-(2-tert-Butoxycarbonylamino-ethoxy)-ethoxy]-ethoxy}-ethoxy)-acetic acid 7b 
(3.00 g, 8.5 mmol) was diluted with 10 mL of water, then half concentrated HClaq. (14.2 mL
85.3 mmol) was added until formation of CO2 was observed. After stirring for 1 h the reaction
was complete. The solvent was removed by lyophilization of the aqueous solution to obtain 
the product as highly viscous, yellowish oil (2.50 g, quant.). 
.75 (m, 14H, 6+7+9+10+12+13 
, 
 
1H-NMR (400 MHz, D2O): δ [ppm] = 4.28 (s, 2H, 4), 3.84-3
+15), 3.28 (t, 3JH,H = 5.0 Hz, 2H, 16) ― 13C-NMR (100 MHz, D2O): δ [ppm] =  174.4 (Cquat., 
1C, 3), 70.1, 69.7, 69.6, 69.5, 67.7, 66.4 (–, 8C, 4+6+7+9+10+12+13+15), 39.2 (–, 1C, 16) ― 
ESI-MS (H2O/MeOH + 10 mmol/L NH4Ac): m/z (%) = 252.0 (100) [MH+], 274.0 (9) [MNa+] 
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l-methoxycarbonylamino)-ethoxy]-ethoxy}-ethoxy)-ethoxy]-
(9b) 
ino-ethoxy)-ethoxy]-ethoxy}-ethoxy)-acetic acid hydrochloride 8b (2.25 g, 
mmol) was diluted in 5 mL of water, then Potassium carbonate (3.24 g, 23.5 mmol) was 
ved as gas formation occurred. After 15 min stirring at 
room temperature, N-(9H-Fluoren-2-ylmethoxycarbonyloxy)succinimide (3.96 g, 11.7 mmol) 
 
[2-(2-{2-[2-(9H-Fluoren-9-y
acetic acid 
2-{2-[2-(2-Am
7.8 
added and deprotonation was obser
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was added in portions over 30 min and stirring was continued for 16 h. The solution was 
adjusted to pH 9 by adding aqueous Sodium hydroxide solution (2 M) and the aqueous layer
o reach pH ~ 2 
9.8 (–, 6C, 6+7+9+10+12+13), 69.6 (–, 1C, 4), 66.5 (–, 
 
was washed with DCM (3 x 200 mL). Conc. HClaq. was added while stirring t
and the crude product was extracted with DCM (5 x 100 mL). After drying of the organic 
layer over MgSO4, filtration and evaporation, the product was purified by flash column 
chromatography (DCM → DCM : MeOH = 95 : 5 → DCM : MeOH = 9 : 1; Rf DCM : MeOH : TFA 
= 9 : 0.5 : 0.5 = 0.22) to obtain a greenish-yellow, hygroscopic solid (1.70 g, 46%). 
MP: 51°C ― 1H-NMR (400 MHz, CDCl3, COSY, NOESY, HSQC, HMBC): δ [ppm] = 7.73 
(d, 3JH,H = 7.5 Hz, 2H, 26), 7.60 (d, 3JH,H = 7.3, 2H, 23), 7.37 (dd, 3JH,H = 7.4 Hz, 7.4 Hz, 2H, 
25), 7.29 (ddd, 3JH,H = 7.4 Hz, 7.4 Hz, 4JH,H = 1.1 Hz, 2H, 24), 5.90 (bs, 1H, 17), 4.37 (d, 
3JH,H = 6.9, 2H, 20), 4.20 (t, 3JH,H = 6.8, 1H, 21), 3.98 (s, 2H, 4), 3.68-3.47 (m, 14H, 
6+7+9+10+12+13+15), 3.42-3.29 (m, 2H, 16) ― 13C-NMR (100 MHz, CDCl3, COSY, 
NOESY, HSQC, HMBC): δ [ppm] = 174.6 (Cquat., 1C, 3), 156.7 (Cquat., 1C, 18), 144.0 (Cquat., 
2C, 22), 141.2 (Cquat., 2C, 27), 127.6 (+, 2C, 25), 127.0 (+, 2C, 24), 125.1 (+, 2C, 23), 119.8 
(+, 2C, 26), 70.1 (–, 1C, 15), 70.0-6
1C, 20), 47.2 (+, 1C, 21), 40.7 (–, 1C, 16) ― IR (ATR) [cm–1]: ~  = 3049, 2874, 1710, 1607, 
1538, 1449, 1349, 1246, 1092, 1030, 945, 858, 760, 740 ― UV (MeOH) [nm]: λ (ε) = 269 
(12664), 272 (12784), 288 (4672), 300 (5344) ― ESI-MS (DCM/MeOH + 10 mmol/L 
NH4Ac): m/z (%) = 474.2 (100) [MH+], 491.3 (15) [MNH4+], 496.2 (45) [MNa+] ― HR-MS 
PI-LSI (MeOH/Glycerine): (C25H32NO8) calc. 474.2128 [MH+], found 474.2136 
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0-Methoxycarbonylmethyl-1,4,7,10-tetraaza-cyclododecane-1,4,7-tricarboxylic acid tri-
rt-butyl ester (12) 
-Boc-cyclen 11 (1.00 g, 2.1 mmol) was dissolved in 20 mL of MeCN, then Potassium 
arbonate (0.35 g, 2.6 mmol) and Methyl bromoacetate (0.36 g, 2.4 mmol) were added. The 
mixture was stirred over night at 50°C, then solids were filtered off and the solvent was 
 
1
te
3
c
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evaporated to obtain the crude product, which was purified by column chromatography 
(EtOAc : PE = 1 : 1; Rf EtOAc : PE = 7 : 3 = 0.63) yielding a pale yellow solid (1.16 g, quant.). 
P: 69°C ― 1H-NMR (600 MHz, CDCl3, NOESY, HSQC, HMBC): δ [ppm] = 3.66 (s, 3H, 
5), 1.42 (s, 18H, 19) 
M
1), 3.60-3.11 (m, 14H, 4+7+9+10), 2.99-2.75 (m, 4H, 6), 1.45 (s, 9H, 1
― 13C-NMR (150 MHz, CDCl3, NOESY, HSQC, HMBC): δ [ppm] = 171.1 (Cquat., 1C, 3), 
156.1, 155.7, 155.3 (Cquat., 3C, 12+16+16’), 79.7 (Cquat., 1C, 18), 79.5 (Cquat., 1C, 18’), 79.2 
(Cquat., 1C, 14), 54.9 (–, 1C, 6), 53.6 (–, 1C, 6’), 51.2 (+, 1C, 1), 50.9 (–, 1C, 4), 50.0 (–, 2C, 
9+9’), 47.7 (–, 2C, 7+7’), 47.3 (–, 1C, 10), 47.0 (–, 1C, 10’), 28.7 (+, 3C, 15), 28.4 (+, 6C, 19) 
― IR (ATR) [cm–1]: ~  = 2974, 2933, 2874, 1739, 1692, 1456, 1413, 1364, 1246,1180, 978, 
 
 
859, 772 ― ESI-MS (DCM/MeOH + 10 mmol/L NH4Ac): m/z (%) = 345.2 (10) [MH+ – 
2Boc], 389.2 (10) [MH+ – Boc – C4H8], 445.3 (38) [MH+ – Boc], 489.3 (7) [MH+ – C4H8], 
545.4 (100) [MH+] ― EA: calc. (%) for C26H48N4O8 (544.69): C 57.33, H 8.88, N 10.29; 
found: C 57.04, H 8.83, N 10.05 
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10-Carboxymethyl-1,4,7,10-tetraaza-cyclododecane-1,4,7-tricarboxylic acid tri-tert-butyl 
ester (13) 
10-Methoxycarbonylmethyl-1,4,7,10-tetraaza-cyclododecane-1,4,7-tricarboxylic acid tri-tert-
butyl ester 12 (1.26 g, 2.3 mmol) was dissolved in 30 mL of Acetone/water (3 : 1), Lithium 
hydroxide monohydrate (0.29 g, 6.9 mmol) was added and the mixture was stirred over night 
at 50°C. Afterwards, Acetone was evaporated and the aqueous layer was acidified with 
aqueous KHSO4 (5%). The product was extracted with EtOAc and isolated after drying over 
MgSO4, filtration and evaporation of the solvent as yellowish solid (1.10 g, quant.). 
MP: 138°C ― 1H-NMR (600 MHz, CDCl3, NOESY, HSQC, HMBC): δ [ppm] = 3.61-3.21 
(m, 14H, 4+7+9+10), 2.85 (bs, 4H, 6), 1.45 (s, 9H, 15), 1.43 (s, 18H, 19) ― 13C-NMR 
(150 MHz, CDCl3, NOESY, HSQC, HMBC): δ [ppm] = 173.4 (Cquat., 1C, 3), 156.2 (Cquat., 
2C, 16), 155.5 (Cquat., 1C, 12), 80.1 (Cquat., 2C, 18), 79.7 (Cquat., 1C, 14), 54.3 (–, 2C, 6), 52.4 
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T
 
moc-protected amino-PEG-acid spacer and also the cyclen building block were dissolved in 
MP as 0.4 M solutions. The syntheses were carried out in a 96 well reactor block where 
wells were left empty in between used ones due to the danger of resin being blown across the 
block, thus contaminating other wells. The peptides were synthesized on 50 mg resin. The lot 
f the resin used had a loading of 0.72 mmol/g (manufacturer’s claims). Before each synthesis
 or HPLC or both and purified by preparative HPLC. 
+ 3+
 
(–, 1C, 4), 49.9 (–, 2C, 9), 47.5 (–, 4C, 7+10), 28.6 (+, 3C, 15), 28.4 (+, 6C, 19) ― ESI-MS 
(DCM/MeOH + 10 mM NH4OAc): m/z (%)= 431.3 (52) [MH+ – Boc], 475.3 (10) [MH+ – 
C4H8], 531.4 (100) [MH+] 
 
 
Solid-phase peptide-cyclen conjugate synthesis (17a and 17b) 
he peptides were synthesized on an Advanced Chemtech 496 MOS synthesizer. Rink Amide 
MBHA resin and Fmoc protecting group strategy were used. Coupling was achieved by 
TBTU/HOBt/DIPEA. HOBt was used as a 0.45 M solution, TBTU as a 0.44 M solution and 
DIPEA as a 1.2 M solution, all in DMF. The Fmoc-protected amino acids as well as the
F
N
o  
the resin was allowed to preswell in DMF for 30 min. Each coupling was done twice using a 
5-fold excess of HOBt and slightly less than 5-fold excess of TBTU. DIPEA was used in 10-
fold excess. Fmoc deprotection was done by shaking the resin with 40% Piperidine in DMF 
for 3 min, subsequent washing and addition of 20% Piperidine in DMF followed by shaking 
for 10 min. After completion, the resin was washed with MeOH, DCM and Et2O (5 x 2 mL 
each). Cleavage from the resin was afforded by shaking the resin for 3 h after addition of 
1.5 mL of TFA/TIS/water (90 : 5 : 5). After filtering off the resin, the TFA solution was 
reduced in volume to about 0.5 mL. It was then transferred to a Falcon tube and precipitated 
with cold Et2O. The precipitate was centrifuged at –4°C for 10 min. The solution was then 
carefully decanted off and the precipitate resuspended in cold Et2O before being centrifuged 
again. This resuspending/centrifuging step was repeated five times. Finally, Et2O was 
decanted off again and the peptide dried under vacuum. The peptides were analysed by ESI-
MS and LC-MS
Peptide-cyclen conjugate 17a: ESI-MS: m/z (%) = 305.8 (100) [M + 3H ] , 458.3 (74) [M + 
2H+]2+, 573.6 (4) [M + 2H+ + TFA]2+, 915.7 (1) [MH+] 
Peptide-cyclen conjugate 17b: ESI-MS: m/z (%) = 480.3 (100) [M + 2H+]2+, 1073.9 (9) [MH+ 
+ TFA] 
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s
ybrid-ligand 1a: ESI-MS (MeOH + 10 mmol/L NH4Ac): m/z (%) = 489.4 (100) [M2+], 
19.4 (74) [M2+ + CH3COOH], 546.4 (20) [M2+ + TFA], 977.8 (1.2) [M2+ – H+] 
Hybrid-ligand 1b: ESI-MS (H2O/MeOH + 10 mmol/L NH4Ac): m/z (%) = 511.3 (100) 
[M2+]2+, 541.3 (12) [M2+ + CH3COOH]2+, 568.3 (8) [M2+ + TFA]2+, 1021.5 (0.3) [M2+ –
+], 1035.6 (0.1) [M2+ – H+ + TFA], 1057.6 (0.2) [M2+ + Cl–] 
 of THF and cooled to 0°C in an 
turated NH4Cl-solution and water and were dried over MgSO4 before evaporating the 
lvent. The clean product was obtained by column-chromatography (EtOAc : MeOH = 
95 : 5; Rf EtOAc : MeOH = 9 : 1 ~ 0,6) as a orange-brown, viscous oil (12.9 g, quant.) identical in 
every aspect to that prepared by the literature procedure.42 
 
 
 
 
General procedure hybrid-ligand  1a and 1b  
Hybrid-ligand precursors were dissolved in a small amount of water and pH 8 was adjusted 
by addition of LiOH (1 M) or NaHCO3 (10% w/v). Then, 1 eq of ZnCl2 was added as 1 M 
aqueous solution, which was prepared in advance. After heating the mixtures to reflux for 2 h, 
the products were obtained by lyophilization as colorless, amorphous solids in sufficient 
purities and with quantitative yields. 
H
5
 
H
 
 
2-{2-[2-(2-{[(4-Methylphenyl)sulfonyl]oxy}ethoxy)ethoxy]ethoxy}ethyl-4-methyl-benzene 
sulfonate (tetra(ethylene glycol)-ditosylate) (21b) 
Tetra(ethylene glycol) 20b (5.00 g, 4.40 mL, 25.7 mmol) and 4-Methylbenzene-1-sulfonyl 
chloride (14.7 g, 77.2 mmol) were dissolved in about 100 mL
ice-bath. Then, Potassium hydroxide (10.1 g, 180.2 mmol) dissolved in 25 mL of water was 
added dropwise (~1 h). After additional 2 h of stirring at room temperature the mixture was 
poured into water/Et2O (50 mL/150 mL). The organic layer was separated and the aqueous 
layer was re-extracted three times with Et2O. The combined organic layers were washed with 
sa
so
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N-10-(2-Aminoethyl)-1,4,7,10-tetraazacyclododecan-1,4,7-tricarbonylicacid-tri-
m
+10), 2.43-2.39 (m, 2H, 3), 2.35 (t, 3JH,H = 7.1 Hz, 2H, 4), 1.90 (t, 3JH,H = 2.5 Hz, 1H, 1), 
.38 (s, 9H, 19), 1.36 (s, 18H, 23) ― 13C-NMR (150 MHz, CDCl3, COSY, HSQC, HMBC): 
δ [ppm] = 172.9 (Cquat., 1C, 5), 155.8 (Cquat., 2C, 20), 155.4 (Cquat., 1C, 16), 83.0 (Cquat., 1C, 2), 
79.6 (Cquat., 3C, 18+22), 69.0 (+, 1C, 1), 55.0 (–, 2C, 10), 52.3 (–, 1C, 8), 49.8 (–, 2C, 14), 
48.5 (–, 2C, 13), 47.9 (–, 2C, 11), 36.4 (–, 1C, 7), 35.0 (–, 1C, 4), 28.4 (+, 9C, 19+23), 14.8 
(–, 1C, 3) ― IR (ATR) [cm–1]:
tert-butyl ester-pent-4-ynamide (24) 
4-Pentynoic-acid (0.04 g, 0.4 mmol) was dissolved in a mixture of DCM and DMF in a 
nitrogen flushed round bottom flask, then DIPEA (0.24 g, 250 µL, 1.8 mmol) and HOBt 
onohydrate (0.08 g, 0.5 mmol) were added. When the mixture was cooled to 0°C, EDC 
(0.08 g, 87 µL, 0.5 mmol) and 10-(2-Aminoethyl)-1,4,7,10-tetraazacyclododecan-1,4,7-
tricarbonylic-acid-tri-tert-butylester 23 (0.32 g, 0.6 mmol) – in portions – were added. After 
12 h of stirring at room temperature, the mixture was quenched with water. Then, the organic 
layer was separated and the aqueous layer was extracted with DCM. The combined organic 
layers were washed with Citric acid solution (10%), dried over MgSO4 and the solvent was 
evaporated. The crude product was purified by flash chromatography (EtOAc : MeOH = 
95 : 5, Rf = 0.4) to obtain a colorless solid (0.20 g, 82%). 
MP: 66-68°C ― 1H-NMR (600 MHz, CDCl3, COSY, HSQC, HMBC): δ [ppm] = 6.76 (bs, 
1H, NH), 3.44 (s, 4H, 13), 3.32 (s, 4H, 14), 3.29-3.15 (m, 6H, 7+11), 2.73-2.43 (m, 6H, 
8
1
 ~  = 2975, 2927, 1763, 1543, 1458, 1413, 1364, 1246, 1152, 
1039, 975, 858, 773― ESI-MS (DCM/MeOH + 10 mmol/L NH4Ac): m/z (%) = 596.4 (100)
H+] ― HR-MS PI-EI: (C30H53N5O7) calc. 595.3945 [MH+], found 595.3937 
 
 
[M
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Boc-N-[2-(1,4,7,10-Tetraazacyclododec-1-yl)-ethyl]-3-{1-[2-(2-{2-[2-(4-{2-[2(1,4,7,10-tetraaza-
cyclododec-1-yl)-ethy arbamoyl]-ethyl}-[1,2,3]triazol-1-yl)ethoxy]-ethoxy}-ethoxy)-ethyl]-
1H-[1,2,3]triazol-4-yl}-propionamide (25) 
N-10-(2-Aminoethyl)-1,4,7,10-tetraazacyclododecan-1,4,7-tricarbonylicacid-tri-tert-butyl-
ester-pent-4-ynamide 24 (0.50 g, 0.84 mmol) was dissolved in 20 mL of MeOH. Then, 
Copper(II)sulfate hexahydrate (0
lc
.03 g, 0.13 mmol) and Sodium ascorbic acid (0.05 g, 
.25 mmol) were dissolved in a small amount of water – resulting in a dark brown solution, 
hich turned slowly into beige – and poured into the reaction flask while stirring. When the 
reaction solution’s color turns from beige to light blue within the first minute’s further sodium 
ascorbic acid was added. The mixture was then warmed to 40°C and stirred for 20 min 
followed by the addition of 1-{2-[2-(2-Azidoethoxy)ethoxy]ethoxy}-2-azido-ethane 22b 
(0.10 g, 0.42 mmol). Reaction was complete after stirring at 50°C for 30 min. Subsequently, 
MeOH was evaporated and a brown, viscous residue was left, insoluble in water. After
ddition of water (15 mL) and Chloroform (20 mL), the organic layer was separated and the 
 over MgSO4, filtered and evaporated. The resulting residue was cleaned by a short 
, CDCl3, 
26), 28.3 (+, 12C, 30), 21.3 (–, 2C, 10) ― IR (ATR) [cm–1]:
0
w
 
a
aqueous solution was extracted with Chloroform (3 x 20 mL). The combined organic layers 
were dried
column filtration using flash silica gel (1.5 cm x 4 cm; EtOAc : EtOH = 95 : 5 → 7 : 3) to 
gain a colorless, resin-like solid (0.55 g, 91%). 
MP: 89°C ― 1H-NMR (400 MHz, CDCl3, COSY, HSQC, HMBC): δ [ppm] = 7.45 (s, 2H, 
8), 6.76 (bs, 2H, NH), 4.40 (t, 3JH,H = 5.1 Hz, 4H, 6), 3.77 (t, 3JH,H = 5.1 Hz, 4H, 5),  3.55-3.39 
(m, 16H, 2+3+20), 3.38-3.10 (m, 20H, 14+18+21), 2.93 (t, 3JH,H = 7.4 Hz, 4H, 10), 2.74-2.33 
(m, 16H, 11+15+17), 1.38 (s, 18H, 26), 1.36 (s, 36H, 30) ― 13C-NMR (100 MHz
COSY, HSQC, HMBC): δ [ppm] = 172.9 (Cquat., 2C, 12), 155.8 (Cquat., 4C, 27), 155.3 (Cquat., 
2C, 23), 146.4 (Cquat., 2C, 9), 122.2 (Cquat., 2C, 8), 79.5 (Cquat., 4C, 29), 79.3 (Cquat., 2C, 25), 
70.3 (–, 4C, 2+3), 69.3 (–, 2C, 5), 55.6-53.7 (–, 4C, 17), 51.8 (–, 2C, 15), 49.9 (–, 2C, 6), 49.7 
(–, 4C, 21), 48.2 (–, 4C, 20), 47.8 (–, 4C, 18), 35.8 (–, 2C, 14), 35.3 (–, 2C, 11), 28.5 (+, 6C, 
 ~  = 2972, 2931, 1681, 1543, 
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 (4) [MNa+] ― EA: calc. (%) for C68H122N16O17 (1435.83) + 4 
2O: C 54.16, H 8.69, N 14.86; found: C 54.11, H 8.50, N 14.70 
1459, 1414, 1364, 1247, 1153, 1107, 1050, 976, 858, 773 ― UV (MeCN) [nm]: λ (ε) = 215 
(4821) ― ESI-MS (DCM/MeOH + 10 mmol/L NH4Ac): m/z (%) = 718.7 (100) [M + 2H+]2+, 
1436.2 (13) [MH+], 1458.3
H
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N-[2-(1,4,7,10-Tetraaza-cyclododec-1-yl)-ethyl]-3-{1-[2-(2-{2-[2-(4-{2-[2(1,4,7,10-tetraaza-
cyclododec-1-yl)-ethylcarbamoyl]-ethyl}-[1,2,3]triazol-1-yl)ethoxy]ethoxy}-ethoxy)-ethyl]-H-
[1,2,3]triazol-4-yl}-propionamide octahydrochloride (26 · 8 HCl) 
Boc-protected N-[2-(1,4,7,10-Tetraaza-cyclododec-1-yl)-ethyl]-3-{1-[2-(2-{2-[2-(4-{2-[2(1,4,7,10-
tetraaza-cyclododec-1-yl)-ethylcarbamoyl]-ethyl}-[1,2,3]triazol-1-yl)ethoxy]ethoxy}-ethoxy)-
ethyl]-1H-[1,2,3]triazol-4-yl}-propionamide 25 (0.10 g, 0.07 mmol) was dissolved in a small 
amount of DCM and cooled down to 0°C. While stirring rapidly, HCl saturated Et2O (2.7 mL) 
was dropped into the reaction mixture. After 12 h of stirring at room temperature, the solvent 
was evaporated in vacuo to dryness to obtain the product (0.07 g, 99%) as a greenish-yellow 
solid. 
MP: 85°C ― 1H-NMR (600 MHz, D2O, COSY, HSQC, HMBC): δ [ppm] = 8.10 (s, 2H, 8), 
4.55 (t, 3JH,H = 4.9 Hz, 4H, 6), 3.80 (t, 3JH,H = 4.9 Hz, 4H, 5), 3.46-3.42 (m, 4H, 2), 3.41-3.35 
(m, 4H, 3), 3.18 (t, 3JH,H = 6.5 Hz, 14), 3.13 (t, 3JH,H = 5.0 Hz, 8H, 19), 3.10-3.05 (m, 8H, 18), 
3.10-3.05 (m, 8H, 20), 2.93 (3JH,H = 7.3 Hz, 4H, 10), 2.86 (3JH,H = 4.7 Hz, 8H, 17), 2.64 (t, 
3JH,H = 6.4 Hz, 4H, 15), 2.51 (t, 3JH,H = 6.4 Hz, 4H, 11) ― 13C-NMR (150 MHz, D2O, COSY, 
 2C, 6), 51.9 (–, 2C, 15), 48.2 (–, 4C, 
0) ― ESI-MS (DCM/MeOH + 10 mmol/L NH4Ac): m/z (%) = 279.2 (100) [M + 
H+]3+, 418.7 (96) [M + 2H+]2+, 835.7 (5) [MH+] 
HSQC, HMBC): δ [ppm] = 174.0 (Cquat., 2C, 12), 143.2 (Cquat., 2C, 9), 126.5 (Cquat., 2C, 8), 
69.5 (–, 2C, 2), 69.3 (–, 2C, 3), 67.8 (–, 2C, 5), 52.3 (–,
17), 43.4 (–, 4C, 20), 42.4 (–, 4C, 18), 41.8 (–, 4C, 21), 35.1 (–, 2C, 11), 33.6 (–, 2C, 14), 19.2 
(–, 2C, 1
3
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xchange resin (OH–-form; 1.5 cm x 3 cm) and A column was filled with a strong basic anion e
rinsed first with a mixture of water/MeOH (1 : 1) then followed by pure water. The above 
obtained compound was dissolved in a small amount of water and eluted from the column 
thus yielding the salt-free ligand 26 (0.05 g, quant.). 
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}-[1,2,3]triazol-1-
MP: 109°C ― 1H-NMR (400 MHz, D2O, COSY, HSQC, HMBC): δ [ppm] = 7.88 (s, 2H, 8), 
4.64 (dd, 3JH,H = 4.9 Hz, 5.2 Hz, 4H, 6), 3.99 (dd, 3JH,H = 4.9 Hz, 5.2 Hz, 4H, 5), 3.93-3.85 
(m, 2H, 13), 3.68-3.63 (m, 4H, 2), 3.62-3.56 (m, 4H, 3), 3.18 (dd, 3JH,H = 6.9 Hz, 7.3 Hz, 14), 
3.13-2.78 (m, 40H, 10+15+17+16+20+21), 2.65 (dd, 3JH,H = 7.2 Hz, 7.3 Hz, 4H, 11) ―
13C-NMR (100 MHz, D2O, COSY, HSQC, HMBC): δ [ppm] = 175.0 (Cquat., 2C, 12), 146.4 
(Cquat., 2C, 9), 123.7 (Cquat., 2C, 8), 69.7 (–, 2C, 2), 69.5 (–, 2C, 3), 67.8 (–, 2C, 5), 51.3 (–, 
2C, 15), 50.0 (–, 2C, 6), 49.5 (–, 4C, 17), 44.4 (–, 4C, 21), 43.5 (–, 4C, 20), 42.2 (–, 4C, 18), 
35.2 (–, 2C, 11), 33.6 (–, 2C, 14), 21.0 (–, 2C, 10) ― ESI-MS (H2O/MeOH + 10 mmol/L 
 
Bis-Zinc(II){N-[2-(1,4,7,10-Tetraaza-Cyclododec-1-yl)-ethyl]-3-{1-[2-(2-{2-[2-(4-{2-
[2(1,4,7,10-tetraaza-cyclododec-1-yl)-ethylcarbamoyl]-ethyl
yl)ethoxy]ethoxy}-ethoxy) -ethyl]-1H-[1,2,3]triazol-4-yl}-propionamide} tetrachloride (18c) 
N-[2-(1,4,7,10-Tetraaza-cyclododec-1-yl)-ethyl]-3-{1-[2-(2-{2-[2-(4-{2-[2(1,4,7,10-tetraaza-
cyclododec-1-yl)-ethylcarbamoyl]-ethyl}-[1,2,3]triazol-1-yl) ethoxy]ethoxy}-ethoxy)-ethyl]-
1H-[1,2,3]triazol-4-yl}-propionamide 26 (60.0 mg, 0.07 mmol) and Zinc(II)chloride 
(19.6 mg, 0.14 mmol) were dissolved separately in a small amount of water and then dropped 
simultaneously in 2 mL of warm water while stirring. The pH was adjusted to 7-8 with 
aqueous Lithium hydroxide (1 M). After 7 h of reflux, the mixture was cooled down to ~5°C 
in the fridge. As no precipitation occurred, also when MeOH or EtOH were added, the solvent 
was evaporated and subsequently lyophilized to obtain the product (62 mg, 92%) as a light 
brown solid. 
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NH4Ac): m/z (%) = 480.4 (70) [M + 2H+]2+, 498.4 (17) [M + 3H+ + Cl–]2+, 517.4 (23) [M + 
4H+ + 2Cl–]2+ 
 
Bis-Copper(II){N-[2-(1,4,7,10-Tetraaza-cyclododec-1-yl)-ethyl]-3-{1-[2-(2-{2-[2-(4-{2-
[2(1,4,7,10-tetraaza-cyclododec-1-yl)-ethylcarbamoyl]-ethyl}-[1,2,3]triazol-1-yl)ethoxy] 
thoxy}-ethoxy) -ethyl]-1H-[1,2,3]triazol-4-yl}-propionamide} tetrachloride (19c) 
yl}-[1,2,3]triazol-1-yl) ethoxy]ethoxy}-ethoxy)-ethyl]-
e
N-[2-(1,4,7,10-Tetraaza-cyclododec-1-yl)-ethyl]-3-{1-[2-(2-{2-[2-(4-{2-[2(1,4,7,10-tetraaza-
cyclododec-1-yl)-ethylcarbamoyl]-eth
1H-[1,2,3]triazol-4-yl}-propionamide 26 (68.0 mg, 0.07 mmol) and Copper(II)chloride 
(18.6 mg, 0.14 mmol) were dissolved separately in a small amount of water and then dropped 
simultaneously in 2 mL of warm water while stirring resulting in a deep blue solution. The pH 
was adjusted to 7-8 with aqueous Lithium hydroxide (1 M). After 7 h of reflux, the mixture 
was cooled down to ~5°C in the fridge. The solvent was evaporated and subsequently 
lyophilized to obtain the product (68 mg, 89%) as a dark green solid. 
MP: 126°C ― ESI-MS (H2O/MeOH + 10 mmol/L NH4Ac): m/z (%) = 479.3 (95) [M + 
2H+]2+, 497.3 (35) [M + 3H+ + Cl–]2+, 516.3 (19) [M + 4H+ + 2Cl–]2+ 
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Florian Schmidt, Michael Spoerner, Hans Robert Kalbitzer and Burkhard König, Synth. Commun. 2010, submitted. 
 
All syntheses were performed by F. Schmidt. 1H-NMR spectra for determination of water-solubilty were recorded by M. Spoerner. 
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OF NEW WATER-SOLUBLE CHOLESTEROL 5 SYNTHESIS 
DERIVATIVES 
 
 
Water-soluble cholesterol derivatives for studies investigating the role of Cholesterol in 
ma al ent syntheses for 
new ho e been developed. Either 
substitution at C(3)-OH of Cholesterol with ethylene glycols or reductive amination at the 
keto group of Pregnenolone yielded stero e 
solubility 1
D2O with
resonanc th in water and chloroform solution showed little aggregation for 
com on for 
compoun
 
mm ian cells under physiological conditions are rare. Therefore, effici
 c lesterol derivatives with enhanced water-solubility hav
ids with significantly increased water-solubility. Th
 of the cholesterol derivatives in water was determined by H-NMR spectroscopy in 
 DSS as reference to be 1 to 6 mg/mL at room temperature. The comparison of 
e signal line wid
pound 4 and 5, while broader resonance signals indicate micelle formati
d 9. 
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5.1
Cholesterol is an essential lipid, which plays an important role as structural and functional 
comp ne nd 
permeability of the plasma membrane of mammalian cells. In cells, Cholesterol is the 
mole ula
aci w er, Cholesterol was 
sug te rt 
beneficia
ant
D loodstream is 
accompli ity 
lipoprote e bloodstream 
are ne d 
Coronary heart d  
form
was discussed in connection with the pathogenesis of Alzheimer disease, as it is assumed to 
prom in 
neurons.1
In  thus, in aqueous solution would be 
use  to  
Binding stu wards several proteins will benefit dramatically from 
deriv tiv ter-
soluble cholesterol derivatives have been published or are commercially available so far. 
Seve l 
attachment of polar residues to the C(3)-OH group via ester bond formation.17-20 However, 
beyo d p  
wat so rol 
onto branched Poly(ethyleneimine) of 1800 and 10,000 Da, respectively,21-23 hydrophilicity of 
Chol te e of 
Methyl-β-cyclodextrin. Preparations of the latter kind are commercially available. However, 
the l  c ally 
the se nding 
studies as well as investigations with NMR spectroscopic methods is not possible. More 
 INTRODUCTION 
o nt regulating membrane fluidity over the range of physiological temperatures a
c r precursor for steroid hormones (e.g. Testosterone, Progesterone, etc.) and bile 
ds, hich are both compounds of biological importance. Moreov
ges d to show antioxidative effects1 and to be connected with biosynthesis of hea
l glycosides (cardiotonic steroids),2-7 which were furthermore reported to possess 
icancer activity.8-11 
ue to insolubility in water, transport of Cholesterol via the b
shed by incorporation in lipoproteins. Among those, particularly low-dens
ins (LDL) and high-density lipoproteins (HDL) and their levels in th
ge rally accepted to play an important role in pathogenesis of Atherosclerosis an
isease. In the gallbladder, changes in the composition of bile can lead to
ation of gallstones, which consist mainly of Cholesterol. In the last decades, Cholesterol 
ote the formation of plaques, which finally intercept the synaptical transmission 
2-16  
vestigations under physiological conditions and
ful  further understand the role of Cholesterol and its derivatives in mammalian cells.
dies of Cholesterol to
a es that show enhanced water-solubility. However, only a small number of wa
ra working groups have introduced cholesterols with enhanced polarity due to 
n hysiological conditions this linkage is pH sensitive. While Wang et al. reported
er- luble lipopolymers for gene delivery, which were obtained by grafting Choleste
es rol can also be enhanced by formation of a host - guest complex in presenc
ow ontent (4%) and the stability of this complex are limitations that reduce drastic
pre nce of free Cholesterol as such in aqueous solution. Therefore, its usage for bi
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con ie lene 
glycol phosphorothioate monogalactosides to C(3)-OH of Cholesterol via an ether bond. 
How er ions of their 
beh ou
 
We report the synthesis of two different types of cholesterol derivatives with enhanced water-
lubility. Attachment of hydrophilic ethylene glycol to mediate solubility was performed by 
either ether-bond formation at the cholesteryl-hydroxy group or reductive amination of 
Pregnenolone using the corresponding mono-amino functionalized ethylene glycols. The 
solubility and aggregation behaviour of these cholesterol derivatives in buffered aqueous 
solution was investigated by 1H-NMR. 
 
 
5.2 RESULTS & DISCUSSION 
 
5.2.1 Design of Water-Soluble Cholesterol Derivatives & Synthesis Strategy 
In order to enhance the water-solubility of Cholesterol, derivatives 4, 5 and 9 were 
synthesized using two different approaches: In a first approach, the hydrophobic aliphatic side 
chain was replaced by hydrophilic ethylene glycol to increase the water-solubility. The 
starting material Pregnenolone 1 is a natural product obtained by enzymatic cleavage of the 
aliphatic steroid chain. The keto group was derivatized by reductive amination under mild 
conditions yielding 3β-Hydroxy-20-aza-(8-N-2,5-dioxaoctan)-pregnane 4 or 3β-Hydroxy-20-
aza-(12-N-3,6,9-trioxaundecan-1-ol)-pregnane 5. Similar to reported procedures,25 primary 
aminoethylene glycols 2 or 3 were reacted with 1 in the presence of Sodium 
cyanoborohydride at pH 6 to give the cholesterol derivatives 4 and 5 in moderate to good 
yield. (Scheme 1) The aminoethylene glycols 2 and 3 were synthesized as previously reported 
in literature.26-30 
ven ntly, Roelen et al.24 synthesized water-soluble derivatives by attachment of ethy
ev , these cholesterols were reported to form micelles and hence, investigat
avi r as single molecules are hampered. 
so
HO
H
HH
H
N
O R
n
HO
H
HH
O
O
RH2N
n
2: n = 2, R = Me: 66%
3: n = 4, R = H: 37%
4: n = 2, R = Me
5: n = 4, R = H1  
Scheme 1: Synthesis of pregnenolone-derived cholesterol derivatives with enhanced water-solubility by 
reductive amination. Reagents and conditions: Na(CN)BH3, MeOHabs., THF abs., AcOH (pH 6), reflux, 12 h 
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In a second approach, the ethylene glycol chain was introduced by substitution of the hydroxy 
group of Cholesterol and thus, without changing the steroid scaffold. The log P values for 
such cholesterols were calculated (ACD/Labs, Advanced Chemistry Developments, Toronto, 
Ontario/Canada) to estimate an appropriate length of the ethylene glycol chain; for 
comparison the log P values of compound 4 (4.90 ± 0.52) and 5 (3.95 ± 0.60) were calculated. 
Octaethylene glycol substituted Cholesterol (8.15 ± 0.75) was selected for synthesis, as 
further extension of the glycol chain lengths changed calculated log P values only marginal. 
To synthesize compound 9, freshly recrystallised Cholesterol was tosylated to obtain Cholest-
5-en-3β-ol-p-toluenesulfonate as previously reported.31 Subsequently, Tetra(ethylene) glycol 
and Cholest-5-en-3β-ol-p-toluenesulfonate were reacted according to a published method in a 
Williamson type ether synthesis to give 11-(5-Cholesten-3β-yloxy)-3,6,9-trioxaundecan-1-ol 
(6) in good yield.24 Tetra(ethylene) glycol was first mono-THP-protected and the remaining 
alcohol functionality was transformed into the corresponding mesylate to give 11-(2H-
Tetrahydropyran-2-yloxy)-trioxaundecan-1-ol 7 in moderate overall yield.32-33 Compound 6 
was converted into 11-(5-Cholesten-3β-yloxy)-1-(2H-tetrahydropyran-2-yloxy)-
3,6,9,12,15,18-hepta oxatricosan 8 by ether formation with 7. Finally, acidic cleavage of the 
THP protecting group by adding para-Toluenesulfonic acid gave 11-(5-Cholesten-3β-yloxy)-
3,6,9,12,15,18-heptaoxatricosan-1-ol 9 (OEG-Chol). (Scheme 2)  
 
O
O
4
O
O
H
HH
4
HO
6
Ms
O
H
HH
8
O
8
O
7
O
H
HH
8
HO
9
a
b
51%
59%
 
 
Scheme 2: Synthesis of OEG-cholesterol 9. Reagents and conditions: a) NaH, THFabs., 60°C, 24 h; b) p-TsOH, 
MeOH, rt, 12 h 
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The new cholesterol derivatives 4, 5 and 9 were investigated on their water-solubility and 
aggregation by pound a saturated solution in D2O was 
prepared, which was spiked by a defined amount of DSS (2,2-Dimethyl-2-silapentane-5-
sulfonic acid) as reference. Comparison of the integral of DSS (9H at 0.00 ppm) with that of 
the methyl group Me-1834 (3H at ~0.5-0.8 ppm) of the steroid scaffold allowed to determine 
the concentration of cholesterol derivatives 4 and 5 in the investigated aqueous solution. For 
compound 9, the DSS signal was compared with the integral of its octa-ethylene glycol 
chain.35 Numerical values for water solubility are summarized in Table 1 and were calculated 
by Equation 1. 
 
5.2.2 Determination of Water Solubility of Compounds 4, 5 and 9 by NMR 
1H-NMR. Therefore, from each com
DSS
 theor.Chol.,
exp. Chol.,
exp. DSS,
 theor.DSS,
Chol. cI
I
I
I
c      Equation 1 
 
1H-NMR spectra of saturated solutions in D2O of compounds 5 and 9 resulted in line-
broadening of the resonance signals, which indicates the presence of aggregates. In contrast, 
compound 4 showed a small line width, which is similar to that in corresponding 1H-NMR 
resonance signals of 4 in CDCl3 (see Supporting Information for spectra). Therefore, the 
water solubility of compound 4 was deduced directly from this spectrum, while the solutions
f compounds 5 and 9 were diluted for recording of further 1H-NMR spectra. 
compound 9 only the concentration of the saturated solution likely containing 
ggregates was determined from the octa-ethylene glycol resonance signal. According to the 
aggregation characteristics of a similar cholesterol derivative published by Roelen et al.,24 
compound 9 is assumed to form micelles.  
 
 
o
Upon 1:12.5 dilution of compound 5 with D2O / DSS (0.2 mM), a narrow line width indicated 
the absence of aggregates and thus, the solubility of 5 as single molecules was calculated from 
this spectrum (see Supporting Information for spectrum); further dilution steps did not change 
the line width. Moreover, the 1H-NMR spectra of compound 5 in D2O (1:12.5) and CD3OD, 
respectively, were in good agreement (see Supporting Information) and showed similar line 
width. 
In contrast, aggregation of compound 9 could not be reduced perceptibly by dilution. The 1:5 
dilution did not cause decreasing line widths.36 Line-broadening in D2O was only found for 
the signals assigned to the steroid scaffold, but not for those of the ethylene glycol residue. 
Therefore for 
a
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S Solubility of 4, 5, 9 in D2O37 log Pcalc. Compound DS
 cDSS [mM] int.DSS, exp. int.Chol., exp. cChol. [mM] βChol. [mg/mL]  
4 0.05 0.92 3.00 (a) 2.0 (a) 0.8 (a) 4.90 ± 0.52 
5 0.20 0.63 3.00 (b) 2.8 (b) 1.4 (b) 3.95 ± 0.60 
9 0.20 0.29 32 (c,d) 6.2 (c,d) 6.2 (c,d) 8.15 ± 0.75 
Cholesterol 0.05 9.00 — (e) — (e) 3·10–5 (f) 38 9.62 ± 0.28 
Pregnenolone — (g) — (g) — (g) — (g) — (g) 4.60 ± 0.28 
 
Table 1: Numerical values determined for water-solubility of cholesterol derivatives 4, 5 and 9. 
IDSS, theoret. = 9, IChol., theoret. = 3; (a) spectra of saturated solutions of 4 did not show any aggregation effects, 
therefore, water-solubility 
form aggregates and hence
of 4 was calculated from those integrals; (b) at high concentrations, 5 was found to 
, a saturated solution of 5 was diluted (1:12.5) to obtain spectra from that water-
solubilit
consequ
 p sibilities for spectroscopic investigations of cholesterol binding to proteins at 
physiol
y of single molecules could be determined; (c) aggregates of 9 could not be disrupted by dilution (1:5), 
ently, maximum concentration of aggregates of 9 in aqueous solution was determined from a saturated 
solution; (d) due to strong line-broadening in the steroid range of the obtained spectra for 9, the overall integral 
for the ethylene glycol chain was used for calculation, since this signal group was found to be hardly affected by 
aggregation; (e) no cholesterol derived signals were detected in spectra obtained for saturated solution of 
Cholesterol; (f) literature derived value determined at 30°C; (g) not investigated 
 
 
5.3 CONCLUSIONS 
We presented three new cholesterol derivatives with enhanced solubility in water, which were 
obtained by attaching ethylene glycol chains to the steroid scaffold. These compounds may 
offer new os
ogical conditions. With regard to the length of the attached ethylene glycols, 
replacement of the non-polar aliphatic side-chain of Cholesterol (compounds 4 and 5) was 
more efficient than substitution of the hydroxyl group (compound 9). 1H-NMR studies 
revealed that solubility of 4 and 5 in water is about 1 mg/mL and thus, drastically enhanced 
compared to Cholesterol (3 x 10–5 mg/mL).38 In contrast, the high aggregation tendency of 
compound 9 interfered with solubility calculations. In particular compound 4 is a suitable 
compound to probe cholesterol – protein interactions in aqueous solutions by spectroscopic 
studies, as it has sufficient water solubility and a low tendency to form aggregates.  
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ryo) (1H: 600.1 MHz, 13C: 150.1 MHz, T = 
00 K), Bruker Avance 400 (1H: 400.1 MHz, 13C: 100.6 MHz, T = 300 K), Bruker Avance 
 in 13C-spectra was determined with DEPT-technique 
ulse angle: 135°) and given as (+) for CH3 or CH, (–) for CH2 and (Cquat.) for quaternary 
quat.. Error of reported values: chemical shift: 0.01 ppm for 1H-NMR, 0.1 ppm for 13C-NMR 
solvent used is reported for each spectrum. 
ass spectrometry. Finnigan MAT 95 (LSI), Finnigan MAT TSQ 7000 (ESI).  
a Specac 
ed ithout further purification. 
 
5.4.2 NMR Studies in Aqueous Solution 
Saturated solutions of cholesterols were prepared by dissolving them in excess in 99% D2O 
containing 50 µM (compound 4) or 200 µM (compound 5 and 9), DSS (2,2-Dimethyl-2-
silapentane-5-sulfonic acid) for direct referencing. Subsequently, insoluble particles were 
5.4 EXPERIMENTAL SECTION 
 
5.4.1  General 
NMR spectroscopy. Bruker Avance 600 (C
3
300 (1H: 300.1 MHz, 13C: 75.5 MHz, T = 300 K). The chemical shifts are reported in δ [ppm] 
relative to internal standards (solvent residual peak). The spectra were analyzed by first order, 
the coupling constants are given in Hertz [Hz]. Characterization of the signals: s = singlet, 
d = doublet, t = triplet, q = quartet, m = multiplet, bs = broad singlet, dd = double doublet, 
ddd = double double doublet. Integration is determined as the relative number of atoms. If not 
stated otherwise, assignment of signals
(p
C
and 0.1 Hz for coupling constants. The 
M
IR spectrometry. Recorded with a Bio-Rad FTS 2000 MX FT-IR equipped with 
Golden Gate Mk II ATR 
Optical rotation. Perkin-Elmer PE 241 at 589 nm and room temperature. Cuvette length was 
1 dm and data is presented as [α] 20D  in [mL · g–1 · dm–1] 
Melting point. Melting points were determined on Büchi SMP. 
TLC analysis and column chromatography. Analytical TLC plates (silica gel 60 F254) and 
silica gel 60 (70-230 or 230-400 mesh) for column chromatography were purchased from 
Merck. Spots were visualized by staining with ninhydrine in EtOH or anisaldehyde in 
EtOH/AcOH/H2SO4.  
Methanol (MeOH) was dried by distillation from Mg, tetrahydrofuran (THF) by adsorption. 
Both were stored over molecular sieves. All other solvents and chemicals were of reagent 
grade and us w
pelletized by centrifugation and the so obtained saturated supernatant was transferred in a 
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NMR tube. 1H NMR measurements were performed at 293 K on a Bruker AVANCE-600 
spectrometer equipped with a 5 mm TXI cryo probe operating at a resonance frequency of 
600.13 MHz. 90° pulses were applied with a repetition time of 9 s. Water suppression was 
achieved by applying presaturation or WATERGATE sequence,39 respectively.  
 
5.4.3 Syntheses 
The following compounds were synthesized according to literature known procedures and 
determined to be consistent with analytical data derived from the corresponding published 
syntheses: 8-N-2,5-Dioxaoctan 2,26-30 12-N-3,6,9-Trioxaundecan-1-ol 3,26-30 Cholest-5-en-3β-
ol-p-toluenesulfonate,31 11-(5-Cholesten-3β-yloxy)-3,6,9-trioxaundecan-1-ol 6,24 11-(2H-
Tetrahydropyran-2-yloxy)-trioxaundecan-1-ol 7.32,33 
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3β-Hydroxy-20-aza-(8-N-2,5-dioxaoctan)-pregnane (4) 
In a nitrogen flushed round bottom flask Pregnenolone 1 (50 mg, 0.16 mmol) was dissolved 
in 2.5 mL of MeOHabs. and 8-N-2,5-Dioxaoctan 2 (223 mg, 0.95 mmol) was added. The pH of 
the solution was adjusted to ~6 by adding Glacial acetic acid. Then, Sodium 
cyanoborohydride (11 mg, 0.17 mmol) was dissolved in 1 mL of MeOHabs., mixed with 
2.5 mL of THFabs. and added to the reaction mixture, which was finally stirred over night 
under reflux. After evaporation of the solvent, the obtained residue was resuspended in 
2.5 mL of H2O and the pH was adjusted to ~8. The solution was extracted with CHCl3 (3 x 
10 mL) and the combined organic layers were washed with water and dried over MgSO4. 
After filtration, the solvent was evaporated yielding a yellow, viscous oil. After flash 
chromatography (CHCl3 : EtOH = 6 : 4) the clean product (44 mg, 0.10 mmol, 66%) was
btained as a slightly yellow oil, turning into a colorless solid after several days under 
ure (1.0 x 10  mbar). 
P: 95°C ― 1H-NMR (600 MHz, CDCl3, COSY, HSQC, HMBC): δ [ppm] = 5.38-5.30 (m, 
H, 7), 3.76-3.67 (m, 2H, 21), 3.66-3.59 (m, 2H, 23), 3.56-3.49 (m, 3H, 2+24), 3.37 (s, 3H, 
6), 3.09-3.02 (m, 1H, 20), 2.83-2.73 (m, 2H, 18+20’), 2.29 (dd, 2JH,H = 12.9 Hz, 3JH,H = 
 
o
reduced press –3
M
1
2
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16), 1.67-
) [cm–1]:
3.3 Hz, 1H, 1), 2.22 (m,  1H, 1’), 2.02-1.91 (m, 2H, 8+12), 1.87-1.74 (m, 3H, 3+4+
1.61 (m, 1H, 15), 1.61-1.36 (m, 7H, 3’+8’+9+11+12’+16’+17), 1.35-1.16 (m, 2H, 11’+15’), 
1.12 (d, 3JH,H = 6.1 Hz, 3H, 29), 1.10-1.05 (m, 2H, 4’+14), 1.00 (s, 3H, 27), 0.96 (dt, 2JH,H = 
11.7 Hz, 3JH,H = 4.7 Hz, 1H, 10), 0.74 (s, 3H, 28) ― 13C-NMR (150 MHz, CDCl3, HSQC, 
HMBC): δ [ppm] = 140.1 (Cquat., 1C, 6), 121.4 (+, 1C, 7), 71.7 (–, 1C, 24), 71.6 (+, 1C, 2), 
70.3 (–, 1C, 23), 68.6 (–, 1C, 21), 59.0 (+, 1C, 26), 56.2 (+, 1C, 18), 56.1 (+, 1C, 14), 54.9 (+, 
1C, 17), 49.8 (+, 1C, 10), 45.8 (–, 1C, 20), 42.2 (–, 1C, 1), 42.0 (Cquat., 1C, 13), 39.7 (–, 1C, 
12), 37.2 (–, 1C, 4), 36.4 (Cquat., 1C, 5), 31.7 (+, 1C, 9), 31.7 (–, 1C, 8), 31.6 (–, 1C, 3), 26.4 
(–, 1C, 16), 24.1 (–, 1C, 15), 21.0 (–, 1C, 11), 19.4 (+, 1C, 27), 17.8 (+, 1C, 29), 12.3 (+, 1C, 
28) ― IR (ATR  ~
 PI-LSI (DCM/MeOH/Glycerine): (C
= 3342, 2934, 2884, 1681, 1454, 1379, 1106, 1061, 1024, 951, 
49, 808 ― ESI-MS (DCM/MeOH + 10 mmol/L NH4Ac): m/z (%) = 420.3 (100) [MH+] ― 
HR-MS +
420.3473 ― optical rotation: [α  = –39.4° 
8
26H46NO3) calc. 420.3478 [MH ], found 
] 20D
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3β-Hydroxy-20-aza-(12-N-3,6,9-trioxaundecan-1-ol)-pregnane (5) 
In a nitrogen flushed round bottom flask Pregnenolone 1 (127 mg, 0.40 mmol) was dissolved 
in 2.5 mL of MeOHabs. and 12-N-3,6,9-Trioxaundecan-1-ol 3 (155 mg, 0.80 mmol) was 
added. The pH of the solution was maintained to ~6 by addition of Glacial acetic acid, a 
solvent, the crude product was purified by flash 
mixture of 2.5 mL of THFabs. and Sodium cyanoborohydride (28 mg, 0.44 mmol) dissolved in 
1.5 mL of MeOHabs. was added. The reaction mixture was stirred over night under reflux. 
After addition of further reducing agent (28 mg, 0.44 mmol), reflux continued for additional 
12 h. Then, solvents were evaporated and the remaining residue was resuspended in 2.5 mL 
H2O. In the following, the pH was set to ~8 and the solution was extracted with CHCl3 (3 x 
10 mL). The combined organic layers were washed with water and dried over MgSO4. After 
filtration and subsequent evaporation of the 
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chr y (CHCl3 : EtOH = 2 : 1 → EtO re targe
as an orange-brown oil (70 mg o
1H-NM 3OD, C , HSQC, HMBC): ] = 5.37-5.31 (m, 1H, 7), 3.75-
3.70 (m H, 21), 3 .63 (m , 23+ 27+3 2-3.59 
(m, 2H, 29), 3.43-3.38 (m, 1H, 2), 3.06-3.01 , 1H, 2 .00-2.9 , 1 83 
(m .28- m, 2H, ), 2.03 (m, 1H, 12), 1.98-1.94 (m, 1H, 8), 1.86 (dt, 
 = 13.3 Hz, 3J  = 3.4 Hz, 1H, 4), 1.84-1.76 (m, 2H, 3+16), 1.73-1.65 (m, 1H, 15), 1.65-
, 1C, 17), 51.6 (+, 1C, 10), 46.3 (–, 1C, 20), 43.2 (Cquat., 1C, 13), 43.0 (–, 1C, 1), 40.5 (–, 
.7 (Cquat., 1C, 5), 33.1 (+, 1C, 9), 32.9 (–, 1C, 8), 32.3 (–, 1C, 3), 
omatograph H 100%) to obtain the pu t compound 
, 0.14 mm l, 37%). 
R (600 MHz, CD OSY δ [ppm
, 1 .68-3 , 10H 24+2 +6 0), 3.6 (m, 1H, 21’), 3.57-3.53 
(m 0), 3 2 (m, 1H 8), 2.92-2.
, 1H, 20’), 2 2.16 (  1+1’ -1.98 
2JH,H H,H
1.60 (m, 1H, 11), 1.60-1.40 (m, 5H, 3’+8’+9+11’+17), 1.44-1.37 (m, 1H, 16’), 1.34 (dt, 2JH,H 
= 12.7 Hz, 3JH,H = 4.2 Hz, 1H, 12’), 1.22-1.15 (m, 1H, 15’), 1.15-1.05 (m, 5H, 4’+14+34), 
1.03 (s, 3H, 32), 0.99 (dt, 2JH,H = 12.1 Hz, 3JH,H = 4.8 Hz, 1H, 10), 0.78 (s, 3H, 33) ― 
13C-NMR (150 MHz, CD3OD, HSQC, HMBC): δ [ppm] = 142.2 (Cquat., 1C, 6), 122.3 (+, 1C, 
7), 73.6 (–, 1C, 29), 72.3 (+, 1C, 2), 71.58 (–, 1C, 26), 71.54 (–, 1C, 27), 71.33 (–, 1C, 24), 
1.30 (–, 1C, 23), 68.7 (–, 1C, 21), 62.2 (–, 1C, 30), 57.6 (+, 1C, 14), 56.4 (+, 1C, 18), 55.8 7
(+
1C, 12), 38.6 (–, 1C, 4), 37
26.8 (–, 1C, 16), 25.1 (–, 1C, 15), 22.2 (–, 1C, 11), 19.9 (+, 1C, 32), 17.5 (+, 1C, 34), 12.7 (+, 
1C, 33) ― IR (ATR) [cm–1]: ~ = 3343, 2928, 2867, 2111, 1711, 1606, 1461, 1375, 1101, 
1069, 963, 841 ― ESI-MS (DCM/MeOH + 10 mmol/L NH4Ac): m/z (%) = 494.5 (100) 
[MH+], 496.5 (5) [MNa+], 528.4 (35) [MCl–], 552.5 (100) [MCH3COO–] ― HR-MS PI-LSI 
(MeOH/Glycerine): (C29H52NO5) calc. 494.3845 [MH+], found 494.3846 ― optical rotation: 
[α] 20D  = –41.9° 
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11-(5-Cholesten-3β-yloxy)-1-(2H-tetrahydropyran-2-yloxy)-3,6,9,12,15,18-heptaoxatricosan (8) 
In a nitrogen flushed round bottom flask 11-(5-Cholesten-3β-yloxy)-3,6,9-trioxaundecan-1-
ol 6 (190 mg, 0.34 mmol) and Sodium hydride (0.03 g, 1.13 mmol) in THFabs. (2 mL) were 
stirred for 10-15 min, then 11-(2H-Tetrahydropyran-2-yloxy)-trioxaundecan-1-ol 7 (181 mg, 
0.51 mmol) in 1 mL of THFabs. was added dropwise. Subsequently, the mixture was stirred 
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was carefully destroyed with MeOH, the solvent was 
vaporated and the solid partitioned between EtOAc and H2O (1:1). The aqueous layer was 
bined organic layers were dried over MgSO4, filtered and 
, 15’+17), 
26), 0.85 (d, 
, HMBC): δ [ppm] = 140.9 (Cquat., 1C, 6), 121.5 (+, 1C, 7), 98.9 (+, 
 17), 50.1 (+, 1C, 10), 42.3 (Cquat., 1C, 
C, 4), 36.8 (Cquat., 1C, 5), 36.1 
 IR (ATR) [cm ]:
24 h at 60°C. Excess of Sodium hydride 
e
extracted with EtOAc, the com
evaporated. The clean product (144 mg, 0.17 mmol, 51%) could be isolated after column 
chromatography on flash silica gel (EtOAc → EtOAc : EtOH = 8 : 2, Rf, EtOAc = 0.10) as a 
slightly yellow oil. 
1H-NMR (600 MHz, CDCl3, COSY, HSQC, HMBC): δ [ppm] = 5.34-5.29 (m, 1H, 7), 4.64-
4.58 (t, 3JH,H = 3.6 Hz, 1H, 52), 3.88-3.82 (m, 2H, 50+56), 3.76-3.70 (m, 1H, 49), 3.67-3.58 
(m, 30H, 49’+50’+28(‘)-47(‘)), 3.51-3.46 (m, 1H, 56’), 3.21-3.11 (m, 1H, 2), 2.38-2.31 (ddd, 
2JH,H = 13.2 Hz, 3JH,H = 4.6 Hz, 4JH,H = 2.3 Hz, 1H, 1), 2.22-2.16 (m, 1H, 1’), 2.02-1.99 (m, 
1H, 12), 1.99-1.92 (m, 2H, 8+12’), 1.91-1.86 (m, 1H, 3), 1.85-1.75 (m, 3H, 4+16+54), 1.72-
1.67 (m, 1H, 53), 1.62-1.58 (m, 1H, 53’), 1.58-1.54 (m, 2H, 15+55), 1.54-1.45 (m, 6H, 
8’+20+20’+22+54’+55’), 1.45-1.41 (m, 2H, 3’+9), 1.38-1.34 (m, 1H, 18), 1.34-1.30 (m, 2H, 
11+19), 1.28-1.23 (m, 1H, 16), 1.18-1.10 (m, 3H, 11’+21(’)), 1.10-1.05 (m, 2H
1.05-1.01 (m, 1H, 4’), 1.01-0.95 (m, 5H, 14+19’+24), 0.94-0.87 (m, 4H, 10+
3JH,H = 2.7 Hz, 3H, 23), 0.84 (d, 3JH,H = 2.7 Hz, 3H, 23’), 0.66 (s, 3H, 25) ― 13C-NMR 
(150 MHz, CDCl3, HSQC
1C, 52), 79.4 (+, 1C, 2), 70.8 (–, 1C, 49), 70.6-70.2 (–, 12C, 31-47), 67.2 (–, 1C, 28), 66.9 (–, 
1C, 50), 62.2 (–, 1C, 56), 56.7 (+, 1C, 14), 56.1 (+, 1C,
13), 39.7 (–, 1C, 12), 39.5 (–, 1C, 21), 39.0 (–, 1C, 1), 37.2 (–, 1
(–, 1C, 19), 35.7 (+, 1C, 18), 31.9 (+, 1C, 9), 31.8 (–, 1C, 8), 30.5 (–, 1C, 53), 28.3 (–, 1C, 3), 
28.2 (–, 1C, 16), 28.0 (+, 1C, 22), 25.4 (–, 1C, 55), 24.2 (–, 1C, 15), 23.8 (–, 1C, 11), 22.8 (+, 
1C, 23), 22.5 (+, 1C, 23’), 21.0 (–, 1C, 20), 19.4 (–, 1C, 54), 19.3 (+, 1C, 24), 18.7 (+, 1C, 
26), 11.8 (+, 1C, 25) ― –1  ~ = 2931, 2866, 1462, 1530, 1251, 1109, 1503, 
+988, 872 ― ESI-MS (DCM/MeOH + 10 mmol/L NH4Ac): m/z (%) = 840.7 (100) [MNH4 ]  
― optical rotation: [α] 20D  = –11.7° 
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yloxy)-3,6,9,12,15,18-heptaoxatricosan-1-ol (9) 
eva
roduct (22 mg, 0.03 mmol, 59%) could 
be isolated by column chromatography on flash silica gel (EtOAc : EtOH = 8 : 2, Rf = 0.15)
as an almost colorless oil. 
1H-NMR (600 MHz, CDCl3): δ [ppm] = 5.38-5.30 (m, 1H, 7), 3.73-3.71 (m, 2H, 50), 3.67-
3.59 (m, 30H, 28(‘)-49(‘)), 3.21-3.13 (m, 1H, 2), 2.38-2.34 (ddd, 2JH,H = 13.2 Hz, 3JH,H = 
4.6 Hz, 4JH,H = 2.3 Hz, 1H, 1), 2.23-2.18 (m, 1H, 1’), 2.02-1.76 (m, 6H, 3+4+8+12(’)+16), 
1.59-1.40 (m, 7H, 3’+9+8’+15+20+20’+22), 1.38-1.23 (m, 4H, 11+16+18+19), 1.17-0.82 (m, 
24H, 4’+10+11’+14+15’+17+19’+21(’)+23(’)+24+26), 0.66 (s, 3H, 25) ― 13C-NMR
 (+, 1C, 7), 79.5 (+, 1C, 2), 72.6 (–, 
 
11-(5-Cholesten-3β-
A solution of 11-(5-Cholesten-3β-yloxy)-1-(2H-tetrahydropyran-2-yloxy)-3,6,9,12,15,18-
heptaoxatricosan 8 in MeOH was acidified with p-Toluene sulfonic acid and left stirring over 
night at room temperature. Afterwards, water was added and MeOH was porated, followed 
by extracting the aqueous layer with DCM. After drying the combined organic layers over 
MgSO4, filtration and evaporation of the solvent, the p
 
 
(150 MHz, CDCl3): δ [ppm] = 141.0 (Cquat., 1C, 6), 121.5
1C, 49), 70.8 (–, 1C, 29), 70.6-70.2 (–, 12C, 31-47), 67.3 (–, 1C, 28), 61.6 (–, 1C, 50), 56.8 
(+, 1C, 14), 56.2 (+, 1C, 17), 50.2 (+, 1C, 10), 42.3 (Cquat., 1C, 13), 39.8 (–, 1C, 12), 39.5 (–, 
1C, 21), 39.0 (–, 1C, 1), 37.2 (–, 1C, 4), 36.9 (Cquat., 1C, 5), 36.2 (–, 1C, 19), 35.8 (+, 1C, 18), 
32.0 (+, C, 9), 31.9 (–, 1C, 8), 28.3 (–, 1C, 3), 28.2 (–, 1C, 16), 28.0 (+, 1C, 22), 24.3 (–, 1C, 
15), 23.8 (–, 1C, 11), 22.8 (+, 1C, 23), 22.5 (+, 1C, 23’), 21.1 (–, 1C, 20), 19.4 (–, 1C, 24), 
18.7 (+, 1C, 26), 11.8 (+, 1C, 25) 
5 Synthesis of New Water-Soluble Cholesterol Derivatives 
 
 
 
 
5.5 SUPPORTING INFORMATION 
 
 
 
 
 
 
 
 
 
119 
5 Synthesis of New Water-Soluble Cholesterol Derivatives 
 
 
 
 
 
Figure S1: Final 1H-NMR spectra of solutions of compounds 4, 5 and 9 in D2O / DSS (0.2 mM) for 
determination of water-solubility. Saturated solutions of compound 4, 5 and 9 in D2O were prepared, 
centrifuged and in the following, the sup natants were investigated by 1H-NMR; due to regular line width, the 
amount of dissolved compound 4 in D2O was directly calculated from the integrals of DSS and CH3 (Me-18); 
spectra for compound 5 and 9 show broadened signals indicating formation of aggregates; consequently, 
solutions of 5 and 9 were diluted for further solubility studies; upon 1:12.5 dilution of a saturated solution of 5 in 
D2O, aggregates could be broken up nd water-solubility could be calculated; line width of 9 could not be 
decreased and therefore, only th ma um concentration of aggregated 9 in solution was estimated from the 
spectrum shown above; H2O signals were suppressed by WATERGATE (compounds 4 and 9) or presaturation 
(compound 5) 
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Figure S2: Overlaying 1H-NMR spectra of compounds 4, 5 and 9 in D2O and organic solvent, respectively. 
or compound 4 and 5, signals obtained in D2O (4: saturated solution; 5: 1:12.5 dilution of saturated solution) 
e in good agreement with those in organic solvents (4: 22 mg / 0.7 mL CDCl3; 5: 60 mg / 0.9 mL CD3OD); in 
ntrast, spectra for compound 9 (D2O: 1:5 dilution of saturated solution; org.: 20 mg / 0.8 mL CDCl3) are only 
sistent in the range of signals that were assigned to the ethylene glycol chain, while the steroid scaffold 
signals are flattened; D2O spectra are depicted in black, spectra in organic solvents in red; H2O signals were 
suppressed either by WATERGATE (compound 4 and 9) or presaturation (compound 5) 
F
ar
co
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Figure S3: Stacked plot of the 1H-NMR spectra for dilution of a saturated solution of compound 5 in D O / 
 highe lrea
2
DSS (0.2 mM). By successive dilution of a saturated starting solution of compound 5 with D2O / DSS (0.2 mM) 
line width could be decreased; no further improvement was obtained by dilutions r than 1:12.5, a dy 
indicating the presence of monomers of compound 5 in solution; moreover, at higher concentrations, line-
broadening was almost exclusively found for protons of the steroid scaffold, but not for those assigned to the 
ethylene glycol chain, which is in accordance with results for compound 9; H2O signals were suppressed by 
presaturation 
 
 
 
1Figure S4: Overlaying H-NMR spectra for dilution of a saturated solution of compound 9 in D2O / DSS 
(0.2 mM). By 1:5 dilution (black) of a saturated solution (red) of compound 9 with D2O / DSS (0.2 mM), line 
width was not found to decrease; integrals changed in accordance with the dilution ratio; hence, aggregates were 
not broken up, only their concentration in solution was reduced; H2O signals were suppressed by WATERGATE 
122 
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6 SUMMARY 
 
Chapter 1 of this work deals with pyrene-excimer signalled analyte recognition of small 
biomolecules. Therefore, pyrene labelled Zn2+-cyclen and bis-Zn2+-bis-cyclen complexes 
were synthesized. The reversible coordination at physiological pH of Zn2+-cyclens to 
phosphate anions and to imide moieties, as present in thymine and uracil nucleotides, is well 
known. In the presence of analytes bearing a phosphate and an imide or two phosphate groups 
the formation of a ternary complex consisting of two pyrene-labelled metal complexes and the 
analyte molecule, was observed. The close proximity of the pyrene labels in the complex 
induced pyrene excimer emission, which was observable by the unarmed eye. By this, the 
presence of UMP, UDP, UTP and TTP in buffered aqueous solution was signalled, while 
other nucleotides were not able to induce excimer emission. In the same way, Zn2+-Cyclen-
 
hapter 2 demonstrates the ability of pyrene labelled Zn2+-cyclen, which was already 
introduced in Chapter 1 to be a staining reagent for DNA in agarose gels. The metal chelate 
was found to coordinate reversibly to the DNA phosphate backbone inducing the formation of 
pyrene excimers. The typical pyrene excimer emission was used for the detection of the DNA. 
Staining was limited to agarose gels and less sensitive than Ethidium bromide, but DNA 
amounts down to 10 ng and short DNA strands (~300 bp) were detectable. Moreover, gel 
extraction as a standard technique in molecular biology was successfully performed after 
staining with Zn2+-Cyclen-pyrene. Finally, cytotoxicity tests on HeLa and V-79 cells reveal 
that the zinc-cyclen pyrene probe is significant less toxic compared to Ethidium bromide. 
 
In Chapter 3, fluorescent probes for the detection of protein phosphorylation on SDS-PAGE 
are presented. The probes were designed using bis-Zn2+-bis-cyclen as a dinuclear metal-
chelate phosphate recognition unit equipped with an environment-sensitive fluorophore. The 
specificity of the probes is determined by their binding site selectivity towards phosphate ions 
pyrene acted as luminescent chemosensor for PPi and Fructose-1,6-bisphosphate in aqueous 
buffer. In contrast, Bis-Zn2+-bis-cyclen-pyrene was found to be not as selective as the mono-
nuclear complex since IDP and ITP also lead to formation of ternary complexes; moreover, 
UMP, PPi and Fructose-1,6-bisphosphate did not result in excimer formation. 
C
and the emission wavelength shift induced by the change in the electrostatic environment of 
the fluorophore upon binding to a phosphorylated amino acid residue. The staining is fully 
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alent binding of the probe. Gel bands with less than 100 µg of 
hosphorylated -Casein were detectable with these new probes on a normal UV-table 
wit ut s a cooled camera detector.  
 
In C apt
complexes is described as potential binders of the guanine nucleotide binding protein Ras, an 
imp tan
based on  
for hib
transduct yclen selectively stabilizes conformational state 1 of active Ras, a 
conforma
To achieve higher binding affinities of such Ras-Raf interaction inhibitors, Zn2+-cyclen 
con ate
prepared by solid phase synthesi 2+-cyclen complexes were 
obta ed 
compounds revealed that the peptide conjugates do not lead to an increase in Ras binding 
affin ty o
immediate precipitation of the protein prohibiting spectroscopic investigations of their 
bind g. 
 
Chapter 5 shows the synthesis of three new cholesterol derivatives with enhanced water-
sol ity
Choleste malian cells under physiological conditions are rare so far. Therefore, 
effi t 
develope
aminatio significantly increased 
water-sol mined by 1H-
NM sp
The com ittle 
agg ati
formation
 
reversible due to the non-cov
p
ho pecialized equipment like a laser-based gel scanner or 
h er 4, the preparation of Zn2+-cyclen-peptide hybrid compounds and bis-Zn2+-cyclen 
or t molecular switch in cellular signal transduction. The design of the compounds is 
 the previous observation that Zn2+-cyclen complexes could serve as lead compounds
 in itors of Ras-effector interaction and thus be able to interrupt Ras induced signal 
ion. Zn2+-C
tional state with drastically decreased affinity to effector proteins like Raf-kinase. 
jug s with short peptides, derived from the sequence of the Ras-activator SOS, were  
s protocols. Dinuclear bis-Zn
in from alkyne-azide cycloaddition reactions. NMR investigations of the prepared 
i f the metal complex – peptide conjugates. The dinuclear zinc complexes lead to an 
in   
ubil . Water-soluble cholesterol derivatives for studies investigating the role of 
rol in mam
cien syntheses for new cholesterol derivatives with enhanced water-solubility have been 
d. Either substitution at C(3)-OH of Cholesterol with ethylene glycols or reductive 
n at the keto group of Pregnenolone yielded steroids with 
ubility. The solubility of the cholesterol derivatives in water was deter
R ectroscopy in D2O with DSS as reference to be 1 to 6 mg/mL at room temperature. 
parison of resonance signal line width in water and chloroform solution showed l
reg on for compound 4 and 5, while broader resonance signals indicate micelle 
 for compound 9. 
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7 
 
In Kapitel 1 dieser Arbeit wird die m
mitte  A oordination 
von Zn2+
literaturb lexen in Kombination mit Pyren 
als or
Komplexe, die aus zwei Pyren-tragenden Metall-Komplexen und einem Analytmolekül 
bes en
Verhalten. Die somit erzwungene räumliche Nähe der beiden Pyren-Einheiten führte 
sch lic
von der heidet. Dieser Unterschied war auch mit dem bloßen 
Au rk
UTP und TTP nachgewiesen werden, während andere Nukleotide ohne Imid-Einheit als 
we  B 2+
und ledig 2+-Cyclen-
pyr als
der zwei - und Uracil-
Nu ti
bildete. D r-Emission mit 
den al
 
Ka l 2
Zn2+-Cyclen-pyren auf – es kann als DNA-Färbereagenz eingesetzt werden. Die reversible 
We el
DNA induzierte bei A
Pyre Ex erfahren 
auf
Ethidium n, jedoch konnten bis zu 10 ng DNA nachgewiesen sowie auch kurze 
DN tr
Zn2+-Cyclen-pyren angefärbten DNA-Banden und anschließender erneuter Gelelektrophorese 
gez t, 
Strangbruch) hervorgerufen hatte. A
ZUSAMMENFASSUNG 
olekulare Unterscheidung von kleinen Biomolekülen 
ls nalyt-induzierter Pyren-Excimer-Fluoreszenz gezeigt. Die reversible K
-Cyclenen an Phosphatanionen und Imide unter physiologischen Bedingungen ist 
ekannt. Diese Eigenschaft von Zn2+-Cyclen Komp
 Flu ophor führte im Fall von Thymin- und Uracil-Nukleotiden, zur Bildung ternärer 
teh . Auch andere Analyten mit zwei entsprechenden Bindungsstellen zeigten dieses 
ließ h bei Anregung zur Bildung eines Pyren-Excimers, dessen Emission sich deutlich 
eines Pyren-Monomers untersc
ge e ennbar. Durch dieses Prinzip konnten in gepufferter, wässriger Lösung UMP, UDP, 
itere indungsstelle für den Zn -Cyclen Komplex keine Excimer-Emission induzierten 
lich Pyren-Monomer Fluoreszenz zeigten. In gleicher Weise fungierte Zn
en  Chemosensor für PPi und Fructose-1,6-bis-Phosphat. Im Gegensatz dazu erwies sich 
kernige Bis-Zn2+-bis-cyclen Komplex als weniger selektiv für Thymin
cleo de, da er neben diesen auch in Gegenwart von IDP und ITP ternäre Komplexe 
arüber hinaus wurde bei dieser Verbindung keine induzierte Excime
 An yten UMP, PPi und Fructose-1,6-bis-Phosphat beobachtet. 
pite  zeigt eine weitere interessante Eigenschaft des bereits in Kapitel 1 vorgestellten 
chs wirkung des Pyren-markierten Metall-Komplexes mit dem Phosphatrückgrat der 
nregung im UV-Bereich – ähnlich wie in Kapitel 1 beschrieben – 
n- cimer Emission was zu sichtbaren Gelbanden führte. Zwar ist dieses Färbev
 Agarose-Gele beschränkt und auch die Sensitivität reicht nicht an die von 
bromid hera
A S änge sichtbar gemacht werden. Darüber hinaus wurde durch Gelextraktion der mit 
eig dass dieses Färbeverfahren in DNA offensichtlich keine größeren Schäden (z. B. 
us einer abschließenden Cytotoxizitätsstudie auf HeLa- 
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und -7
wesentlic
 
In Kapitel 3 werden Fluoreszenzsonden vorgestel  Färbereagentien in der Lage sind 
Pro ph  Hierfür wurden 
zw rn
Car oxyf e Fluorophore synthetisiert. Die Spezifität der 
erbindung ist begründet durch die Selektivität der zweikernigen Metall-Komplexer für 
hosphat-Gruppen und die durch die Bindungswechselwirkung dieser Metall-Komplexer mit 
Seitenketten-phosphorylierten Aminsosäuren bewirkte Änderung der elektronischen Struktur 
des Fluorophors. Diese führt schließlich zur Verschiebung der Emissionsbande. Durch nicht-
kovalente Bindungswechselwirkung zwischen Fluoreszenzsonde und Phosphat-Gruppe ist der 
Färbeprozess reversibel. Somit konnten auf einem gängigen UV-Tisch Gelbanden mit 
weniger als 100 µg phosphoryliertes -Casein detektiert werden. 
 
Kapitel 4 behandelt die Synthese von Zn2+-Cyclen-Peptid Hybrid-Liganden und zweikernigen 
Bis-Zn2+-cyclen Komplexen. Diese Verbindungen sollten an das Guanin-Nukleotid bindende 
Protein Ras binden, um dessen Funktion als wichtiger molekularer Schalter zellulärer 
Signaltransduktion zu beeinflussen. Da frühere Ergebnisse zeigten, dass Zn2+-Cyclen in der 
Lage ist gezielt den Effektorprotein schwach bindenden Zustand 1 von Ras zu stabilisieren, 
wurde Zn2+-Cyclen als Lead-Struktur zur Synthese neuer potentieller Inhibitoren der Ras-Raf 
Wechselwirkung herangezogen. Um Inhibitoren mit höheren Bindungsaffinitäten zu erhalten, 
wurden Zn2+-Cyclen-Peptid Konjugate mittels Festphasenpeptidsynthese dargestellt, deren 
Peptid-Sequenz vom Ras-aktivierenden Protein SOS abgeleitet wurden. Darüber hinaus 
wurden auch zweikernige Bis-Zn2+-cyclen Komplexe mittels 1,3-dipolarer Alkin-Azid 
Cycloaddition synthetisiert. NMR-Spektroskopische Untersuchungen zeigten jedoch, dass die 
Zn2+-Cyclen-Peptid Konjugate keine verstärkte Bindungswechselwirkung mit Ras aufweisen. 
Die Bindungseigenschaften der zweikernigen Zink Komplexe konnten hingegen nicht mittels 
NMR-Techniken untersucht werden, da deren Zugabe zur Protein-Lösung eine 
Fällungsreaktion zur Folge hatte. 
 
Kapitel 5 zeigt die Synthese von neuen Cholesterinderivaten mit erhöhter Wasserlöslichkeit. 
Bislang existieren kaum wasserlösliche Cholesterinderivate an Hand derer man die Rolle, die 
Cholesterin in Säugerzellen spielt unter physiologischen Bedingungen genauer untersuchen 
 V 9-Zellen ging hervor, dass Zn2+-Cyclen-pyren verglichen mit Ethidiumbromid 
h weniger toxisch ist. 
lt, die als
tein osphorylierung nach der Durchführung von SDS-PAGE anzuzeigen.
eike ige, an Phosphatgruppen bindende Bis-Zn2+-bis-cyclen Komplexe mit Coumarin und 
luorescein als umgebungsabhängigb
V
P
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d wurden effiziente Synthesen zur Herstellung solcher Cholesterine 
ntwickelt. So wurden Steroide mit gesteigerter Wasserlöslichkeit erhalten indem man 
könnte. Aus diesem Grun
e
entweder die C(3)-OH Gruppe des Cholesterins mit Ethylenglykolen substituierte oder unter 
Verwendung von Ethylenglykolaminen eine reduktive Aminierung an der Keto-Funktion von 
Pregnenolon durchführte. Mittels 1H-NMR Spektren der erhaltenen Verbindungen in D2O mit 
DSS als Referenz konnte schließlich die Wasserlöslichkeit bestimmt werden (1-6 mg/mL bei 
Raumtemperatur). Aus den Spektren erkennbare Unterschiede der Linienbreiten wiesen des 
Weiteren darauf hin, dass Substanzen 4 und 5 nur sehr geringen Tendenz zur Aggregation 
aufweisen. Für Verbindung 9 hingegen wurde eine deutliche Verbreiterung der Resonanz-
linien festgestellt, die auf Mizellenbildung zurückzuführen sein könnte. 
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abs   absolute 
a
TP   Cytidine triphosphate 
d   days 
electron impact 
eq/equiv  equivalents 
ESI   electronic spray ionisation 
8  ABBREVIATIONS 
 
AA   amino acid 
AcOH  Acetic cid 
ADP   Adenosine diphosphate 
AMP  Adenosine monophosphate 
aq   aqueous 
Arg   Arginine 
ATP   Adenosine triphosphate 
Boc   tert-Butyloxycarbonyl 
c   concentration 
calc   calculated 
Cbz   Benzyloxycarbonyl 
CDP   Cytidine diphosphate 
CHCl3  Chloroform 
CMP  Cytidine monophosphate 
COSY  correlated spectroscopy 
C
DCM  Dichloromethane 
decomp  decomposition 
DIPEA  Diisopropylethylamine 
DMAP  4-(Dimethylamino)-pyridine 
DMF  Dimethylformamide 
DMSO  Dimethylsulfoxide 
DNA  Deoxyribonucleic acid 
EA   elemental analysis 
ED   Ethylene diamine 
EDC   1-(3-Dimethylaminopropyl)-3-ethylcarbodiimide 
EI   
8 Abbreviations 
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Et2O   Diethylether 
IDP   Inosine diphosphate 
MeOH  Methanol 
Et   ethyl 
EtOAc  Ethylacetate 
EtOH  Ethanol 
Fmoc  Fluorenylmethyloxycarbonyl 
FRET  fluorescence resonance energy transfer 
GDP   Guanine diphosphate 
GMP  Guanine monophosphate 
GppNHp  GTP analog 
GTP   Guanine triphosphate 
h   hour 
HBTU  2-(1H-Benzotriazole-1-yl)-1,1,3,3-tetramethyl-uronium 
hexafluorophosphate   
HCl   Hydrochloric acid 
HEPES  4-(2-Hydroxyethyl)-piperazine-1-ethane sulfonic acid 
HOBt  1-Hydroxybenzotriazole 
HPLC  high performance liquid chromatographie 
HR   high resolution 
HMBC  heteronuclear multiple bond correlation 
HSQC  heteronuclear single quantum coherence 
I/int.   fluorescence intensity; integral 
Ile   Isoleucine 
IMP   Inosine monophosphate 
IR   infrared spectroscopy 
ITP   Inosine triphosphate 
J   coupling constant 
Log P  partition coefficient between n-octanol and water 
Leu   Leucine 
Lys   Lysine 
M   molecule 
Me   methyl 
MeCN  Acetonitrile 
8 Abbreviations 
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nutes 
MP   Melting point 
Raf   Rat fibrosarcoma (Ras-effector) 
ine monophosphate 
UTP   Uridine triphosphate 
Met   methionine 
min   mi
MS   mass spectrometry 
NEt3   Triethylamine 
NMR  nuclear magnetic resonance 
NOE   nuclear overhauser effect 
NOESY   nuclear overhauser enhancement spectroscopy  
Ph   phenyl 
Pi   Orthophosphate 
PPi   Pyrophosphate 
Rf   retention factor 
ROESY  rotating frame NOE spectroscopy 
rt   room temperature 
Ras   Rat sarcoma (G-protein) 
sat   saturated 
SDS-PAGE  Sodium dodecyl sulphate polyacrylamide gel electrophoresis 
SOS   Son of Sevenless (Ras-activator) 
SPPS  Solid phase peptide synthesis 
TBTU 2-(1H-benzotriazole-1-yl)-1,1,3,3-tetramethyl uranium 
tetrafluoroborate 
THF   Tetrahydrofuran  
THP   Tetrahydropyranyl 
TLC   thin layer chromatography  
Tos   toluenylsulfonyl 
TRIS  Tris(hydroxymethyl)-aminomethane 
TTP   Thymidine triphosphate 
UDP   Uridine diphosphate 
UMP  Urid
UV   ultraviolet, UV-Vis spectroscopy 
Vis   visible 
x   mole fraction
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